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ABSTRACT
The objective of this project is to establish a model system to study the direct effect, the bystander
effect and the combinational effect of alpha-particle irradiations of human prostate tumor cells, toward
the goal of improving the effectiveness of alpha-particle involved radiation therapies such as
radioimmunotherapy and BNCT.
This project consists of an engineering part and a biological part. In the engineering part, an apparatus
for alpha-particle irradiation of cells was designed and constructed. Dosimetry of this irradiator was
conducted. The average dose rate to the cell monolayer in the specially designed Mylar dish was
calculated to be 1.2 Gy/min. In the biological part, three in vitro studies were carried out with the DU-
145 human prostate tumor cells using the established alpha-particle irradiator. Firstly, the direct effects
of the alpha-particle irradiation of DU-145 cells were studied using the clonogenic assay, the comet
assay and the micronucleus assay. A novel co-culture system was then designed to study the bystander
effect transmitted through the cell culture medium. The micronucleus assay was used as endpoint for
the bystander studies. A bystander effect was observed. Mechanism studies suggested that the nitric
oxide was not involved in the process and indicated a short effective lifetime (< min) of the bystander
signal. In the combinational studies, the effects of two anticancer drugs (Taxol and Oxaliplatin)
together with direct alpha-particle irradiation were studied and no synergistic effect was observed for
both drugs. Finally, the combined effect of the bystander effect and drug Taxol was studied, which was
the first time that a combined effect between an anticancer drug and the radiation-induced bystander
effect was studied.
The results of the model studies carried out in the two-dimensional monolayer of cells in this project
can serve as a fundamental frame to be further applied to a three dimensional tumor micrometastasis
model (spheroids) in the future. The understanding of the role the bystander effect plays in tumor cell
killing, its mechanisms and its interaction with other agents, may make it possible to manipulate these
factors to improve the effectiveness of alpha-particle involved therapies.
Thesis Supervisor: Jeffrey A. Coderre, Ph.D.
Associate Professor of Nuclear Science & Engineering, Massachusetts Institute of Technology
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Chapter 1 Introduction
1.1 Background
1.1.1 Prostate cancer
Carcinoma of the prostate is the most common male cancer in Western countries.
Approximately 230,000 new cases were diagnosed, and about 30,000 died of prostate cancer in
2004 in the United States ( 1).
The prostate is a walnut-sized gland located between the bladder and the penis and
in front of the rectum. The primary function of the prostate is the production of seminal
fluid. Prostate cancer occurs when cells within the prostate grow uncontrollably, creating
small tumors. There are different types of prostate tumor. The term "primary tumor" refers
to the original tumor; secondary tumors are caused when the original cancer spreads to
other locations in the body. In the early stage, prostate cancer typically is comprised of
multiple very small, primary tumors within the prostate. At this stage. the disease is often
curable (rates of 90% or better) with a wide range of treatments, such as external beam
radiotherapy (2), surgery (radical prostatectomy), brachytherapy and hormone therapy
(androgen deprivation therapy) (3), that aim to remove or kill all cancerous cells in the
prostate (4). Unfortunately, at the early stage the cancer produces few or no symptoms and
can be difficult to detect. The use of prostate-specific antigen (PSA) testing has allowed
physicians to detect prostate tumors before the primary tumor spreads (5).
PSA is an enzyme produced by cells in the prostate that is found in the seminal
fluid and the bloodstream. Although with a name specific to prostate, PSA is produced by
other tissues as well, such as breast tissue and the periurethral glands. Prostate cancer tends
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to elevate the PSA level in the bloodstream but an elevated PSA level does not necessarily
indicate prostate cancer, since PSA can also be raised by infection or other prostate
conditions. For diagnosis of prostate cancer in asymptomatic men, clinical practice
guidelines recommend the use of both PSA and digital rectal exam, in which a physician
will insert a gloved finger into the rectum to feel the peripheral zone of the prostate where
most prostate cancers occur. Detection of the prostate cancer at an earlier stage is very
important and can significantly increase the cure rate (5, 6).
If the prostate tumor is undetected and untreated, the cells from these tumors can
spread through the lymphatic system and the bloodstream to other parts of the body where
they lodge and form secondary tumors. This process is called metastasis. Once the cancer
spreads beyond the prostate gland (30,000 - 40,000 cases annually in the US), the
treatment options are largely ineffective and the cure rates drop dramatically. Metastatic
prostate cancer responds initially to hormone therapy but the majority of patients develop
hormone-resistant disease that in 80% of cases will develop metastases in bone.
Chemotherapy is largely ineffective due to systemic toxicity (7). Bone-seeking
radiopharmaceuticals are used for palliative relief of pain. The attachment of radioisotopes
to tumor-specific monoclonal antibodies (Radioimmunotherapy) is an experimental
approach being evaluated against both blood-borne tumors (leukemia) and metastatic solid
tumors including prostate (8, 9).
1.1.2 Radioimmunotherapy
Radioimmunotherapy offers the potential for exquisite targeting of radionuclides
to microscopic metastatic sites (9). Monoclonal antibodies recognize the antigenic
determinant (epitope) on the surface of specific cancer cells and bind to it. The antibodies
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can be used in two ways: conjugated or unconjugated. The unconjuaged or "naked"
antibodies can kill cancer cells by enhancing complement fixation or initiating antibody-
dependent cell-mediated cytotoxicity. They may also exert antitumor activity by
modulating signaling pathways activated by the cell surface target to which they bind.
When conjugated. antibodies can be used to deliver a variety of toxic agents to tumor cells.
Antibodies can be conjugated to radioisotopes, cytotoxic agents or immunotoxins.
Antibodies currently being investigated for prostate cancer include those that target tumor-
specific antigens, such as mucin and prostate specific membrane antigen PSMA, cell
surface receptors such as epidermal growth factor receptor EGFR, and immunostimulatory
molecules such as CTLA-4, an antigen expressed on T cells. Radioimmunotherapy or RIT
has been used for the treatment of leukemia and lymphoma. Compared with external
radiation beam therapy, in which a limited area of the body is irradiated, and with
chemotherapy in which the treatment is systemic and the therapy depends on the
differences in drug toxicity between normal tissue and the tumor, systemic targeted
radioimmunotherapy delivers the toxic substance - radiation - to the site of the tumor by
monoclonal antibody. The radioisotope is linked to the monoclonal antibody by a chemical
linkage that includes a specifically designed chemical chelator linkage to hold the
radioisotope (9).
Multiple considerations are involved in selection of the therapeutic radioisotope.
Ready availability and a half-life sufficiently long fbr formulation and delivery are clearly
important. A major consideration is the path length of the decay particle, which can range
from < 1 m for Auger electrons to millimeters for some beta particles. The radioisotopes
that are most commonly used in RIT are the -particle-emitting radioisotopes, such as
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iodine-131 (1-131) (8, 10, I1i), yttrium-90 (Y-90) (11-14) and samarium-153 (Sm-153) (14,
15). 1-131 is a beta decay product from tellurium- 131. It has a half-life of eight days and
decays by emitting a beta particle, forming a stable isotope of xenon-131, (decay energy:
0.971 MeV). It also gives off gamma radiation, which can be imaged with a standard
gamma camera. Y-90 is the decay product of strontium-90. Y-90 has a half-life of 64
hours and decays to zirconium-90 by emitting a beta particle (decay energy: 2.282 MeV).
There is essentially no gamma radiation associated with the decay of Yt-90, making it hard
to image directly. Sm-153 is a beta decay product from promethium-153. Sm-153 has a
half life of 46 hours and decays to europium-153 by emitting a beta particle, (decay
energy: 0.808 MeV). -particles emitted from these radioisotopes have maximum energies
from 0.5 to 2.0 MeV and ranges of 1-10 mm in tissue, which are much larger than the
diameter of a cell. This causes problems because the neighboring normal cells also receive
a radiation dose even when the radioisotope is attached only to the tumor cells. Meanwhile,
compared to high-LET (linear energy transfer) radiation such as alpha particles, protons
and neutrons, the relatively low LET and small RBE (relative biological effect) of 3-rays
make them not very efficient in killing tumor cells. While successful in some applications,
such as thyroid cancer and lymphoma, 3-particle RIT has generally been disappointing,
requiring high activities to compensate for poor overall efficiency in clinical trials (16).
To limit alpha-particle emitters deposit a large amount of energy over a short track
length, and consequently a few alpha particles through the nucleus are sufficient to kill a
cell (17-19). For example, by one dosimetric calculation, 8 alpha particle decays per cell
(average dose 8 Gy) can provide 4 logs of cell killing, while 9,600 beta particles (average
dose 30 Gy) would be required for the same effect (19). In addition, the cytotoxicity of
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alpha particles is not affected by oxygen. Due to the short range, little collateral damage
may be inflicted upon non-targeted cells so less side effects would be caused. Alpha
emitters have the potential to yield a more homogeneous distribution of dose within a
tumor, particularly in micrometastatic sites, compared to the longer-range beta emitters
(20). It has been calculated that 60% of the radiation energy from a uniformly distributed
alpha emitter is absorbed within a 100 tm diameter spheroid, while only 2% of the energy
from a beta emitter is retained within a spheroid this size (19). As a result, alpha-particle
therapy has received renewed interest recently, especially with bismuth-212 and bismuth-
213, which can be eluted from radium-224 and actinium-225 generators, respectively (21).
There are other alpha-particle emitting radioisotopes of therapeutic interests such as
terbium- 149, astatine-2 11 and actinium-225. Their properties are listed in table 1.
Table 1 -1. The alpha-particle emitting radioisotopes of current interest in RIT (21)
Radioisotope Half-life Alpha-particle Branching ratio Range
Energy (MeV) (%) (tm)
Terbium-149 4 h 3.97 17 26
Astatine-211 7.21 h 6.0 41.7 65
7.5 58.3 75
Bismuth-212 I h 8.79 64 87
6.0 36 65
Bismuth-213 45.6 min 8.4 97.8 80
5.9 2.2 58
Actinium-225 10 days 6.0 100 65
6.0 100 65
7.0 100 70
8.4 97.8 85
5.9 2.2 58
In principle, alpha-emitting radionuclides are significantly more selective and
potent in killing targeted cells. They have been proposed for use in single-cell disorders,
such as leukemia, lymphoma and micrometastatic carcinomas (9, 17). Promising results for
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alpha-emitting actinium antibody conjugates were recently reported in mouse xenograft
models (22). However, the short range of the alpha particles (20 - 90 tm in tissue,
depending on the energy), together with the limited penetration of the monoclonal
antibodies or monoclonal antibody fragment into the tumor site, make it difficult to deliver
a lethal dose to cells at depth in the tumor. Radioimmunotherapy has had most success in
bloodborne tumors where access of the antibody to the tumor cells is unimpeded (13). In
solid tumors, however, radioimmunotherapy has had only limited success due largely to
the problems associated with non-uniform binding of the radioimmunoconjugate to the
tumor and/or poor penetration of the antibody into tumor sites (23, 24).
1.1.3 The bystander effect
Until a decade ago, it had been generally accepted that the important biological
effects of ionizing radiation in mammalian cells were direct consequences of un-repaired
or mis-repaired DNA damage in the irradiated cells. It was presumed that no effect would
be expected in cells that receive no direct radiation. However, recent experimental
evidence, mainly from in vitro alpha-particle studies, indicated that ionizing radiation
could also cause biological effects, including DNA damage, by mechanisms that are
independent of nuclear traversal: cells in the vicinity of directly irradiated cells or
recipients of medium from an irradiated culture can also show damage response (25-29).
The radiation-induced bystander effect has been broadly defined as referring to the
occurrence of biological effects in un-irradiated cells as a result of exposure of other cells
to ionizing irradiation. The "bystander effect" was first described by Nagasawa and Little
using low doses of alpha particles and sister chromatid exchange as endpoint (25). The
fraction of Chinese Hamster ovary cells traversed by an alpha particle was calculated to be
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less than 1%, but over 30% of cells showed chromosome damage (sister chromatid
exchange). These results indicated that the target for genetic damage by alpha particles is
much larger than the nucleus or even the cell itself. Since then, the literature on the
bystander effect has expanded enormously. Other endpoints for bystander responses
include gene mutations, micronucleus formation, apoptosis, changes in gene expression,
oncogenic transformation and cell survival (28, 30-35).
The bystander effect is actually a class of effects that differs with cell type,
endpoint and in actual mechanism (33. 34). Radiation induced bystander effects are under
intense investigation in the radiation protection area, where the effects predominate at low
doses and have been discussed mainly in terms of the impact on low-dose risk assessment.
As a result, most of the bystander effect studies have been done with normal cell lines. The
relevance of the bystander effect in vivo remains unclear. There have been very few studies
of the bystander effect in three dimensional cell systems. Mothersill irradiated human
urothelium explants and showed that the overlying medium could cause effects in
unirradiated urothelium explants or cells in culture (36). Howell has used pelleted mixtures
of V79 hamster fibroblasts, some with 125I incorporated into the DNA, to show cell killing
in a greater fraction of cells than was labeled; interpreted as evidence of a bystander effect
in the cell pellet (37, 38). All of the above studies used normal cells or tissues. Carcinoma
cells have been shown to undergo a bystander effect in vitro, where cells not directly
irradiated, nevertheless die (39), and in vivo, where the specific irradiation of human tumor
cells leads to a bystander effect in subcutaneously growing tumors (40).
These recent reports of bystander effects in tumor cells, together with the need to
improve the uniformity of cell kill during targeted alpha-particle therapies of solid tumors
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or micrometastatic disease prompted the studies described in this paper. In this project, we
focus on the possible therapeutic implications of the bystander effect in RIT to see whether
the bystander effect can be manipulated or exploited to increase the level of tumor cell kill
in those cells not directly targeted with the alpha particles. (A more detailed background of
the bystander effect will be given at the beginning of Chapter 4)
1.1.4 Combined modality therapy and synergy effect
There is a long history of attempts to combine radiation and chemotherapy with
the hope of producing specific interactions that can enhance cytotoxicity in the tumor, but
not in critical normal tissues. In 1979, Steel proposed a nomenclature for mechanisms by
which radiation and chemotherapy might be combined (41). Synergistic effects between
chemotherapy drugs and low LET irradiation (X-ray and gamma irradiation) have been
reported in various cancer types, both in vitro and in vivo (42-48). Paclitaxel (Taxol), a
microtubule stabilizer, has demonstrated efficacy in the treatment of various types of
cancers (49-52). Taxol is also a potential radiation sensitizer. It has shown synergistic
enhancement with both external beam radiation therapy (53) and Y-90 conjugated
radioimmunotherapy in breast cancer (54, 55), ovarian cancer (56), prostate cancer (57)
and lung cancer (43). Another chemotherapy drug Oxaliplatin, which forms reactive
platinum complexes and interferes in the work of DNA repair enzymes, was also reported
to demonstrate irradiation sensitizing activity, both in vitro and in vivo (46, 58).
Hydroxymethylacyflulvene (HMAF), a novel agent with alkylating activity and a potent
inducer of apoptosis, was shown to work with gamma irradiation additively or
synergistically in inducing apoptosis in several prostate tumor cell lines, but not in normal
cells (59). Most of the synergy studies have been investigated with low-LET irradiations.
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Our studies, however, look into the combinational effects of chemotherapeutic drugs and
high-LET alpha-particle irradiation. (A more detailed background of combined modality
therapy will be given at the beginning of Chapter 5.)
1.2 Objective
This project will contribute to the overall goal of improving the effectiveness of
radiation therapy for metastatic prostate carcinoma. The role that the bystander effect plays
in damaging the non-irradiated tumor cells and the mechanisms of the bystander effect
were investigated when the prostate tumor cells were irradiated with alpha particles. A
combined modality study using alpha particles and chemotherapeutic drugs that have been
reported to act synergistically when combined with gamma or beta irradiation, was carried
out. Finally, as a brand new topic, the interactions between the chemotherapeutic drugs and
the bystander effect were investigated. Potential synergistic effects between the drugs and
alpha-particle-based radioimmunotherapy for prostate tumor cells could improve the
clinical management of this disease at an early stage.
1.3 Study Design
Part 1: An alpha particle irradiator was designed, constructed and calibrated. Alpha
particle fluxes were measured using a track-etch detector and the alpha-particle energy
spectra were measured with a solid-state semiconductor detector. The dose rates to
monolayer cells were calculated for different experimental conditions. The irradiator has
been used for several alpha-particle irradiation studies and has proven to be consistent and
convenient. (Chapter 2)
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Part 2: The biologic effects of alpha-particle irradiation on the human prostate tumor cell
line DU-145 were examined with three endpoints: the clonogenic assay (at population-
level), the comet assay (at single-cell level) and micronucleus formation. (Chapter 3)
Part 3: Two experimental models were used to study the bystander effect (Chapter 4):
· Grids model: Three plastic mesh grids were designed and fabricated that can be
interposed between the alpha-particle source and the Mylar bottoms of the cell
dishes to block part of the monolayer of cells from the alpha-particle irradiation. As
a result, two subpopulations of cells were formed - cells that were directly subject
to alpha particle irradiation (hit cells) and the non-hit, neighboring cells. The
clonogenic assay was used to measure if there is a bystander effect in those non-hit,
neighboring cells.
* Co-culture model: A novel co-culture system was designed that enabled two layers
of cells growing in the same medium. The cells growing on the bottom Mylar
membrane were directly exposed to alpha particles. The cells co-cultivated on the
inserts, positioned -4 mm above the bottom cell layer and out of the range of the
alpha particles, served as the non-targeted bystander cells. DNA damage, as
measured by micronucleus (MN) formation in the non-targeted prostate tumor cells
was used as a measure of the bystander effect.
Chapter 5: The effects of two chemotherapeutic drugs, Taxol and Oxaliplatin on the DU-
145 cells were studied first. The combined effects of each drug with high-LET alpha-
particle irradiation as well as the interactions between the drugs and the bystander effect in
vitro were examined, with the hope of an enhanced toxicity or synergistic effect. A
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synergetic effect in vitro indicates a possibility of beneficial combined drug-irradiation
therapy in vivo.
Once established, this model system can be used to test for the synergistic effects in
combined modality studies using other drugs and other cell lines.
The results of the model studies carried out in the two-dimensional monolayer of
cells in this project can serve as a fundamental frame work to be further applied to a three
dimensional tumor micrometastasis model - spheroids - in the future. The understanding
of the role the bystander effect plays in tumor cell killing and its mechanisms may make it
possible to manipulate these factors to improve the effectiveness of radioimmunotherapy.
The ability of the treatment to increase the cell kill at depths beyond the range of the alpha
particles will provide the ultimate test of this combined modality therapy.
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Chapter 2 Bench-top Alpha-Particle Irradiator
2.1 Introduction
Alpha particles are a type of ionizing radiation. Ernest Rutherford discovered alpha
particles in 1899 while working with uranium. They are large subatomic fragments
consisting of 2 protons and 2 neutrons. An alpha particle is identical to a helium nucleus. It
is a relatively heavy, high-energy particle, with a positive charge of two. Alpha-emitting
atoms are usually large atoms with atomic numbers of 82 or more. There are many alpha-
emitting radioactive elements, both natural and manmade, for examples: americium-241
(Am-241). plutonium-236 (Pu-236), uranium-238 (U-238). radium-226 (Ra-226), radon-
222 (Rn-222) and polonium-210 (Po-210). Compared to X-rays or y-rays, which are
electromagnetic radiations, alpha particles belong to a category called particulate
radiations.
The positive charge of alpha particles is useful in some industrial processes. For
example, polonium-210 serves as a static eliminator in paper mills and other industries.
The alpha particles, due to their positive charge, attract loose electrons, thus reducing static
charge. Some smoke detectors take advantage of alpha emissions from americium-241 to
help create an electrical current. The alpha particles strike air molecules (oxygen and
nitrogen) within a chamber, knocking electrons off. The resulting positively charged ions
and negatively charged electrons create a steady current as they are collected by the
positively and negatively charged plates in the chamber. When smoke particles enter the
chamber, they attach to the ions and neutralize them. This causes the electric current to fall,
which sets off an alarm.
37
When radiation is absorbed in biological material, the energy is deposited along the
tracks of charged particles in a pattern that is characteristic of the type of radiation
involved. After exposure to x or gamma rays, the ionization density would be quite low.
After exposure to neutrons, protons, or alpha particles, the ionization along the tracks
would occur much more frequently, producing a much denser pattern of ionizations. Linear
energy transfer (LET) is used to quantify the energy transferred per unit length of the track.
The special unit usually used for this quantity is kiloelectron volt per micrometer (keV/gm.
According to this definition, alpha particles are considered high LET radiations, and X-
rays are considered low LET radiations (1).
The interests of researchers in alpha-particle irradiation mainly come from the
concern of radiation exposure to the general population from natural sources, which are
dominated by the alpha-emitting radionuclides radon-222 (Rn-222) and its progeny. Radon
is a gas produced by the radioactive decay of radium-226, which is a decay product of
uranium-238. The major source of radon is the soil; ground water, natural gas and building
material also contribute to some radon dose. Radon has three decay products: polonium,
bismuth and lead. The great majority of the radiation dose is not from radon itself, but
from the short-lived alpha-emitting radon daughters, most notably Po-218 (physical half-
life T1/2=3 minutes), and Po-214 (T1/2=0.164 milliseconds), along with beta particles from
Bi-214 (T'12=19.7 minutes). The external dose from Rn-222 and its airborne progeny is a
very small fraction of the natural external radiation dose received by individuals. However,
inhalation of radon and its daughters may be followed by deposition of potentially large
amounts of energy, i.e. absorbed dose in the tracheobronchial epithelium from the short-
lived a-particle emitting decay products, primarily from Po-218, Pb-214, Bi-214, and Po-
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214. According to the National Council on Radiation Protection and Measurements (NCRP
1987), the average annual effective dose equivalent for United States citizens from inhaled
radon and its progeny is about 2 mSv. which accounts for two thirds of the estimated total
of 3 mSv individual dose equivalent per year. The major health risk from exposure to
radon progeny is bronchogenic carcinoma and lung cancer.
For research purposes. it is possible to produce mono-energetic alpha particles from
a linear accelerator or cyclotron. Accelerator-based microbeams (2), which can provide
single-particle and single-cell irradiation, have very elegant applications in some fields like
bystander effect studies. But the prohibitively high cost and the difficulties in running and
maintaining the complicated machine force many investigators to turn to natural
radionuclide scources. As a result, many in vitro radiobiological studies were carried out by
utilizing an alpha-particle exposure apparatus made from wide-field radioactive sources
like Po-210, Pu-238, Pu-239 or Am-241, or adding shorter-lived isotopes Ra-222 (3) and
Bi-212 (3-6) directly to cell culture medium. The alpha particles generated from these
radionuclides have energies of 5 to 9 MeV and total ranges between 35 to 90 Vlm in tissue-
equivalent material. They lose energy along densely ionizing tracks, starting with an initial
linear energy transfer (LET') from 60 to 90 keV /m and reaching a maximum LET of
about 250 keV/ptm near the end of the track (7). Examples of such convenient alpha-
particle irradiators include the bench-top alpha-particle irradiator in J. Little's laboratory at
the Harvard School of Public Health (7) and the multi-port alpha-particle irradiator in R.
W. Howell's laboratory at the New Jersey Medical School (8).
Our study was to investigate the effect of alpha-particle irradiation on human
prostate tumor cells in vitro, with the purpose to explore the possibility of increasing tumor
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cell killing through the bystander effect or synergistic effect. In order to implement this
investigation, it was necessary to construct an alpha-particle irradiator with well-defined
exposure conditions for irradiation of cell monolayers.
Two alpha-particle irradiators were designed, constructed and calibrated. The first
one was very simple but had no mechanism to control the exposure time accurately for
short exposures. The second design includes an electronic shutter and was proven to meet
the requirements and was used in all experiments in this study, as well as several other
research projects. Simulations were used to understand the influences of different thickness
of air gap and Mylar/polypropylene film on the energy and LET spectra of the alpha
particles at the position of the monolayer of cells. The energy spectra were measured using
a passivated implanted planar silicon (PIPS) detector. The energy spectra were then
translated into the LET spectra through published energy-LET tables for alpha particles.
Two methods were used to measure the alpha-particle flux at the cell position: the PIPS
detector and the CR-39 "track-etch" detector. The measuring results from the two different
detectors were compared. The average dose rate to the monolayer of cells was calculated
from the average alpha-particle flux and the average LET.
2.2 Materials and Methods
2.2.1 The alpha isotope foils
Five sealed Am-241 alpha foils were purchased from NRD LLC, Grand Island,
NY. Am-241 has a half life of 433 years. It decays to Np-237 by releasing an alpha particle
and a low energy gamma ray: 41Am= 7Np+4 He(a) + y
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From the 8 h edition of the Table of Isotopes the alpha-particle energies from the
decay of Am-241 are (with branching ratio): 5.486 MeV (85.2%), 5.443 MeV (12.8%),
5.388 MeV (1.4%), 5.544 MeV (0.34%), and 5.512 MeV (0.2%). The weighted average
energy is 5.476 MeV. The energy of the gamma ray with the highest branching ratio (36%)
is 59.537 keV.
The Am-241 foils were produced by mining AmO, and gold powders into a 0.5-
Lm-thick active layer. The active layer was sandwiched between gold foil layers, mounted
on a silver plate and electro-coated with an additional layer of gold (figure 2-1)
--r
r_C>
E
xPOL
I
A: Gold plate 0.00005 cm
B: Gold, 0.0001 cm
C: Am-241 and gold. 0.00005 cm
D: Gold, 0.00076 cm
E: Silver, 0.018 cm
Fiure 2-1. The layer structure of the Am-241
Table 2-1. Dimensions and activities for the five Am-241 alpha foils
Different applications need different activities. The activities of the five foils
obstained from the manufacturer vary by factors of 10. The dimensions and activities of
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A
B
C
D
E
alpha foils
Am-241 Active area Nominal activity Total activity
alpha foil # (cm2) (tCi/cm 2) (mCi)
# 5 7.6x7.6 100 5.8
9#4 7.6x7.6 10 0.58
#3 _ 7.6x17.8 1 0.135
#2 7.6x17.8 0.1 0.013
# I 7.6x 17.8 0.01 0.0013
the foils are listed in Table 2-1. The total activity equals the product of the nominal activity
and the active area.
2.2.2 The alpha-particle irradiator
In 1995, Noelle F. Metting, Hatsumi Nagasawa and John B. Little at the Harvard
School of Public Health published a paper describing the design, construction and
calibration of a collimated Pu-238 alpha-particle irradiator. In their construction, a
plexiglas beam delimiter and a stainless steel honeycomb collimator were used to constrain
the direction of the beam. The source and collimator were located in a helium-filled
plexiglass box, with a 1.5plm-thick Mylar exit window to separate the inside helium gas
from the outside air. A Copal shutter was located above the Mylar exit window and used to
control the radiation time. Alpha particles traveled through 42 mm of helium gas, 1.5 pm
Mylar (the exit window), 6 mm of air, and the 1.5 plm thick Mylar bottom of a custom-
built cell culture dish to reach the monolayer of cells (7).
Based on the above design, Prasad Neti and Roger Howell at the New Jersey
Medical School built an advanced multi-port alpha-particle irradiator (figure 2-2). Four
individual planar Am-241 alpha-particle sources (NRD Inc., Buffalo, NY) are housed
inside a helium-filled Plexiglas box (53.34 x 40.64 x 20.32 cm). Three of the radioactive
sources consist of 0.540 mCi (60 mCi/in 2) each of 2 41Am oxide foil. The fourth source,
used to produce higher dose-rates, consists of 13.5 mCi (1500 mCi/in 2). Americium-241
emits alpha particles with almost the same energy as 238 Pu, the source used in the original
Metting design. The foil is comprised of a silver overcoat and undercoat, silver plus 24lAm
oxide active layer, and 0.01524 cm thick silver backing that is welded and rolled. The foil
was fabricated with the active layer centered between 2 inactive margins. The result is a
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planar 7.62 x 7.62 cm source that emits 4.7 MeV alpha particles (0.7 MeV FWHM). The
four sources are mounted parallel to their respective 1.5-pm-thick Mylar exit windows on
turntables rotated at 88 rpm. The turntables are included to ensure uniform irradiation of
the Mylar-bottomed cell culture dishes. A stainless-steel honeycomb collimator is placed
between the four sources and their exit windows by a cantilever attachment to the platform
of an orbital shaker (Roto Mix, Thermolyne) that moves its table in an orbit of 1.9 cm.
During the irradiation the collimator is moved at 150 orbits per minute. Each exit window
is equipped with a beam delimiter to optimize the uniformity of the beam and a high
precision electronic Copal specialty shutter (model DC-392). Opening and closing of the
shutters is controlled with a high precision timer (Logotron LGT 12C DC, Entrelec). The
specially designed stainless steel Mylar-bottomed dishes are placed on an adaptor on the
shutter. The latter allows irradiation of the monolayer over times ranging from 0.01 s to 20
min. (8).
Figure 2-2. The multi-port alpha-particle irradiator built in Roger Howell's Lab (8)
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Based on these two designs, we aimed to build a more flexible and convenient
irradiator to facilitate our studies.
2.2.2.1 The first design of irradiator
In the first design, as shown in figure 2-3, the Am-241 foil was adhered to the
surface of the bottom aluminum plate with 2-sided tape. The upper aluminum plate with
holes served as a holder for the Mylar dishes. There were three holes/holders for the
bigger-size alpha foil #1, #2 and #3 to enable simultaneous irradiation of three cell dishes.
Four screws were used to connect the two plates together with screw caps and thin washers
in between. The distance (air gap) between the alpha foil and the Mylar bottom of the cell
dishes was adjustable by changing the number of screw caps or washers. The advantage of
this design was that the air gap could be easily adjusted, starting from virtually 0. The
distance would affect the alpha-particle energy received by the monolayer of cells. The
biggest drawback of this design was that with no shutter, it was hard to control the
exposure time accurately, especially for very short exposures.
I I
alpha source (Am 41)
Figure 2-3. The first design of the alpha-particle irradiation system. The Am-241 foil was
adhered to the surface of the bottom aluminum plate with 2-sided tape. The upper
aluminum plate with holes served as a holder for the Mylar dishes.
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2.2.2.2 The second design of irradiator
The second design (figure 2-4) solved the exposure control problem. A Copal
electronic shutter (model DC-392) sitting right above the alpha foil was used to control the
exposure time. A metal adaptor was made to hold the Mylar dish on the shutter so that the
bottom of the Mylar dish was as close to the blades of the shutter as possible. which
resulted in a 5 mm air gap between the alpha foil and the Mylar dish bottom. The system
was located in a 185 mm x 185 mm lead-acrylic transparent box, with a lid not shown in
the picture. The lead-acrylic box effectively shielded the 60 keV gamma rays and allowed
the users to handle and use the irradiator more safely.
An external power supply (Model 250, GIBCO BRL, Life Technologies) was used
to provide the 24 V voltage to open the electronic shutter. A single shot digi-set timing
module (Part number: ENTTDUSL3002A from SSAC), connecting the power supply and
the electronic shutter. was used to control the exposure time of the shutter accurately from
0.1 s to 100 s. Longer exposures could be controlled manually with the help of an external
timer.
There was no collimator and delimiter in this design. The alpha particles hit the
cells at all angles, theoretically. There was no rotation of either the alpha source or the cell
dish. The uniformity of the alpha-particle hits was directly determined by the uniformity of
the americium foil itself. The alpha-particle uniformity and the resulting energy spectrum
to the monolayer of cells needed to be carefully examined before the irradiator was put into
use.
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mylar dish
-air gap 5mm
/ 'alpha source
cells on mylar
Figure 2-4. The second design of the alpha-particle irradiation system. The cells are grown
on the Mylar membrane 5 mm above the surface of the alpha-emitting foil. An electronic
shutter controls the exposure time.
2.2.2.3 The Mylar dish
Stainless steel cell culture dishes with replaceable Mylar-bottoms were constructed
according to the prototype in Metting's paper (7). Some changes were made to enable the
dish to fit into our own irradiator. A market search was done for the thinnest Mylar film
commercially available. As a result, 1.4 ptm-thick Mylar film was used to make the dish
bottom, on which the cells were grown (Steinerfilm, Inc., Williamstown, MA). Cells do
not attach well to Mylar, therefore pretreatment was needed to facilitate the attachment of
cells. FNC coating mix from AthenaES (Athena Environmental Sciences, Inc. Baltimore,
MD) was used to pre-coat the surface of the Mylar bottom before the cells were added. If
not otherwise specified, the Mylar dish was always pre-coated for use in this paper. The
cell culture dish had a total height of 4.05 cm and an inside diameter of 3.81 cm, providing
a surface area of 11.4 cm2 (figure 2-5).
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Body
,Avlar Film
Culture Dish J '- Clamp Ring
Figure 2-5. Schematic view of the Mylar dish. The Mylar dish was composed of three
parts: the dish body, 1.4 [tm-thick Mylar film and a clamp ring to tighten the Mylar film as
dish bottom.
2.2.3 Simulations
Before the construction of the alpha-particle irradiator, simulations were utilized to
estimate the energy spectra and LET spectra that cells would receive from a non-
collimated alpha source, assuming it was a uniform source. The design parameters were
not decided at the beginning, including the material of the film used as dish bottome
(Mylar film or the polypropylene film), the thickness of the Mylar/polypropylene and the
distance between the alpha foil and the dish bottom. By choosing different inputs, the
SRIM simulations were used to examine the influences of these factors and variables on
the energy spectra and LET spectra that the monolayer of cells received.
SRIM (the Stopping and Range of Ions in Matter) is a group of programs which
calculate the stopping and range of ions (up to 2 GeV/amu) into matter using a quantum
mechanical treatment of ion-atom collisions. TRIM (the Transport of Ions in Matter) is the
most comprehensive program included. TRIM will accept complex targets made of
compound materials with up to eight layers, each of different materials. It will calculate
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both the final 3D distribution of the ions and also all kinetic phenomena associated with
the ion's energy loss: target damage, sputtering, ionization, and photon production. All
target atom cascades in the target are followed in detail. The programs were made so they
could be interrupted at any time, and then resumed later. Plots of the calculation may be
saved, and displayed when needed (9). The version used in this paper was SRIM 2003.
In order to run the simulation, two types of information were needed: the Ion Data
and the Target Data (figure 2-6). The Ion Data included the name of the ion, the initial
energy of the ion and the angle of incidence. The target consisted of multiple layers. The
Target Data included the material and thickness of each layer. In our case, the alpha
particles emitted from the foil would pass through a certain thickness of air, a thin
Mylar/polypropene film and hit the monolayer of cells in the medium. For simplification,
liquid water was used to represent the cell and medium layer due to the similarity in
density and elemental components. Once a material was chosen, the program would give
the overall density and the components of the material automatically. The program tracks
the path of each individual ion and produces a record for it. The movement of all the ions
could be visualized in four different views: XY Longitudinal, XZ Longitudinal, XY Ions
Only and YZ Lateral. All the input information and results were output to the SRIM sub-
directory "SRIM Output" in txt files. The easiest way to manipulate these files was to load
them into a spreadsheet.
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Layer Name Width (A) Ilensity JU (15.S !)IN (14.UU)IAr (3.u;I4,lH (1.UUll
1 Air 50000000 0.001250 0.23200 0.75500 0.01 300 0.0000GB
2 Mylar 9997615814 1.397 0.18182 0.00000 0.00000 0.36364
3 WaterLiquid 10000000 1.000 0.33333 0.00000 0.00000 066667
1_l ti 0Jo
r~~~~~~~~~~~~~~~~~~~~~~'
Depth vs. Y-Axis
:
~_
~. . ' -- . -.
.
'C
. I I I I
OA - Target Depth -
%1
0 _
a,
6.00 mm
Figure 2-6. SRIM interface: Top. the Input data for the Ion, including ion name, initial
incident energy, number of ions; Mididle: the target data for each layer, including material
and thickness; Bottom Left: the XY Longitudinal view of an ongoing simulation. Bottom
Right: the calculation parameters and results for ion statistics.
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2.2.4 Dosimetry Measurements
2.2.4.1 Alpha-particle energy spectra
A passivated implanted planar silicon (PIPS) detector (Canberra, Meriden, CT;
model A450-18AM) (figure 2-7) was used to measure both the flux and the energy spectra
of the 24lAm a-particles under different conditions. The detector active area is 450 mm2;
the energy resolution is 18 keV; the bias voltage used was 40 V. A multichannel analyzer
software package (Canberra AccuSpec) was used to obtain alpha-particle energy spectra.
The detector was calibrated by measuring a standard 2 41Am point source in vacuum. The
channel number corresponding to the peak of the 241Am standard source was set to 5.486
MeV. The energy spectra of the alpha particles emitted from the 241Am foils were
measured directly above the gold surface of the foil, and in the cell irradiation position, i.e.,
inside the cell irradiation dish above the surface of the 1.4 tm-thick Mylar membrane. For
the high-activity sources, the detector surface was shielded with a 0.025 mm-thick stainless
steel foil containing a 0.8 mm-diameter pinhole to avoid count rate saturation (figure 2-8).
Because the size of the pinhole was much larger than the thickness of the stainless steel
foil, the collimation effect from the pinhole was minimal. The pinhole method was tested
with a low activity source to verify that the count rate and the energy spectrum were the
same with and without the pinhole. The alpha-particle flux was also measured by the
system. A similar pinhole method was used to avoid count rate saturation and a large dead
time. The alpha-particle flux was calculated by dividing the total number of recorded
particles by the measurement time and the effective detector area.
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Figure 2-7. The PIPS detector(Canberra, Meriden. CT; model A450-18AM). The active
area of the detector is 450 mm2.
_L
Figure 2-8. Schematic pinhole method. Left. the unshielded detector; Right. for the high-
activity sources, the detector surface was shielded with a 0.025 mm-thick stainless steel
foil containing a 0.8-mm-diameter pinhole to avoid count rate saturation. The drawing is
not in proportion of the real situation. The distance between the source surface and the
active area of the PIPS detector was about 5 mm.
2.2.4.2 Alpha-particle LET spectra
The LET spectrum of the alpha particles at the cell irradiation position was
generated by converting the energy in each channel of the energy spectrum into the
corresponding LET using the ASTAR program and the stopping power and range tables
available in the National Institute of Standards and Technology database.
(http://physics.nist.gov/PhysRefData/Star/Text/ASTAR.html).
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2.2.4.3 Alpha-particle flux uniformity
The alpha-particle flux at the cell irradiation position was also measured using a
"track-etch" technique (10). The plastic track detector CR-39 is sensitive to damage by
heavy charged particles but not to x-rays or gamma rays (10). All charged particles deposit
energy along their trail when they travel through matter. In organic plastic materials this
energy loss creates a submicroscopic cylinder of 'damaged" molecules, the so-called latent
track. This latent track is invisible under optical microscopes and it can be made visible by
etching the exposed detector with appropriate chemical solutions, usually high
concentration NaOH solution. In the etching solution, two etching processes happen at the
same time: the bulk or material etching which removes a layer of the detector surface, and
the track etching which produces cone-shape etch-pits (11) (see figure 2-9). For the
experiments, the CR-39 track detector was obtained from Track Analysis Systems, Ltd.
(Bristol, UK). The manufacturer cut the CR-39 into disks 3.7 cm in diameter that fit into
the cell irradiation dishes. The CR-39 disk was placed on the Mylar bottom and irradiated
with alpha particles at the same position of the cell monolayer. After the irradiation, the
CR-39 was etched to enlarge the latent molecular-scale damage along the alpha-particle
tracks for visual inspection under light microscopy. The chemical etching was carried out
in 7 N NaOH at 90 C for 50 minutes. Images of the etched tracks were recorded in a
rectangular area using a CCD camera at 50x magnification. The image area was calibrated
by using a stage micrometer at the same magnification. The track images were printed and
the track numbers were scored in 20 random fields per source.
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(a) before etching (b) after etching
Figure 2-9. Left: Schematic etching process along alpha-particle trajectory a) the damage
along the trajectory caused by the passage of the alpha particle is invisible; b) the damage
zone is revealed as a cone shaped etch-pit when the surface of the CR-39 is etched in a
controlled manner using a hot sodium hydroxide solution. Right: a picture of "etch pits" on
CR-39. Each dot represents one alpha-particle hit.
2.2.4.4 Dose calculation
The average absorbed dose rate to the cells on the Mylar surface was calculated by
multiplying alpha-particle fluence N by the stopping power S in cells, and by the
appropriate conversion factors: Dose (Gy) = NxSxO.016 (12, 13), where N is the number
of alpha particles hitting the monolayer of cells per pm; S defined by -dE/dx, is the
stopping power for tissue in MeV cm2/g. The concept of stopping power is closely related
to the concept of linear energy transfer (LET). The difference between these two concepts
is that the LET refers to all the energy deposited in or absorbed by the material, while
stopping power S refers to the energy transferred or lost from the charged particle itself. In
practice, the numerical value of LET is often equal to that of S, with the exception that
LET does not include the energy released due to bremmstrahlung radiation, which usually
accounts for one or two percent of the total energy loss. Dose, or absorbed dose, measured
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in gray (Gy), is defined as the amount of energy actually absorbed in some material. One
gray is equal to one joule of energy deposited in one kg of a material. For the purpose of
measuring absorbed dose in the monolayer of cells, the LET should be more appropriate
than stopping power since it represents the energy that is actually deposited in that small
volume. Thus we used the LET of the alpha particle in water to calculate the absorbed dose
to the monolayer of cells. The factor 0.016 is a unit conversion factor. LET (MeV-cm 2/g)
x N (number of alpha particles/gm 2) results in dose unit in MeV cm2/g Ltm2.
Merr-cm- 106eVx( 0 4 ) 2 lm 106 x1.6x10 (' '9) xl0 8 JOotlle Jodle
=~~um2 10,kg~pm2 = 0' = 0.016 = 0.016Gy
g um 2 10 kg am" 10 3'kg kg
In order to get dose rate in Gy/min, we can directly apply alpha-particle flux F, which is
fluence N divided by time (min), to the equation.
The dose rate from the 60 keV gamma rays released during the decay of 24'Am in
the alpha-particle foils was measured directly above the surface of the foils using an ion
chamber (Bicron). The direct measurements were in units of gamma exposure (Roentgen),
which were converted to dose by assuming I R = 0.95 rad in tissue.
2.3 Results
2.3.1 The Simulation Results
The alpha particles hit the cells from different incident angles, leading to different
path lengths through the cells and hence to different absorbed doses. A simple
mathematical model was established to address the incident angle problem in order to get
the overall energy spectra at the cell position. All the simulations were based on the second
irradiator design, in which the # 4 alpha foil was used. The size of the # 4 foil was 7.6 cm
x 7.6 cm. The vertical distance between the foil surface and the cell layer was symbolized
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as h, which was fixed at 5 mm. From the information provided by the manufacturer, the
energy spectrum at the # 4 foil surface peaks at 4.9 MeV with a FWHM of 58.3 keV. We
assumed a single energy (4.9 MeV) emission from the foil surface in the simulation for
simplicity. For each different incident angle which corresponded to a different r in figure
2-10, alpha particles produced different residual energies at the cell layer. These different
residual energies formed the energy spectra that the cells received. The residual energies of
alpha particles with different incident angles can be obtained from the SRIM simulation by
setting the incident energy at 4.9 MeV and varying the incident angles. When the incident
angle was larger than 78 degrees, the alpha particles could not penetrate the Mylar film due
to long passage distance in the Mylar (Mylar density is much higher than air density). At
that incident arngle, r was equal to 2.35 cm.
After calculating the residual energies of the alpha particles with different incident
angles. the number of alpha particles at each incident angle was also needed in order to get
the overall energy spectra at the cell position. Assuming a homogeneous activity in the foil
surface, the number of alpha particles hitting cells from each incident angle and resulting
in specific residual energy deposition was determined by two factors: one factor was the
perimeter for different radius 2r, which represents the contribution of all alpha particles
from the alpha foil with the same incident angle P. However, for each source point on the
perimeter, the irradiation was isotropic. So the other factor was the percentage of
irradiation a cell could receive from each source point on the 2r perimeter, which was
inversely proportional to the surface area of the sphere centered at the source point with a
radius d: 4rd 2. F'rom figure 2-10, d2 = (r2+h2). So the overall contribution from any
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particular incident angle was proportional to r/(r2+h2). For a fixed h, the value r could be
obtained from the incident angle 3 according to the relation tan(p) = r/h.
cell
Figure 2-10. Illustrative mathematic model for a cell irradiated by alpha particles from
different incident angles.
In Table 2-2, different cases with different air and Mylar thicknesses were
simulated. The first column is different incident angles for the alpha particles. In the actual
situation, the incident angles are continuous and range from 0 degrees (vertical) to 90
degrees (horizontal). Twelve to thirteen representative incident angles were picked for the
simulation in each case. The maximum representative incident angles were obtained in the
following way: a series of integral incident angles around 80 degrees were used in the
simulation to determine the minimum angle at which there was no alpha particle passing
through the air and the Mylar layers. The maximum representative incident angles are the
minimum angles plus 1 degree. For simplicity, only the incident angles with integral values
were considered. The second column is corresponding r for a chosen h and different
incident angles according to the geometric relationship r = tan([)xh in figure 2-10. The h is
the vertical distance between the alpha foil and the cell layer, which is equal to air distance
plus Mylar distance. The third column is the relative contribution of the alpha particles at a
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h = 2mm
corresponding
r (mm)
r = tan(p)xh
0
0.353
0.536
0.728
1.155
1.678
2.384
3.464
4.289
5.495
7.464
9.409
11.34
h = 3mm
0
0.529
0.804
1.092
1.732
2.517
3.575
5.196
6.433
8.242
11.20
12.03
17.01
h = 2mm
0
0.354
0.536
0.728
1.155
1.678
2.384
3.464
4.289
5.495
7.464
10.29
11.34
h = 2mm
0
0.353
0.536
0.728
2mm air + 4Lm polypropylene
relative
contribution standardized Energy LET
r/(r 2+h 2) contribution (MeV) (keV/itm)
0 0 3.935 108.3
0.086 0.347 3.925 108.5
0.125 0.508 3.915 108.7
0.161 0.653 3.890 109.1
0.217 0.879 3.826 110.4
0.246 1.000 3.712 112.6
0.246 1.000 3.555 115.9
0.216 0.879 3.200 124.3
0.192 0.778 2.890 132.9
0.161 0.653 2.415 149.4
0.125 0.508 1.425 203.5
0.102 0.413 0.045 97.6
0.086 0.347 0 0
3mm air + 4m polypropylene
0 0 3.830 110.3
0.057 0.347 3.815 110.6
0.083 0.508 3.800 110.8
0.107 0.653 3.775 111.3
0.144 0.879 3.710 112.6
0.164 1.000 3.580 115.3
0.164 1.000 3.370 120.1
0.144 0.879 2.920 131.9
0.128 0.778 2.578 143.2
0.107 0.653 1.965 170.2
0.083 0.508 0.500 242.8
0.078 0.477 0.062 113
0.057 0.347 0 0
2mm air + 31pm polypropylene
0 0 4.040 106.4
0.086 0.347 4.030 106.5
0.125 0.508 4.020 106.7
0.167 0.653 4.000 107.0
0.217 0.879 3.960 107.7
0.247 1.000 3.870 109.5
0.246 1.000 3.720 112.3
0.217 0.879 3.460 118.0
0.192 0.778 3.230 123.5
0.161 0.653 2.856 133.9
0.125 0.508 2.000 160.4
0.094 0.380 0.715 247.5
0.086 0.347 0 0
2mm air + 2pm
0
0.086
0.125
0.161
polypropylene
0
0.347
0.508
0.653
4.153
4.150
4.140
4.125
104.4
104.5
104.5
104.9
57
incident
angle
(degree)_
0
10
15
20
30
40
50
60
65
70
75
78
80
0
10
15
20
30
40
50
60
65
70
75
76
80
0
10
15
20
30
40
50
60
65
70
75
79
80
0
10
15
20
30
40
50
60
65
70
75
81
0
10
15
20
30
40
50
60
65
70
75
81
0
10
15
20
30
40
50
60
65
70
75
78
1.155
1.678
2.384
3.464
4.289
5.495
7.464
12.63
h = 2mm
0
0.353
0.536
0.728
1.155
1.678
2.384
3.464
4.289
5.495
7.464
12.63
h = 3mm
0
0.529
0.804
1.092
1.732
2.517
3.575
5.196
6.434
8.242
11.20
14.11
0.217
0.246
0.246
0.217
0.192
0.161
0.125
0.077
2mm air +
0
0.086
0.125
0.161
0.217
0.246
0.246
0.217
0.192
0.161
0.125
0.077
3mm air
0
0.057
0.083
0.107
0.144
0.164
0.164
0.144
0.128
0.107
0.083
0.068
1.3
0.879
1.000
1.000
0.879
0.778
0.653
0.508
0.314
Lm
+ 2[tm
Mylar
0
0.347
0.508
0.653
0.879
1.000
1.000
0.879
0.778
0.653
0.508
0.3 14
Mylar
0
0.347
0.508
0.653
0.879
1.000
1.000
0.879
0.778
0.653
0.508
0.413
4.080
4.000
3.905
3.710
3.530
3.250
2.730
0
4.157
4.150
4.140
4.125
4.080
4.000
3.905
3.710
3.530
3.250
2.550
0.816
3.970
3.960
3.952
3.938
3.870
3.775
3.620
3.320
3.038
2.570
1.730
0.641
105.6
107.0
108.8
112.6
116.4
123.0
137.9
0
104.4
104.5
104.5
104.9
105.6
107.0
108.8
112.6
116.4
123.0
144.2
244.4
107.6
107.8
107.9
108.3
109.5
ll1.3
114.4
121.3
128.7
143.5
183.4
248.1
Table 2-2. Simulation Results for residual energy and LET at the cell position for different
alpha-particle incident angles. The influences of different thickness of air and different
thickness of polypropylene/Mylar were examined, assuming an initial incident energy of
4.9 MeV.
specific incident angle and specific residual energy. The forth column is a standardized
contribution which came directly from the relative contribution in column three and
divided by the maximum relative contribution value in each case. The standardized
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contribution was used to facilitate plotting visualization and comparison for different
cases. The fifth column is the average residual alpha-particle energy from SRIM
simulations for each incident angle. It is the energy that the monolayer of cells received
from the incident alpha particles. For each case, about 106 alpha particles were tracked.
Each alpha particle produced a residual energy. The average residual energy from all alpha
particles was calculated as the energy that the cells received from the alpha particles with a
certain incident angle. The final column is LET value corresponding to residual energy in
water.
Figure 2-11 shows graphically the relationship between the incident angle and
residual energy as well as the resulting energy spectra at the cell position for various
thicknesses of Mylar, polypropylene and air.
Figure 2-12 shows graphically the relationship between the incident angle and the
LET, as well as the resulting LET spectra at the cell position for various thicknesses of
Mylar. polypropylene and air.
Table 2-3 repeats the mathematical modeling described in Table 2-2 for the actual
geometry of the alpha-particle irradiator used in all cell irradiation experiments assuming
the initial incident alpha-particle energy of 4.7 MeV, which was obtained from our surface
energy measurement. Figure 2-13 shows the simulated energy spectrum and LET spectrum
at the cell position for the actual geometry of the irradiator. The initial alpha-particle
energy from the #4 foil was 4.7 MeV. The alpha particles passed through 5 mm air and 1.4
pm Mylar before they hit the monolayer of cells.
59
Incident Angles vs. Residual Energy Incident Angle vs Residual Energy
(initial incident energy = 4 9 MeV) (initial incident energy = 4.9 MeV)
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Figure 2-11. Top: the alpha-particle residual energies for different incident angles. The
initial alpha-particle energy from the alpha foil was set at 4.9 MeV. The x-axis represents
different incident angles in degrees and the y-axis represents corresponding residual
energies in MeV, which are the energies that the monolayer of cells received. The left
figure is for Mylar and the right figure is for polypropylene. Bottom: the energy spectra at
the cell layer. The x-axis represents energy in MeV and the y-axis represents relative
frequency, which was from the standardized contribution in Table 2-2. The left figure is for
Mylar and the right figure is for polypropylene.
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Figure 2-12. Top. the LET values at the cell layer for different incident angles. The x-axis
represents different incident angles in degrees. The y-axis represents the corresponding
LET values for the alpha particle at the cell layer. The left figure is for Mylar and the right
figure is for polypropylene. Bottom. the LET spectra at the cell layer. The x-axis represents
the alpha-particle LET in keV/[m at the cell layer. The y-axis represents the relative
frequency, which came from the standardized contribution in Table 2-2. The left figure is
for Mylar and the right figure is for polypropylene.
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h = 5 mm 5mm air + 1.4Am Mylar
corresponding
Incident angle r (mm) relative contribution Residual Energy LET
(degree) r = tan( )xh r/(r2+h2) (MeV) (keV/pm)
0 0 0 4.203 100.0
10 0.882 0.034 4.192 100.2
15 1.340 0.050 4.176 100.4
20 1.820 0.064 4.157 100.8
30 2.887 0.087 4.093 101.8
40 4.195 0.098 3.986 103.7
50 5.959 0.098 3.797 107.2
60 8.660 0.087 3.449 114.5
65 10.72 0.077 3.154 121.5
70 13.74 0.064 2.662 135.9
75 18.66 0.050 1.736 176.2
76 20.05 0.047 1.256 204.9
77 21.66 0.044 0.800 226.0
78 23.52 0.041 0.244 173.4
Table 2-3. The simulation results for residual energies and LET at the cell position for
different incident angles in the second design of alpha-particle irradiator, assuming the
initial incident energy of the alpha particle was 4.7 MeV; the alpha particles passed
through 5 mm air and 1.4 pm Mylar film before they hit the monolayer of cells grown on
the Mylar bottom.
Energy Spectrum at Cell Layer LET Spectrum at Cell Layer
ntlail incident energy = 4 7 MeV) (Inital Incdent energy = 4.7 MeV)
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Figure 2-13. Simulated energy spectrum (left) and LET spectrum (right) at the cell position
for the actual irradiator geometry described in 2.2.2.2 (the second design of the irradiator),
which was used in all following cell irradiation experiments. For the energy spectrum, the
x-axis represents the alpha-particle residual energies at the cell position in MeV. The y-
axis represents the relative frequency of different energies, which came from the relative
contribution in Table 2-3. For the LET spectrum, the x-axis represents the alpha-particle
LET at the cell position in keV/tm. The y-axis represents the relative frequency of
different energies, which came from the relative contribution in Table 2-3.
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2.3.2 Measurements
2.3..1 Alpha-particle energy and LET spectra at the cell irradiation position
The measured energy spectra of the 241Am alpha particles under several different
conditions are shown in figure 2-14. The sharp peak at 5.49 MeV is the 241Am calibration
source measured in a vacuum. The FWHM of the 241Am calibration peak is 0.028 MeV.
The broader peak with a relative frequency maximum at - 4.7 MeV is the energy spectrum
obtained with the PIPS detector directly above the 24 1Am foil # 4 (see Table 2-1). The peak
with a relative frequency maximum at 3.95 MeV was obtained with the PIPS detector
positioned inside the cell irradiation dish directly above the 1.4 pLm-thick Mylar bottom of
the cell culture, dish, positioned in the irradiator above foil #4. The Emax is progressively
attenuated and the peak is broadened due to the energy straggling of the alpha particles
through the gold surface coating of the source, 5 mm of air and then the 1.4 tm of Mylar.
Due to the un-collimated nature of this planar source. the energy spectrum is skewed with a
tail at lower energies. The PIPS detector was used with the 0.8 mm diameter pinhole to
measure the alpha-particle flux at the cell position: inside the cell irradiation dish, directly
above the Mylar membrane. The pinhole method was tested on the # 3 foil first and the
result is shown in figure 2-15. If the pinhole caused a significant collimation effect, it
would differentiate the two spectra (with and without pinhole) at lower energies. From the
result shown in figure 2-15, it is clear that the two spectra overlap each other, which means
that the collimation effect caused by the pinhole was minimal.
The PIPS detector was also used to measure the alpha-particle flux with the 0.8 mm
diameter pinhole. The obtained count rate was 998 ct-particles/mm 2/s. The reproducibility
error of the system was 2 %. So the count rate with error was 998 ± 20 ac-particles/mm2/s.
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Energy Spectra at Cell Position for #4 Source
* cell position
1 2 3 4
Alpha-Particle Energy (MeV)
5 6 7
Figure 2-14. Energy spectra measured with the solid state (PIPS) detector at various
positions above the alpha-particle source used for all of the cell irradiations (24 'Am foil #4:
nominal activity, 10 Ci 2 4 Am/cm2). Triangles: measurement directly above the gold
surface of the bare foil. Circles: measurement at the cell irradiation position, inside the cell
culture dish directly above the Mylar membrane. Filled circles: a 241Am point source
measured in a vacuum. The 241Am energy peak at 5.49 MeV was used to calibrate the
multi-channel analyzer; the FWHM of the calibration peak was 0.028 MeV.
Pinhole Effect Test on #3 source surface
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Figure 2-15. Energy spectra with and without the pinhole tested on the # 3 alpha source
surface. The two spectra overlap each other, suggesting no significant collimation effect
from the pinhole.
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For the #4 alpha source, the average energy to the monolayer of cells was
calculated as a weighted average energy for all energy channels with the weighting factor
being the number of alpha-particle counts per energy channel. The average energy was
3.14 MeV. The reproducibility of the measuring system was estimated to be 2%. So the
error on the average energy was 0.06 MeV. The energy spectrum of the alpha particles at
the cell irradiation position was converted to an LET spectrum by a point-by-point
interpolation using published stopping power and range tables from the National Institute
of Standards and Technology database. As an alpha particle travels through a medium and
continuously loses its energy, its energy deposition demonstrates a peak near the end of the
alpha particle range, which is called the Bragg peak. Figure 2-16 shows the relationship
between the energy and the LET of the alpha particles due to the Bragg peak effect. The
maximum LET was 227 keV/[im, corresponding to the energy of 0.73 MeV. From figure
2-16, two different alpha-particle energies on either side of the peak may have the same
LET value. For example, both 0.17 MeV and 2.33 MeV correspond to the same LET of
148 keV/,m. The final LET spectrum was obtained by adding the counts of each LET
value on the lower energy side to the counts of the same LET value on the higher energy
side of the Bragg peak. The resulting LET spectrum is shown in figure 2-17. The
weighted-average LET was calculated from the LET spectrum using the alpha-particle
counts per channel as the weighting factor. The average LET of the alpha particles at the
cell irradiation position was 127 keV/im. The uncertainty in stopping power depends on
the energy of the particle and the material composition. It's estimated to be 5% (14). So the
average LET with error was (127 ± 6) keV/pm.
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Figure 2-16. The relationship between the energy (x-axis, MeV) and the LET (y-axis,
keV/pm) of alpha particles due to a Bragg peak effect. The maximum LET is 227 keV/pm,
corresponding to the energy of 0.73 MeV.
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Figure 2-17. LET spectrum at the cell irradiation position, calculated from the measured
energy spectrum of the # 4 alpha source shown in figure 2-14.
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2.3.2.2 Alpha-particle fluence and uniformity measurements with CR-39
The CR-39 plastic track detectors were placed inside the cell irradiation dish
directly on the Mylar membrane. The #4 alpha-particle source has a relatively high
activity. In order to avoid track overlap and saturation on the CR-39 track detector, 0.2 s
exposures were used for this high-activity source. Counts from 20 random fields (1.03 mm
x 1.03 mm) indicated 306 ± 15 particles for the 0.2 s exposures, corresponding to an alpha-
particle flux of (1440 ± 70) counts /mm2/sec at the cell irradiation position. This value is
considerably higher than the value (998 + 20) particles/mm 2/sec obtained with the PIPS
detector for the same #4 alpha-particle source using a 0.8 mm diameter pinhole. A possible
explanation is that there was a short shutter opening and closing time. With such a short
irradiation time (0.2 s), the shutter opening/closing time became critical and brought a
large error to the result. When the CR-39 track detectors were used with a lower activity
alpha source (14 Am foil #2, Table 2-1) so that a longer exposure time was used for
recording, the CR-39 results were in much closer agreement with the PIPS detector. CR-39
exposures in 1:5-second increments from 15 to 105 seconds produced a linear response, as
shown in figure 2-18 (R2= 0.9 9 8); scoring 20 random fields per CR-39 exposure resulted in
a variance of approximately 10% at each dose level. The CR-39-determined alpha-particle
flux from all 7 exposure times for the #2 4Am foil was 9.9 ± 0.8 tracks/mm 2/s (n=140).
The PIPS detector produced a reading of 11.2 0.2 tracks/mm 2/s in the same location,
which is slightly higher than the CR-39 average. For the track-etch detector, not all the
alpha particles traveling into the CR-39 are detected: the detection efficiency depends on
the particle energy, charge and incident angle (11). For example, alpha particles with big
incident angles ( > ir/2 - 0i,, ) would not form etch-pits (figure 2-19), which leads to an
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underestimate. These explain why the CR-39 results were 11% lower than the PIPS results.
Similar relationship was obtained by Neti et al.: the PIPS measurements were 6%, 19%
and 22% higher than the CR-39 averages for their three 2 41 Am alpha sources. They
concluded that the fluences obtained with the PIPS detector had a much higher degree of
accuracy and precision than the CR-39 measurements (8). Therefore, the PIPS results was
considered more reliable and has been used in the calculation of the #4 alpha source dose
rate to the cell monolayers.
# 2 Alpha Source Uniformity and Linearity Test
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Figure 2-18. The CR-39 track detector results (tracks/mm 2 ) for the alpha-particle flux,
uniformity and linearity on the #2 alpha foil. Left, middle and right denote the positions of
the three holes shown in figure 2-3. Irradiations were in 15-second increments from 15 to
105 seconds. For each time point, 20 random fields were scored. The average values and
standard deviations from the 20 counts were calculated and shown in the graph.
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Figure 2-19. The track formation for different incident angles 3 (0 = 7/2 - 3 ). (a) when 0 >
01hi the etch-pit is formed; (b) (c) when 0 < Olim , no etch-pit is formed. VB is the bulk or
material etching rate and VT is the track etching rate. The limit angle 01im is decided by
sin( Olim) = V / Vr (I ).
Figure 2-20 shows a superimposed image of DU-145 human prostate carcinoma
cells and CR-39 pits at the same magnification of 50x. The DU-145 cells were grown on a
glass slide until confluent. Then the slide was stained with methylene blue solution and
pictured by an epi-fluorescent microscope. The CR-39 track etch image was from a 0.2
second exposure using the #4 alpha source at the cell position. The CR-39 picture was
superimposed on the confluent DU-145 cell image using Photoshop.
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Figure 2-20. Superimposed image of DU-145 human prostate carcinoma cells and CR-39
pits after 0.2 second exposure of the #4 alpha source. Magnifications for both images were
50x.
2.3.2.3 Dose rate calculation
The dose rate was calculated from the equation: Dose Rate (Gy/min) = FxSxO.016.
The average LET was 127 6 keV/plm and the average track density was 998 ± 20
counts/mm 2 s. The percentage of error to the dose rate was calculated to be 5.4%. The
average dose rate to the cell monolayers on the Mylar dish bottom was calculated to be 1.2
± 0.06 Gy/min.
2.3.2.4 Surface dosimetry of the five alpha-particle foils
Figure 2-21 shows the surface energy spectra for all five alpha foils. Table 2-4
shows the measured and calculated characteristics of the five 241Am alpha-particle foils.
The nominal activity concentration of 241 Am included in each foil during manufacture
ranges from 0.01 gCi/cm 2 for foil #1 and increases by a factor of 10 for each foil up to a
maximum of 100 tCi/cm2 for foil #5. The energy spectra and the total alpha-particle flux
per unit area were measured with the PIPS detector. The variations observed in Table 2-4
for the average energy of the foils was most likely due to slight variations in the thickness
70
of the gold coating on the surface of the foil from the manufacturing process. The average
dose rates were calculated from the measured alpha-particle fluxes and the average LET
values for each foil. The gamma doses measured at the foil surface were negligible
compared to the alpha-particle doses (see Table 2-4). Foil #4 was used for all the cell
irradiation experiments in this study.
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Figure 2-21. Energy spectra at the surface of the five alpha foils. All spectra peak between
4-5 MeV and have skewed tails in the low-energy part due to the non-collimated sources.
All alpha foils should have the same energy spectra if they were manufactured to exactly
the same specifications since the activities do not affect the energies. The differences in the
spectra shown here for the five alpha foils most likely come from variations in the
manufacturing process (homogeneity of the radioisotope layer or the thickness of the gold
layers). Especially for the #1 alpha foil. there is a second peak at about 4 MeV, which may
come from an impurity of the radioisotope.
Alpha Average Average Average Alpha- Alpha Gamma exposure Gamma
foil # Energy LET particle Flux Dose Rate Rate (mR/h) Dose Rate
(MeV) (keV/lm) (counts/mm2s) (Gy/min) R: Roentgen (Gy/min)
#1 3.89 110.6 3.16 0.003 nd nd'
#2 3.54 117.6 12.90 0.015 0.2 3 x 10 -8
#3 3.50 118.4 106.72 0.12 2.5 4 x 10-
#4 3.98 107.4 1162.05 1.17 27 4.3 x 10-°
#5 3.56 116.9 12430.2 13.9 290 4.6 x 10- 5
nd: not detectable
Table 2-4. Surface dosimetry for the five 241Am foils. Alpha-particle energy and flux
measurements were made with the PIPS detector directly over the bare foil surfaces. The
errors of the results are not shown in this table. The percentage errors for the alpha dose
rates were estimated to be 5.4% for all five foils.
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2.3.2.5 The application of #5 alpha-particle source in another project (15)
The highest activity # 5 source was used in another project "Differential Oxidation
of Deoxyribose in DNA by y- and a-Radiation" by Christiane Collins from Prof. Peter C.
Dedon's group in the Biological Engineering Division at MIT. This project was looking at
the chemical mechanisms of how radiation causes DNA single strand breaks and whether
radiations with different LET properties (low-LET gamma vs. high-LET alpha particles)
cause single strand breaks by different mechanisms. The Dedon Lab has developed
analytical techniques to measure the deoxyribose oxidation of the DNA that are
characteristic of radical attack at specific positions on the deoxyribose. For the experiments
with the #5 alpha-particle source, the amount of a fragment known as
phosphoglycolaldehyde (PGA) was used to compare the different radiations. Specifically,
a recently developed gas chromatography/negative chemical ionization mass spectrometry
method was used to quantify PGA residues in purified DNA and in human TK6
lymphoblastoid cells subjected to y-radiation (6Co) and -particles (24'Am). The a-
particle irradiations were done in our lab. Since very high alpha-particle doses were
required in order to produce enough PGA for quantitative analysis by the mass
spectrometry technique, the #5 source was chosen to deliver the ct-radiation to the I ml
DNA solutions., which were contained in the cell irradiation dishes with replaceable 3.7 tm
polypropylene bottom. The depth of I ml DNA solution is -830 ptm in the irradiation dish
with a 3.81 cm diameter. The residual range in water of a-particles coming through the 3.7
plm polypropylene is -25 [pm (16). In order to deliver a homogeneous dose to all the DNA
in the I ml volume, a magnetic stirring system was used. The Mylar dish was placed 1 mm
above the #5 alpha foil, which was placed upon a magnetic stirrer. A specially designed
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stir bar (by Christiane Collins) was place inside the 1 ml DNA solution. DNA solutions
were exposed to a-radiation for 0 to 240 min at ambient temperature with rapid stirring.
For the dosimetry, the PIPS detector was used to measure the energy spectrum
directly above the 3.7 pm polypropylene bottom of the cell irradiation dish. The energy
spectrum is shown in figure 2-22. From the measured spectrum, the average energy was
calculated to be 3.12 MeV. The alpha-particle flux above the polypropylene was measured
to be 9882 particles/mm 2/s. The diameter of the dish was 3.81 cm and the area of the dish
was 21 (3.81/2)2 =1 1.4 cm2. Since the depth of the DNA solution was much larger than the
ranges of the alpha particles in water, all the residual energy of the incident alpha particles
would be deposited in the I ml volume. The total energy deposited per unit time is: (3.12
MeV) x (9882 particles /mm2/s) x (11.4 x 100 mm2) 3.515 x 107 MeV/s, which was
converted into Joules: 3.515x10 7 (MeV/s) x 1.6 x 10'19 (Joule/eV) x 106 (eV/MeV)= 5.6 x
10-6 (J/s).
Assuming that the density of the DNA mixture was 1 g/cm3 , for a total volume of 1
ml, the total mass would be g. Since dose is the energy deposited per unit mass, the dose
rate to the DNA was calculated as:
5.6xlO-6J/sl*xi .6j k = 5.6 x 10-3 J / kg s = 5.6 x10-3Gy'/s = 5.6 x 10-3 x 60Gy / min = 0.34Gy / min
And the error to this dose rate was estimated to be 0.018 Gy/min.kg
And the error to this dose rate was estimated to be 0.018 Gy/min.
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Figure 2-22. Energy spectra of the bare 241Am calibration source in vacuum (A) and the #5
2 41Am foil above the polypropylene in the cell dish (7).
2.4 Discussion
In this chapter, a cell irradiation system based on an isotopic alpha-particle emitter
241Am is described. 2 4 1Am has a half-life of 232.2 years and emits alpha particles with
three main branches of energies that are close enough to make the source essentially
monoenergetic: 5.485, 5.433, and 5.388 MeV (relative abundances 84.5, 13.0, and 1.6%
respectively). The average energy of approximately 5.48 MeV is similar to the energies of
alpha-emitting isotopes used in radioimmunotherapy: e.g., 21 1At, 5.87 MeV, 2 2Bi, 6.05
MeV. Compared to the Pu-238 alpha-particle irradiator of Noelle F. Metting, Hatsumi
Nagasawa and John B. Little (7) and the Am-241 multi-port alpha-particle irradiator of
Neti and Roger Howell (8), the source designed for the studies reported here has been
simplified considerably. Our irradiator does not have the collimator system, the beam
delimiter, rotation of the source or rotation of the collimator. Would these differences
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cause problems for the cell irradiations planned here? What is the advantage of our simple
irradiator?
For the alpha-particle irradiators described in the literature (7, 8)., the collimator,
the delimiter and the rotation system are all intended to produce a more homogeneous
irradiation of the cells: the collimator will eliminate the alpha particles with shallow
incident angles and should produce a narrower energy spectrum without a low-energy tail
(see figure 2-23). The beam delimiter was described as substantially improving the
uniformity of the beam, particularly at the edges of the growth surface (7). The rotation
systems for both the source and the collimator were intended to average out any hot-
spots" or "'cold-spots" on the alpha-particle sources and to provide more uniform
irradiation to the cells. With all these parts built into the irradiation systems, the gap
between the alpha source and the dish bottom was large (48 mm (7) and 51 mm (8)). Both
designs used helium gas to minimize the alpha-particle energy loss because air attenuates
the alpha-particle energy more than helium gas (air contains heavier elements like O and
N). As a result, the alpha particles would travel through 42 mm helium gas (in Metting's
design ) (7) or 45 mm helium gas (in Neti's design) (8), 1.5 tm Mylar (the exit window), 6
mm air and the 1.5 tm Mylar dish bottom to reach the cell layer. In our design, the alpha
particles only needed to travel through 5 mm air and 1.4 pim Mylar dish bottom before they
hit the cell layer.
The simple design is in keeping with the experimental objective of these studies:
the focus is on the bystander cells growing on an insert, the bottom layer of cells receive a
distribution of alpha-particle energies and LETs that is more reflective of the actual
situation during targeted alpha-particle therapy of solid tumors. We have used an
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uncollimated planar source to irradiate a monolayer of tumor cells growing on a Mylar
film. As a result, alpha particles entering the cell layer at shallow angles will have a
broader distribution of energies, LET values and residual ranges compared to a
monoenergetic microbeam source, or to collimated accelerator or planar isotopic sources.
For radiobiological studies on the effects of alpha particles, it is desirable to use
well-defined exposure conditions where the angle of the particle trajectory through the cell,
and the residual range (energy) of the particle at the cell surface are known (and ideally
controlled to a narrow range). It is only the well-collimated accelerator-based alpha-
particle beams and the accelerator-based microbeams that can approach this ideal situation
and carry out cell irradiations in track mode", where the change in LET is small over the
dimensions of -the cellular target. With the planar isotopic sources that have been described
in the literature (7), there is always beam broadening and energy straggling due to the exit
window, the Mylar cell support membrane. the distance of air or other gas traversed by the
alpha particles. even when honeycomb collimators are built into the design of the
irradiators. For example. using a planar 239Pu source electroplated onto stainless steel.
Inkret et al, reported a mean energy of 3.23 MeV (230Pu emits 3 alpha particles at 5.35,
5.45 and 5.50 MeV), an energy-weighted stopping power of 123 keV/Lm, and a cell
surface dose rate of 2.2 Gy/min (17). Nasgasawa and Little also used a collimated 239Pu
source for the initial description of the bystander effect (7, 12). The energy of the alpha
particles coming through the Mylar cell growth membrane was estimated to be 3.65 MeV
by particle range experiments with increasing thicknesses of air or Mylar. This alpha-
particle energy corresponds to an LET of 112 keV/jpm (7). No spectra or range of values
were provided, but the alpha particles were certainly not monoenergetic as can be inferred
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by the broad shoulder on the particle flux vs absorber thickness plots (7). Neti et al. have
used a planar 241Am source in a collimated geometry similar to that described by Metting
et al. The maximum energy for that irradiator was 2.9 MeV: the energy-weighted average
LET was 132 keV/[tm (range: 70-200 keV/tm) (8).
We have used planar 241Am sources from the same manufacturer as Howell (8) (but
different activity concentrations). Interestingly, for the uncollimated irradiator described
here the alpha-particle characteristics are not that different from those reported for
collimated planar sources. For the 24 1Am cell irradiator described here the peak alpha-
particle energy was 3.9 MeV. The corresponding LET spectrum calculated from the
measured energy spectrum showed a maximum at 100 keV/[m (range: - 70 - 220
keV/jim) and an energy-weighted average stopping power of 128 keV/ltm.
The lower Emax (3.9 MeV) and broad tail at lower energies compared to the 2 4 1Am
calibration source represents the energy straggling of the -particles following passage
through 1 to 1.5 m of gold, 5 mm of air and 1.4 }im of Mylar. The maximum residual
range in water of 3.9 MeV a-particles is -30 pm (16). Alpha particles that traverse the
gold, air and Mylar at shallow angles will have a low residual energy, a short residual
range, and a correspondingly high LET. This is reflected in the tails at low energy and high
LET evident in figures 2-14 and figure 2-17. The average dose rate delivered to the cells
on the Mylar membrane inside the cell dish (within the 25 tm range of the ux-particles) was
calculated by assuming that the average dose rate was the product of the average LET
(1266 MeV cm2 g ) and the average track density (998 tracks mm '2 s-). Thus, the average
dose rate using the #4 source at the cell irradiation position on the Mylar surface was 1.2
Gy/min.
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The main purpose of this project is to study the bystander effect as well as its
synergy with anti-cancer drugs in tumor cells. With targeted alpha therapies for solid
tumors or micrometastatic disease, the non-uniform delivery of MAbs bearing alpha
emitting radionuclides, or l°B containing drugs used for boron neutron capture therapy
results in a non-uniform delivery of alpha particles to the tumor site. The bystander cells
are the ones that escape direct alpha-particle traversals. The 3-D tumor site is exposed to
alpha particles of all energies, residual ranges and LETs ranging down from the original
emitted properties. Thus our simplified alpha-particle irradiator design mimics the real
clinical situation of radioimmunotheray.
In addition, our simple and portable design of alpha-particle irradiator makes some
other research applications possible. The small irradiator could be put inside an X-ray
machine to study the combined effects between high-LET and low-LET irradiations, (ie,
additive or synergetic). The irradiator could also be placed into a refrigerator or an
incubator to deliver radiation to cells at different temperatures to study the effect on DNA
repair or the temperature dependence of bystander signal generation. The irradiator can be
easily and safely carried to another location to conduct experiments in other facilities or
labs.
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Figure 2-23. The energy spectrum and LET spectrum for the 241Am irradiator described in
reference (8). They have less low-energy and high-LET tails than the spectra of the
uncollimated alpha source shown in figure 2-14 and figure 2-17, which is due to the cut-off
of the shallow-incident-angle alpha particles by the collimator.
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Chapter 3 Direct Alpha-Particle Irradiation
3.1 Introduction
The interaction of radiation with matter results in physical, chemical and biological
changes. The transfer of energy from radiation to biologic material leads to ionization or
excitation of its atoms or molecules. In the case of ionization, radiation with sufficient
energy (>33.9 eV in dry air) ejects one or more orbital electrons from an atom or molecule
and produces an ion pair. Ion pairs themselves can interact with surrounding matter
producing more ion pairs or secondary ionization. This radiation is called ionizing
radiation. If the energy transferred is not sufficient to cause ionization, excitation happens,
in which an orbital electron is raised to a higher energy level. Electrons in an excited state
may form or break molecular bonds or simply go back to their original energy level by
emission of electromagnetic radiation. There are two basic types of interactions between
radiation and biologic material: direct and indirect interactions. In direct interaction, the
energy of the radiation is deposited directly in critical biologic targets resulting in
excitation or ionization. Direct effects are the dominant process in the case of high-LET
radiations, such as neutrons and alpha-particle irradiations. Alternatively, the radiation may
interact with other atoms or molecules around the critical biologic targets, mostly water, to
produce free radicals that are able to diffuse far enough to reach and damage the critical
targets. This is called the indirect interaction of radiation. A radical is a free atom or
molecule carrying an unpaired orbital electron in the outer shell, which is associated with a
high degree o chemical reactivity. Free radicals like hydroxyl radicals (-OH) are very
reactive and will react with any nearby molecule. If the OH reacts with DNA, a variety of
lesions such as adducts can be formed.
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Radiations of different qualities have different degrees of effectiveness in
producing biological effects. The amount of radiation energy absorbed per unit mass of
biologic material is measured by absorbed dose. The SI unit of absorbed dose is joule per
kilogram (J/kg), which is defined as the gray (Gy). Equal doses of different types of
radiation do not produce equal biologic effects. High-LET radiations produce much denser
ionizations along the tracks than low-LET radiations. These differences in density of
ionizations are a major reason that neutrons, protons, and alpha particles produce more
biological effects per unit of absorbed radiation dose than do more sparsely ionizing
radiations such as x rays, gamma rays, or electrons. Analysis of the relative biologic
effectiveness (RBE) is a useful way to compare the effects of different radiations. The
relative biological effectiveness for a given test radiation is defined by the ratio D250/DT,
where D250 and D,1 are, respectively, the dose of a reference radiation, usually 250-kV x-
rays, and the test radiation required to produce the same biological effect (1).
Many scientific investigations have been conducted to determine the critical
irradiation targets for the cells and the corresponding irradiation properties of the targets.
By employing a polonium tipped microneedle as a microbeam source to selectively
irradiate the nucleus or the cytoplasm of the cell with alpha particles, Munro et al. reported
that irradiation of the cytoplasm did not cause a decrease in cell growth, whereas much
lower doses of alpha particles targeted to cell nuclei were frankly lethal (2). Other
investigators have used radioactive compounds that preferentially localize in the cell
nucleus, the plasma membrane, or the cytoplasm, and have observed that the irradiation of
the extranuclear region of a cell is far less effective than irradiation of the cell nucleus (3,
4). Those experiments showed that although some minor effects could be induced after
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irradiating the cytoplasm, a cell's nucleus and particularly genomic DNA is the critical
target for the biologic effects of ionizing radiation.
Further studies on the relationship between alpha-particle traversal of the cell
nucleus and cell damage were carried out. Raju and co-workers used alpha particles to
irradiate five different cell lines and found that the mean number of alpha-particle
traversals inducing a lethal lesion varied between 2 for HS-23 cells and 6 for C3H 1OT1/2
cells. The RBE values for all cell lines were about 3.8 at 10% survival. The average
number of alpha-particle traversals producing a single lethal lesion w-as greater than one.
The traversals that do not kill the cells may lead to carcinogenic effects (5).
The development of charged-particle microbeam technology (figure 3-1), cell
subcompartment staining techniques, image analysis and automated cell positioning have
provided better tools to assess a variety of endpoints with exact numbers of alpha particles
targeted to cell nuclei and their cytoplasm compartments. Miller et al. investigated the
oncogenic etfects produced by the passage of exact numbers of alpha particles traversing
mammalian cell nuclei. By using a microbeam to produce an exact number of alpha
particles and a broad beam to produce a mean number of alpha particles determined by
Poisson statistics distribution, they found that the effect of exactly one alpha particle
traversal was not significantly different from the controls with no traversal and concluded
that the majority of transformed cells resulted from more than one alpha-particle traversal
(6). Hei et al. used the microbeam source to examine the relationship between exact
numbers of nuclear hits by alpha particles and mutagenicity for a human-hamster hybrid
(A,,) cell line. They found that although single-particle traversal was only slightly cytotoxic
to A, cells (survival fraction approximately 0.82), it was highly mutagenic. The mutant
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induction increased with increasing nuclear traversals over a dose range of 1-8 alpha
particles per nucleus. These data provided direct evidence that a single alpha-particle
traversal of a nucleus would have a high probability of mutation (7). The microbeam
studies also provided further evidence that cellular cytoplasm is less radiosensitive than
DNA (6).
Although the microbeam technique has improved the accuracy of the nuclear
irradiation experiments, other problems still existed. When alpha particles were aimed at
the nuclei of the cells, they had an opportunity to react with nearby extracellular fluid, the
cell membrane and the cytoplasmic compartment on their way to reach the nuclei. So the
nuclear effects might also reflect effects coming from other targets.
Figure 3-1. A schematic diagram of the microbeam system in the Center for Radiological
Research at Columbia University. The microbeam facility was designed to deliver defined
numbers of helium or hydrogen ions produced by a 4-MV van de Graaff accelerator,
covering a range of LET from 30 to 220 keV/[tm, into an area smaller than the nuclei of
human cells growing in culture on thin plastic films. The overall irradiation throughput for
the microbeam was about 10,000 cells/h (6).
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Radiation can induce different types of DNA damage such as DNA single strand
breaks and double strand breaks, modification of deoxyribose rings and bases, intra- and
inter-strand DNA-DNA cross-links and DNA-protein cross-links, through direct and
indirect interactions. Some damage like single strand breaks can be easily repaired,
resulting in little biologic consequence. Mis-repaired or un-repaired damage lead to
destructive consequences such as cell death, immediate or delayed reproductive
incapacitation. chromosomal aberration, mutation and carcinogenesis.
In experimental radiobiology, a variety of protocols or assays have been developed
to detect and measure cell damage. The clonogenic assay (colony frming assay) is a
fundamental way to evaluate one kind of severe cell damage - cell death. A cell-survival
curve describes the relationship between the radiation dose and the proportion of cells that
survive. Cell death may have different meanings in different contexts. In the clonogenic
assay, cell death means loss of the capacity for sustained proliferation or loss of
reproductive integrity. A cell may still be physically present and be able to make proteins
or synthesize I)NA, and may even be able to struggle through one or two cell cycles; but if
it has lost the capacity to divide indefinitely, it is, by definition, dead. Only cells that are
able to proliferate indefinitely to produce a large clone or colony containing more than 50
cells are considered to be clonogenic or to have survived. This assay can only be used with
immortal cell lines.
Compared to the clonogenic assay which provides cell survival information at the
population level, the single cell gel electrophoresis assay (also known as the comet assay)
is a simple. rapid and sensitive technique for analysing and measuring DNA damage in
individual mammalian (and to some extent prokaryotic) cells. It was first introduced by
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Ostling and Johanson in 1984 (8). Their version was a neutral assay in which the lysis and
electrophoresis were done under neutral conditions. Staining was done with acridine
orange. The resulted image looked like a "comet" with a distinct head, comprised of intact
DNA, and a tail, consisting of damaged or broken pieces of DNA. This was where the
name "comet assay" came from. The extent of DNA liberated from the head of the comet
was a function of the radiation dose. However, in this procedure, only double strand breaks
could be analyzed.
The neutral assay was modified by two groups, Singh and co-workers in 1988 (9)
and Olive et al. in 1989 (10). Singh et al. used microgels, involving electrophoresis under
highly alkaline conditions (pH> 13). This enabled the DNA supercoils to relax and unwind,
which are then pulled out during application of an electric current which made possible the
detection of single strand breaks in DNA and alkali-labile sites expressed as frank single
strand breaks in individual cells. This method was developed to measure low levels of
strand breaks (9). Olive and co-workers conducted the electrophoresis under neutral or
mild alkaline conditions (pH=12.3) to detect single strand breaks. This method was
optimized to detect a subpopulation of cells with varying sensitivity to drug or radiation
(10). The alkaline buffer technique of Singh et al. was found to be one or two orders of
magnitude more sensitive than the other techniques.
Since then a number of advancements has greatly increased the flexibility and
utility of this technique for detecting various forms of DNA damage (11-15). The comet
assay essentially measures the sizes of DNA fragments within the cell. It is therefore
necessary to convert DNA damage to DNA fragments by introducing breaks at the sites of
DNA damage before being able to detect with the comet assay. The simplest types of
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DNA damage detected by the neutral comet assay are the Double Strand Breaks (DSBs).
DSBs within the DNA result in DNA fragments and can be detected by merely subjecting
them to electrophoresis at neutral pH. Single Strand Breaks (SSBs) do not produce DNA
fragments unless the two strands of the DNA are separated/denatured. This is
accomplished by unwinding the DNA at pH 12.1. Other types of DNA damage broadly
termed as alkali labile sites (ALS) are expressed when the DNA is treated with alkali at pH
greater than pH 13. Furthermore, breaks can be introduced at the sites of DNA base
modifications by treating the DNA with lesion-specific glycosylases/endonucleases and the
fragments thus produced can also be detected by the comet assay. Therefore, by controlling
the conditions that produce breaks at the sites of specific DNA lesions, the comet assay can
be used to detect various classes of DNA damage and DNA repair in virtually any
eukaryotic cell.
In summary. the assay works upon the principle that strand breakage of the
supercoiled duplex DNA leads to the reduction of the size of the large molecule and these
strands can be stretched out by electrophoresis. Also, under highly alkaline conditions
there is denaturation, unwinding of the duplex DNA and expression of alkali labile sites as
single strand breaks. Comets form as the broken ends of the negatively charged DNA
molecule become free to migrate in the electric field towards the anode. Two principles in
the formation of the comet are:
· DNA migration is a function of both size and the number of broken ends of the DNA
* Tail length increases with damage initially and then reaches a maximum that is
dependent on the electrophoretic conditions, not the size of fragments.
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Jostes et al. used the comet assay to identify cells that are hit by the alpha particles
from the cells that escape damage (16). The histogram of their comet assay results showed
a bimodal distribution after 0.39 Gy Radon (alpha-particle irradiation) in the AL cell line
(figure 3-2) and the CHO cell line (not shown here). Our hypothesis is, if the comet assay
is sensitive enough to differentiate the hit cells from the non-hit cells after the alpha-
particle irradiation, it might be able to differentiate the bystander cells from both hit and
non-hit cells in the same population. To observe and study the bystander effect is the main
focus of this project.
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Figure 3-2. Graph from Jostes's paper "Single-cell gel technique supports hit probability
calculation". Single -cell gel data from the AL cell line. Two slides, representing a total of
60 cells, were evaluated for each of the treatments. The top panel illustrates the probability
distribution for the unirradiated cell population; the middle panel illustrates the probability
distribution for the low-LET X-ray control; the bottom panel illustrate the probability
distribution for the radon-irradiated population (16).
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3.2 Materials and Methods
3.2.1 Cell culture conditions
The DU-145 human prostate carcinoma (metastatic) cell line was obtained from the
American Type Culture Collection (Cat. No. HTB-81). The cells were grown at 37 °C in a
humidified atmosphere of 95% air and 5% CO, with Eagle's Minimum Essential Medium
containing Earle's BSS and 2 mM L-glutamine (MEM/EBSS; HyClone), supplemented
with 1.0 mM sodium pyruvate (SH30239.01, HyClone), 0.1 mM nonessential amino acids
(SH130238.01, HyClone), 1.5 g/L sodium bicarbonate (SH30033.01, HyClone) and 14%
fetal bovine serum (FBS; Sigma). The cell doubling time was about 34 hours. The cells
were sub-cultured once per week, and the medium was changed approximately every 3-4
days. The DU-145 cell line passage number was 57 upon arrival from the ATCC. The cells
were cultured for another three passages before multiple aliquots (- 107 cells per vial) were
frozen in cryovials and stored in liquid nitrogen. Since one passage of cells would be
slightly different than another passage, every frozen vial of stock DU-145 cells was used
for about two months (8 passages) and all experiments were carried out with cells between
passage numbers 60 and 68.
3.2.2 Cell counting methods
For many applications that require the use of suspensions of cells, it is necessary to
determine cell concentration and cell number. The most widely used type of cell counting
device is the hemocytometer (see figure 3-3).
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Figure 3-3. Schematic view of the hemocytometer
Before use, the mirror-like polished surface and the coverslip were carefully
cleaned with alcohol. Coverslips for the hemocytometer are specially made and are thicker
than those for conventional microscopy, since they must be heavy enough to overcome the
surface tension of a drop of liquid. The coverslip was placed over the hemocytometer prior
to putting on the cell suspension. The suspension was introduced into one of the V-shaped
wells with a pipet. The area under the coverslip was filled by capillary action. Enough
liquid should be introduced so that the mirrored surface is just covered. The filled
hemocytometer was then placed on the light microscope stage and the counting grid was
brought into focus at 100x (lOx objective) (see figure 3-4). The main divisions separate the
grid into 9 large squares. Each square has a surface area of one square millimeter, and the
depth of the chamber is 0.1 mm. Thus the entire counting grid lies under a volume of 0.9
mm3
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Figure 3-4. An entire counting grid of a hemocytometer, consisting of nine -mm 2 squares
Cell suspensions should be diluted to an extent that the cells won't overlap each
other on the grid and there are at least 100 cells in each of the nine large squares to achieve
a statistical meaning. The cell numbers in the four large corner squares and the middle one
are counted. For cells that overlapped a ruling, a cell was counted as "'in" if it overlapped
the top or right ruling, and out" if it overlapped the bottom and left ruling. Five cell
numbers were obtained from one counting grid, n, n, n3, n4 and n. Another five cell
numbers were obtained from the counting grid on the other side of the hemocytometer, n6,
n7. n8, n9 and nb. In order to determine the original cell concentration, the average count in
ten large squares was calculated as n; then the average count n was divided by 0.1 mm2 or
0.0001 ml, the volume under each large square. The resulting original cell concentration is
n x 104 cells/ml.
93
Use of the hemocytometer is time consuming and the results are affected by human
factors, such as the volume of cell suspension introduced into the counting chamber. An
automated cell counting device called Coulter Counter was used to save the time and
improve the consistency and accuracy of the results.
The Z2 Coulter Counter from Beckman Coulter is a cell and particle counter using
the Coulter principle (Electrical Sensing Zone Method). The Coulter method of sizing and
counting particles is based on measurable changes in electrical resistance produced by
nonconductive particles suspended in an electrolyte. In addition to reporting cell count and
concentration, it also provides size distribution of the cell population. To use the Coulter
Counter, 1 ml of cell suspension was diluted to a total volume of 10 ml with electrolyte in
a special cup. The cup was then put onto the Coulter Counter stage and the start" button
was pushed to start the process. The results were displayed on the screen of the control
panel connected to the counter. The Coulter Counter was calibrated by the hemocytometer:
the Coulter Counter was regarded as reliable when its counting result agreed with the
hemocytometer counting result for the same cell suspension sample. Three measures were
performed for each cup of cell sample and the average was calculated as the final result.
3.2.3 Cell survival experiments
For cell survival experiments, - 5 x 105 DU-145 cells were plated into the pre-
coated Mylar dishes and allowed to attach overnight (16-22 hr). The medium was changed
half an hour before the irradiation. Dose response curves were obtained by irradiating
dishes with graded doses of alpha particles at room temperature. Following the irradiation,
the cells were trypsinized (0.25% trypsin with 0.1% EDTA at 37 C for 3 min), re-
suspended with full growth medium and plated into 100 mm culture dishes for colony
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formation assay. The medium was changed once after 5 days of growth (some protocol
does not suggest medium change during the colony formation period and similar results
were obtained using the two protocols in our lab). After 10 days of growth, the colonies
were washed with phosphate buffered saline (PBS), fixed with 95% ethanol, and stained
with 1% methylene blue aqueous solution. After staining for 5 to 10 minutes, the extra
methylene blue solution was collected back into the original bottle, and the dishes were
rinsed with running tap water and allowed to air dry. The colonies that contained 50 or
more cells were counted. Each colony represented one surviving cell. Five duplicate dishes
were scored per dose point in each experiment. The average cell sur' ival fraction equaled
the average number of colonies divided by the average number of cells plated. The
surviving fraction for the control group is called plating efficiency (PE ratio). The
surviving fractions in the radiation groups were normalized to the corresponding plating
efficiencies. For X-ray irradiations, DU-145 cells were plated into the pre-coated Mylar
dishes and allowed to attach overnight. Irradiations with X-rays were carried out using a
Phillips RT250 unit operating at 250 kV and 12 mA with 0.4 mm Sn plus 0.25 mm Cu
added filtration and a focus-to-target distance of 32 cm. The average X-ray dose rate in the
cell culture flask was 1.0 Gy/min. After irradiation, the cells were trypsinized and plated
for colony formnnation as described before. The data for each dose point were pooled from
multiple experiments. All data were shown as means ± standard deviation.
3.2.4 The comet assay
In order to run the comet assay, some basic materials and equipment were needed,
including the comet assay slides, an electrophoresis tank and a variety of reagents.
Although regular unpolished glass microscope slides work fine for the comet assay, sample
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loss might occur during the slide washing steps. Trevigen (Trevigen, Inc., MD) provided a
comet assay kit which contained specially designed and treated CometSlides and the
following components:
Component Size Storage Temp
Lysis Solution 2 x 500 ml 18 - 24 °C
Comet LMAgarose 15 ml 18 - 24 °C
CometSlide 25 ea 18 - 24 °C
200 mM EDTA 12.5 ml 18 - 24 °C
SYBR"' Green I nucleic acid gel stain 5 pl -20 °C
Table 3-1. Components of the Trevigen comet assay kit
For convenience, the Trevigen comet assay kit was first used in our comet assay
experiments. But sample loss still occurred during slide processing. Also it was
recommended to use freshly made lysis solution before each experiment. To improve the
outcome of the experiments, the comet assay slides and all necessary reagents were made
freshly before the experiments.
2.1.1.1 Comet assay slides
Singh used newly designed clear window frosted slides for the comet assay in 1999
to improve agarose attachment (17). A similar type of commercially available slides (MGE
slides, Erie Scientific Company, Portsmouth, NH, Cat. No. ES 370) coated with a thin
layer of normal melting agarose were used in our experiments. The surrounding frosted
area provided better attachment for agarose and the middle clear window avoided the
uneven background for image analysis. It worked much better and no sample loss ever
occurred after using these pre-coated slides. The following is the procedure to prepare the
slides:
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1. Prepare 0.5% low melting agarose (LMA) (250 mg per 50 ml) and 1.0% normal
melting agarose (NMA) (500 mg per 50 ml) in PBS. Microwave or heat until near
boiling and the agarose dissolves. For LMA, aliquot 5 ml samples into scintillation
vials (or other suitable containers) and refrigerate until needed. When needed, briefly
melt agarose in microwave or 100°C water bath. Then place melted LMA vial in a
370C water bath to cool and stabilize the temperature.
2. While NMA agarose is hot, dip the MGE slides (or conventional slides) to a desired
position and gently remove. Wipe underside of slide to remove agarose and lay the
slide in a tray on a flat surface to dry. The slides may be air dried or warmed for
quicker drying. Store the slides at room temperature until needed; avoid high
humidity conditions.
3.2.4.1 Electrophoresis apparatus
A horizontal electrophoresis tank with passive re-circulation from Fisher Scientific
(FB-SBR-2025) was used in our experiments. The power supply was set to generate 1 volt
per cm. The distance between the two electrodes was 36 cm. So the applied voltage was 36
volt. The volume of the buffer was adjusted to generate 250 mA current in the buffer
(about 1.6 L). The electrophoresis time was chosen according to the specific cell line and
the extent of the DNA damage. The optimal time should result in minimum DNA
migration in control cells but maximum DNA migration in treated cells. H202 is an agent
known to cause single strand breaks in DNA. 100 [tM H,O0 treatment for 20 minutes at 4
°C was used as positive control. The alkaline comet assay was used for detection of single
strand breaks after HO22 treatment. During electrophoresis, the slides were placed along the
edge of one side (see figure 3-5) to ensure that all samples were subject to as even an
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electric field as possible. If the sample slides were not enough to fill all the positions on the
edge, slides without cell samples were used to occupy the empty positions. The sample
slides were preferably placed in the positions from 2' to '7' to avoid a "fringe effect" of
the electric field. The test for the uniformity of the electric field along the edge was
performed by comparing the comet assay results among slides placed in different positions
from '2' to '7' with the same batch of cells after 100 [M H2 02 treatments for 20 minutes.
I = 20 mA
.6 ~,._,~..
Figure 3-5. Top. Schematic top-view and side-view of the electrophoresis tank. Bottom:
The picture of the electrophoresis tank connected with the power supply.
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3.2.4.2 Reagent preparation
I . 1 xPBS (phosphate buffered saline) was diluted from I OxPBS stock in DI water. It
was calcium and magnesium free to inhibit endonuclease activities.
2. Lysis solution could be obtained directly from the Trevigen kit or made freshly. If
it was made freshly, the following was the procedure: Ingredients per 1000 ml: 2.5
M NaCI (146.1 mg), 100 mM EDTA (37.2 mg) and 10 mM Trizma base (1.2 mg).
Add ingredients to about 700 ml distilled water, (DI water) and begin stirring the
mixture. Add -8 gm NaOH and allow the mixture to dissolve (about 20 min).
Adjust the pH to 10.0 using concentrated HC1 or NaOH and volume to 890 ml with
distilled water (the Triton X-100 and DMSO (dimethyl sulfoxide) will increase the
volume to the correct amount), and store at room temperature. Final lysing
solution: add fresh 1% Triton X-100 and 10% DMSO, and then refrigerate for at
least 30 minutes prior to slide addition.
3. Alkali solution was prepared freshly according to the following formula: 0.6 g
NaOH pellets + 250 tIL 200 mM EDTA + 49.75 ml DI water = 50 ml alkali
solution.
4. Neutralization Buffer was prepared according to the following formula: 48.5 mg
0.4 M Tris was added to -800 ml DI water, adjust pH to 7.5 with concentrated 10
M HCI: q.s. to 1000 ml with DI water, store at room temperature.
5. TBE Electrophoresis buffer was prepared: 1 xTBE (0.089 M TRIS, 0.089 M Borate,
0.002 M EDTA) was diluted from I OxTBE stock in DI water. I xTBE was used for
electrophoresis because of its buffering capacity. To prepare 10 <TBE, dissolve 108
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g Tris base, 55 g boric acid and 9.3 g of EDTA disodium salt in 900 ml of DI
water. Adjust volume to 1 liter and autoclave. The total volume of buffer used in
the experiments was 1.6 liter.
6. SYBR Green staining solution was prepared from the SYBR Green concentrate
provided by the Trevigen kit. Dilute 1 pL of the concentrate to 10 ml TE (pH=7.5).
SYBR Green's maximum excitation and emission are respectively 494nm/521nm.
The diluted stock was stable for several weeks when stored at 4 °C in the dark.
During sample preparation, all the buffers were chilled to 4 C to inhibit
endogenous damage from occurring and to inhibit repair in the unfixed cells.
3.2.4.3 Cell culture and treatment
The DU-145 cells were plated into the Mylar dishes one day before the experiments
and allowed to attach overnight. For positive control experiments with H20 27 the cells
could be grown in either T25 flasks or Mylar dishes. Irradiation or H,0 2 treatments at
different doses were performed. After irradiation or H20 2 treatment, attached monolayer
cells were trypsinized at 4 C for about 10 min. The reason that the trypsinization was
performed at 4 C was to prevent the repair process that happens at 37 °C. This was also
why the cells should be kept on ice or at 4 °C all the time. After trypsinization, the cells
were resuspended at a concentration of about 1 x 105 cells/ml in ice cold medium. To ensure
the required concentration, pilot studies were conducted to determine the yield of cells
from T25 flasks or Mylar dishes and the appropriate volume of ice cold medium to use for
resuspending the cells. Cell samples were handled under dimmed light to prevent DNA
damage from ultraviolet light.
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3.2.4.4 Experimental procedure
Figure 3-6 shows the experimental protocol of the comet assay. After treatment by
radiation or other agents, the single cell suspension of the DU-145 cells was suspended in
low melting aarose and layered onto MGE slides pre-coated with agarose. Lysis of the
cells under high salt concentration was then carried out to remove cellular proteins and
liberate the damaged DNA. The liberated DNA was subjected to unwinding under alkaline
condition to allow DNA supercoils to relax and express DNA single strand breaks and
alkali labile sites. Electrophoresis was then carried out under neutral condition, which
allowed the smaller DNA fragments to migrate towards the anode under the effect of the
electric field. The staining was done using fluorescent DNA dyes SYBR (or Ethidium
Bromide). The slides were then kept in a humidified slide chamber until they were scored.
Wash 
Neutral
Lysis Neutral
Electrophoresis
Preparation Staining
Single of Slides Data
Treatment l Suspension- -U Analysis
L ~j~ Alkaline
DNA Alkaline Electrophoresis
Rejoining-Repair Lysis
Unwinding
Figure 3-6. The schematic experimental protocol of the comet assay (Neutral and Alkaline)
The following is the detailed alkaline comet assay procedure used in the
experiments described in this chapter:
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1) Melt LMA in a beaker of boiling water for 5 minutes, with the cap loosened. Place
bottle in a 370C water bath for at least 20 minutes to cool down. The temperature of
the agarose was critical. If it was too high, the cells would be damaged.
2) Combine cells at 1x105 cells/ml with molten LMA (at 37°C) at a ratio of 1:10 in
volume. Mix them by gently pipetting twice and immediately transfer 75 [tl onto
the pre-coated slides. Let the agarose/cell cover the sample area.
3) Place the slides flat at 4 °C in the dark refrigerator for 10 min for adherence.
4) Immerse the slides in pre-chilled lysis solution and leave at 4 °C for 60 min.
5) Tap off excess lysis solution from the slides and immerse in freshly prepared
alkaline solution (pH > 13). Leave the slides in alkaline solution for 60 minutes at
room temperature, in the dark.
6) Remove the slides from alkaline solution, gently tap excess buffer from the slides
and wash by immersing in I xTBE buffer for 5 min twice.
7) Transfer the slides from I xTBE buffer to a horizontal electrophoresis apparatus.
Place the slides flat onto the gel tray and align equidistant from the electrodes. Pour
1.6 liter pre-chilled 1 xTBE buffer to the tank. Set power supply to 36 volt (1 volt
per cm). The volume of the buffer was adjusted to generate 250 mA current. Apply
voltage for a period of time. The optimal time should result in minimum DNA
migration in control cells but maximum DNA migration in treated cells. It was
determined in one experiment on cells treated with 100 [tM H20 2 for 20 minutes.
8) At the end of the electrophoresis, turn off the power and gently lift the slides from
the buffer and place on a drain tray.
9) Very gently tap off excess liquid and dip the slides in cold 100% ethanol for 5 min.
10) Air dry samples. Drying brings all the cells in a single plane to facilitate
observation. Sample slides were stored at room temperature, with desiccant until
scoring.
11) Before scoring, stain the slides with 100 [tl diluted SYBR Green solution for 10
min at room temperature. Place a cover slip to ensure even staining. Then take off
the cover slip and wash the slides with PBS twice. Place a fresh cover slip and blot
away excess liquid on the back and edges. Score at least 200 cells per sample. After
scoring, remove cover slip, rinse in 100% alcohol to remove stain, let dry and store.
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3.2.4.5 Data analysis
There are a number of different methods to score the DNA in the tail of the
unwound comets. The simplest technique is to score the comets empirically on the basis of
damage extent. Because the assay produces a visual endpoint, it is possible to score the
comets based on their appearance as damaged, undamaged, or with a simple scoring
system to gra(de the extent of damage. This method of evaluation, although lacking in
sophisticated image analysis, has been used with some success (18). This qualitative
analysis was performed at an early stage of the experiments. After staining with SYBR, the
sample slides were observed and recorded under a fluorescent microscope (Zeiss.
Axioplan-2 imaging). The comets were put into one of four categories according to their
appearance (length and intensity of the tails).
To facilitate the data analysis process, an automated comet assay analysis system from
Loats Associates (LAI) was used for the quantitative analysis of the comet data. The LAI
Automated Comet Assay Analysis System (LACAAS) from Loats Associates, Inc. (LAI),
is a modular system of hardware and software that offers the features and components
needed for collection and automated analysis of large sets of fluorescent single-cell comet
images. Appropriate measurement and quantitative analysis of fluorescence intensities
exhibited by the cells indicated cellular DNA content, distribution, and damage. The
LACAAS Comet Assay software was designed to operate under the Windows operating
system. It offers a proprietary image capture system that provides extended dynamic range
imaging (EDRI) capabilities. Unlike conventional image capture systems, the EDRI
system enables detection and digital recording of the full range of fluorescent intensity
important for accurate analysis of comet images. Comet images were corrected to remove
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any superimposed background noise signals, before quantitative analysis for DNA damage
proceeds. The LACAAS automatically generated multiple quantitative measures of each
cell analyzed, including standardized measures of comet tail length, area, moment,
moment arm and moment of inertia, as well as measures of cellular DNA content, percent
of total cellular DNA in the tail and a measure of total cellular DNA fragmentation. All
measures were automatically saved to a data base, along with their corresponding comet
images, for subsequent review and statistical analysis (see figure 3-7). The data were
exported to Microsoft Excel for further analysis.
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Figure 3-7. The integrated window of the LAI's Automated Comet Assay Analysis
System. The upper window is for the comet images. Different colors represent different
fluorescent intensities (white-high intensity; red-low intensity). The image comes with an
intensity curve and two bars, which define the tail region. The lower left window gives
measured data for individual comets. The lower right window provides group statistical
information and comparison of multiple study groups, with respect to the distributional
properties of selected comet analysis endpoints.
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The distance of DNA migration from the nuclear core, as defined as tail length, is a
parameter commonly used to evaluate the extent of DNA damage. An increasing popular
method of comet evaluation is "tail moment", which is defined as the product of the tail
length and the fraction of total DNA in the tail. Tail moment incorporates a measure of
both the smallest detectable size of migrating DNA (reflected in the comet tail length) and
the number of relaxed/broken pieces (represented by the intensity of DNA in the tail). Tail
length and tail moment were two endpoints used in this study.
Three different graphical tools are used to demonstrate the results in this chapter:
mean ± SD, histogram and boxplot. The "mean + SD" is the most fundamental statistical
way to describe a group of experimental data. The histogram shows the frequency
distribution of the experimental data using bars. And the boxplot is a graphical summary of
a distribution as shown in figure 3-8.
Figure 3-8. Illustration of the boxplot. The boxplot is often
called the "box and whisker" plot. The "box" in a boxplot
is defined by the lower 25th percentile line and the upper
75th percentile line. The median is the score at the 50%
percentile: half of all scores are higher than the median,
and half of them are lower than it. The 25th percentile is
75th percentile the point than which 25% of the scores are lower. The 75th
50th percentile pe entile is the point than which 75%/ of the scores are50th percentile
25th percentile lower. Thus, the area in the "box" represents the middle
50% of the data. The length of the box in a box plot, i.e.,
- .1__ _ . -__. _ .__ nO 1_ I - 1_ _______v 1 __ 
* the distance between te zL5mt and /tl percentiles, is
known as the interquartile range. Whiskers above and below the box indicate the 90th and
I 0th percentiles. The symbols beyond the IOth and 90th percentiles represent outliers or
extreme data.
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2.1.2 Micronucleus assay
The presence of micronuclei (MN) was evaluated by the cytokinesis-block
technique (19) (see figure 3-9). After trypsinization, all harvested cells were transferred
into two-well chamber slides (Lab-Tek Il, Nalge Nunc lnt., Rochester, NY). Gentle
pipetting was used to separate the cells and to distribute them evenly on the slides. The
cells were allowed to attach in the chamber slides for 3-5 hrs before the medium was
replaced with fresh growth medium containing 3 glg/ml cytochalasin-B (Sigma) to block
cytokinesis. Cytochalasin-B works to inhibit the actins, proteins involved in cell division
and therefore to inhibit the cytokinesis. The cells were incubated for 42 hrs (-1.5 doubling
times) to accumulate bi-nucleated cells (BN). At the end of the incubation, the cells were
rinsed twice with PBS and fixed twice at 40C with ice cold fixation solution (3:1 methanol
to acetic acid) for 1 hr each time. The chamber slides were air-dried, stained with 1 ml of
10 Ctg/ml DAPI (Sigma-Aldrich) for 10 minutes, and then washed once with PBS. The
chamber walls were then removed, the mounting medium with anti-fade reagent (Fluoro
Guard, Bio-Rad Laboratories) was added to the slides, the cover-slips were added and
pressed to spread the anti-fade reagent evenly and squeeze out the air. The slides were
finally sealed with nail polish. The slides could be stored at 40C in the dark for several
months to be scored before fading became apparent. The slides were observed under an
epi-fluorescence microscope (Olympus BX51) at 400x magnification (see figure 3-10). For
each sample, 1000-2000 bi-nucleated cells were scored and the percentage of bi-nucleated
cells that contains MN (expressed as MN/BN ratio) was determined. Data from multiple
replicate experiments were combined and plotted as mean ± SD. For statistical analyses of
the MN/BN ratios between different experimental groups, the mean, SD and number of
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independent samples scored were compared using an unpaired t-test (GraphPad Software,
Inc.).
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Figure 3-9. Schematic view of the micronucleus formation process. In a normal situation
(the upper process), a cell divides into two separate daughter cells, each containing one
nucleus. With cytochalasin-B, an inhibitor of actins, the cell is blocked from cell division
after the completion of nuclear division (the lower process). The resulting one cell
containing two daughter nuclei is called a binucleated cell or BN. The micronucleus forms
when a fragment of chromosome is broken off the main chromosome body due to damage,
resulting in one or more micronuclei (MN) within the binucleated cell (BN). The presence
of MN is a sign of severe damage to the cells. A BN cell with one or more MN was scored
as one MN.
Figure 3-10. Pictures of binucleated cells (BN) with and without micronucleus (MN).
stained by DAPI and recorded by an Olympus BX51 epi-fluorescence microscope. The
magnification fotbr the left image was 100x and for the right image was 400x.
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Micronucleus assay was conducted on the directly irradiated cells in the Mylar
dishes. Approximately 5 x 105 DU-145 cells were seeded in the Mylar dish the day before
the experiments. The medium over the cells was replaced with fresh full growth medium
half an hour before the irradiation. The monolayer of cells was then irradiated at doses of
0.1 Gy, 0.2 Gy, 0.3 Gy and 0.6 Gy. After the irradiation, the cells were trypsinized and
processed for the micronucleus assay.
3.3 Results
3.3.1 Cell survival curves
Figure 3-11 shows the survival curves for DU-145 cells irradiated with alpha
particles from foil #4 and with 250 kVp X rays. The data represent two independent X-ray
experiments and five independent alpha-particle experiments. The alpha-particle dose
response curve was fitted with an exponential function: surviving fraction SF = exp(-aD),
where a = 3.6 Gy' l. The X-ray survival curve was fitted to the linear quadratic function: SF
= exp(-aD - D2), a = 0.37 Gy-' and = 0.0304 Gy 2. The Do was 0.28 Gy for alpha-
particle survival curve and 1.3 Gy for X-rays. The RBEs of the 24l1Am alpha particles
compared to the 250 kVp X rays at the 0.37, 0.1, and 0.01 surviving fraction levels were
12.0, 9.0, and 6.8, respectively. The RBE of the alpha particles estimated from the ratio of
the initial slopes was 10.0.
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Figure 3-11. D:)U-145 cells survival curves for alpha-particle and X-ray irradiation. The
fraction of cells surviving is plotted on a log scale against dose on a linear scale. For alpha-
particle irradiation, the dose-response curve is a straight line from the origin, described by
a linear function SF = exp (-3.6xD). For X-ray irradiation, the dose-response curve has an
initial linear slope, followed by a shoulder, and tends to become straight again at higher
doses. The X-ray curve can be fitted to a linear-quadratic function SF = exp (-0.37xD -
0.0304xD 2).
3.3.2 Comet assay results
Figure 3-12 shows the comet images at different damage levels after 1.2 Gy alpha-
particle irradiation. Alpha-particle irradiation produced heterogeneous comets since
irradiated cells could receive different numbers of alpha-particle hits for a irradiation dose.
Table 3-2 gives the eight measurements from the LACAAS for the six comet images
shown in figure 3-12.
Figure 3-13 shows comet images with unclean background. In this case, no
accurate measurements could be obtained from the LACAAS.
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Figure 3-14 shows the results of the uniformity test of the electric field in the
electrophoresis tank. Figure 3-15 shows the electrophoresis time responses demonstrated
in mean ± SD (from 20 to 100 minutes) after 100 [tM H20 2 treatment for 20 min at 4 °C.
Figure 3-16 shows the electrophoresis time response demonstrated in box plots for control
and the 100 M H20 2 treatment group. Figure 3-17 shows the tail lengths in histogram and
box plot after graded alpha-particle irradiations (0, 0.2 Gy, 0.6 Gy and 1.2 Gy). Figure 3-
18 shows the tail moment in histogram and box plot after graded alpha-particle
irradiations.
Figure 3-12. The DU-145 comet images at different damage levels after 1.2 Gy alpha-
particle irradiation.
# Moment M. Arm M. Inertia Fragment. % DNA Length Area Intensity
1 0.00 0 0 4.80 0.06 1 54 244000
2 2.15 45 152 3.18 4.82 95 4500 3380000
3 3.30 45 204 3.67 7.29 105 6450 3180000
4 9.24 57 752 3.09 16.17 145 17500 6900000
5 56.57 109 8010 9.36 51.84 235 35300 4370000
6 142.28 168 27200 14.81 84.94 293 42000 3170000
Table 3-2. The comet assay analysis results for the six comet images showed in figure 3-
12. Eight measurements were automatically generated by LACAAS for every captured
comet image. Among the eight measures, the tail moment, % DNA and tail length are most
commonly used for results analysis and demonstration.
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Figure 3-13. A common problem encountered in the comet assay analysis was unclean
background. The LACAAS could not handle this situation therefore the results were
umneliable. The problem usually came from careless handling of the sample slides so that
dirt fell onto the slides and was stained by the fluorescent dye. Data corresponding to these
images should be removed from the Excel files before further statistical analysis.
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Figure 3-14. The uniformity test of the electric field. Group 1 was the control group, in
which the cells were not treated with any damaging agent. Groups 2, 3 and 4 were cells
treated with 100 piM H20 2 for 20 minutes at 4 °C. The control slide was placed in position
3 and the slides with 100 jPM H20 2 treated cells were placed in positions 2, 4 and 6 along
the edge of the electrophoresis tank. Positions 1, 5 and 7 were occupied with spare slides
(see figure 3-7). About 100 cells were scored in each sample.
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Figure 3-15. The test of different electrophoresis time in DU-145 cells treated with 100 ~tM
H202 for 20 min at 4 °C. The x-axis represents different electrophoresis time. On the y-
axis, the tail moment (up left), % DNA in tail (up right) and tail length (bottom) are
demonstrated in mean ± SD. H20 2 is an agent to induce single strand breaks in cellular
DNA. The alkaline comet assay was used to express the single strand breaks. 100-200 cells
were scored in each group.
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Figure 3-16. The tests of different electrophoresis time in control cells (left) and cells
treated with 100 M H0 2 for 20 mins at 4 C (right). The x-axis represents different
electrophoresis time. For the y-axes, the tail moment, tail length and % DNA in tail are
shown in box plots. From the results, 40 mins was chosen for further experiments because
it differentiated the H202 treated cells from the control cells better than 20 mins in all three
endpoints. 60 mrins did not seem to improve much compared to 40 mins.
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Figure 3-17. Tail length histogram (top) and box plot (bottom) for DU-145 cell comet
assay results after 0, 0.2 Gy, 0.6 Gy and 1.2 Gy alpha-particle irradiations, under the
alkaline comet assay condition and 40 minutes electrophoresis. More than 100 cells were
scored in each group.
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Figure 3-18. Tail moment histogram (top) and box plot (bottom) for the DU-145 cells after
0, 0.2 Gy, 0.6 Gy and 1.2 Gy alpha-particle irradiations, under alkaline comet assay
condition and 40 minutes electrophoresis. For the box plot, the y-axis is on a log scale.
More than 100 cells were scored in each group.
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3.3.3 Micronucleus formation results
Figure 3-19 shows that, in the directly irradiated cells, the MN/BN ratio is a linear
function of the average alpha-particle dose in the range of 0.1 to 0.6 Gy. Each data point is
the mean of four independent samples and scoring of approximately 1000 cells per sample.
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Figure 3-19. Dose response for micronucleus formation in DU-145 cells growing on the
Mylar membrane and directly irradiated with alpha particles. Data points represent the
mean ± SD of two independent experiments with approximately 1000 cells scored per
experiment.
Inspection of the data in figures 3-11 and 3-19 allows a direct comparison of
survival and MN/BN ratio for the DU-145 cells under the same irradiation conditions. E.g.,
a direct alpha-particle dose of 0.6 Gy reduced the clonogenic survival to approximately
10% and produced a MN/BN ratio of 60%. The cytochalasin-B block procedure (20)
resulted in 82 0.1% of the control cell population arrested in the binucleated state
(%BN). Analysis of the %BN in the targeted cells exposed to direct alpha particle doses of
0.1, 0.2, and 0.3 Gy (see figure 3-19) indicated that 78 ± 1.2%, 74 ± 0.6%, and 70 ± 0.7%
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of the cells were binucleated. These data suggest that the alpha particle doses may be
causing a growth delay or interfering with the ability of the cells to progress through the
cell cycle.
3.4 Discussion
In this chapter, three endpoints were used to measure the responses of DU-145 cells
to the alpha-particle irradiation. The clonogenic assay was used to measure the cell
survival rate at the population level; the comet assay was used to measure DNA strand
breaks in individual cells; Micronucleus formation was used to measure the presence of
micronuclei (NfN) in binucleated cells. In the clonogenic assay, the DIJ-145 cells showed a
linear dose response on log-scale for alpha-particle dose range 0 - 1.8 Gy, which is a
typical shape flor cell dose-response curves after alpha-particle irradiations (figure 3-11).
Micronucleus formation showed a linear dose response for alpha-particle dose range 0 -
0.6 Gy (figure 3-19).
The comet assay has many advantages and has been frequently used by research
groups from all over the world in the past few years. Its ability to detect DNA strand
breaks or other DNA lesions that could be transformed into DNA strand breaks (such as
alkali-labile sites) at the cellular level as well as its ability to distinguish single strand
breaks (alkaline condition) and double strand breaks (neutral condition) make it a popular
tool in areas such as radiation biology. oxidative damage and genetic toxicology (11, 15.
21).
In the comet assay studies, the electric field uniformity in the electrophoresis tank
was tested first. The results suggested uniform responses from the slides along the edge of
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the tank, more specifically from position '2' to '7' (see figure 3-7). These positions were
used for further experiments. Then different electrophoresis times (20 mins, 40 mins, 60
mins, and 80 mins) were tested in both control groups and H2 0 2 treated groups. 40 mins
was chosen to be used in further experiments because it differentiated the H20 2-treated
groups from the control groups in a relatively short period of time.
The results of the alkaline comet assay for DU-145 cells after alpha-particle
irradiation were shown in histogram and box plot. Due to the heterogeneous property of
alpha-particle irradiation, the exposed cells received different numbers of alpha-particle
traversals, as defined by a Poisson distribution. So the mean and standard deviation are not
ideal statistical tools for results interpretation. The tail length and tail moment were chosen
for their sensitivities. From the histograms, alpha-particle irradiation generated a
distribution of tail length and tail moment, which shifted to higher level of damage
indication as the alpha-particle dose increased. From the box plots, an increasing trend can
be observed with increasing alpha particle doses. Comparing the two groups of results, tail
length shows better sensitivity and linearity in dose response. Even in the control groups,
some cells with long tail and large tail moment were observed. The damage of those
control cells may come from the environmental factors, the handling processes, or the cells
themselves, just like the concept of plating efficiency for the control cells in the clonogenic
assay. Control slides were included in all experiments for background monitoring.
Although our histogram results showed a shift of tail length and tail moment as a
function of average alpha-particle doses, we did not observe the bimodal distribution
shown by Jostes et al. (16) (see figure 3-2). They used the alkaline single-cell gel
technique to provide a biological estimate of the percentage of cell nuclei "hit" by alpha
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particles during in vitro radon exposure and pointed out that the comet assay technique
could be used to detect alpha-particle hits" to cell nuclei (16) and to show both the hit and
the non-hit cells in the population after a low fluence of alpha particles. One possible
explanation is that they used length-width ratio as an endpoint but we used tail length and
tail moment as endpoints. Different endpoint parameters could generate different results.
Ideally, we should use the same "length-width ratio" parameter to compare our results to
Jostes's results. However, the LACAAS Comet Assay software used in our studies did not
include the "length-width ratio" as one of its eight measurement parameters (Table 3-2),
which made it impractical for us to use it. In addition, the length-width ratio" is not a
commonly used parameter in the majority of the comet assay studies. The most commonly
used and highly recommended parameters are tail length, tail moment and percentage
DNA in tail (11, 18, 21). Another reason might come from the different cell lines used in
different studies. They used the Al. cell line (figure 3-2) as well as the CHO cell line (not
shown here) but we used a human prostate tumor cell line DU-145.
Meanvwhile, variations were reported in the comet assay results among different
research groups ( 1). The timing and voltage used for electrophoresis were largely
empirical. Much of the variation in the reported comet assay protocols was found during
electrophoresis. The desired voltage and time of electrophoresis was related to the levels of
DNA damage expressed in the cells and the salt concentration of the buffer (1 1). A variety
of fluorescent dyes such as propidium iodide, acridine orange, SYBR, YC)YO, etc,
different fluorescent microscopes and different image analysis systems used by different
comet assay groups could all contribute to the variations. Lack of consistency among
research groups is still a problem in this field.
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In our come assay studies, variations among experiments conducted at different
time were also observed (data not shown here). Those differences might come from slide
preparation, cell sample preparation, reagent preparation, as well as the actual experimental
handling and processing. Factors like the salt concentration and the volume of the
electrophoresis buffer, the stability of the input voltage and the current could all affect the
results. Fading of the fluorescent dye was another factor contributing to the variations.
Scoring the same sample slide twice at different times could produce different results, even
when the anti-fade solution was used. Lack of consistency was a problem we encountered
in our comet assay experiments.
As a conclusion, the lack of standardization and automation of the procedure, the
lack of sensitivity and consistency in the results, especially the fact that we could not
reproduce the bimodal distribution shown by Jostes et al (figure 3-2) to differentiate the hit
cells from the non-hit cells in a mixed cell population, which we based our hypothesis on,
discouraged us from using the comet assay in the bystander studies described in next
chapter.
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Chapter 4 Bystander Effect Studies
4.1 Introduction
It has been long accepted that the important biological effects of ionizing radiation
of cells resulted from unrepaired or misrepaired DNA damage in the irradiated cells and
the nucleus of a cell is the critical target of radiation. It was presumed that no biological
effects would be expected in cells that receive no direct radiation. However, accumulated
experimental evidence in the recent decade or so indicate that cells receiving no direct
radiation can also show biological consequences from their neighboring irradiated cells.
This phenomenon is called the radiation-induced bystander effect or simply the bystander
effect in appropriate context and in this thesis. The bystander effect w-as first described by
Nagasawa and Little using low doses of alpha particles and a chromosome aberration
endpoint (1). Over 30% of Chinese Hamster Ovary (CHO) cells showed sister chromatid
exchanges (SCE) when less than 1% of cell nuclei were actually traversed by an alpha
particle. These results suggested that the 'effective target" for genetic damage by alpha-
particle irradiation is much larger than the nucleus or even the cell itself Since then, the
literature on the bystander effect has expanded enormously. Four years later, the
phenomenon was confirmed by another group using the same endpoint (SCE) in normal
human lung fibroblasts (2). Enhanced frequencies of gene mutation, micronucleus
formation and apoptosis were subsequently observed in the bystander cells after alpha-
particle irradiation (3-6). The bystander effect is a class of effects that differs with cell
type, endpoint and in actual mechanism: reviewed in (7-9). There are at least two separate
mechanisms for the promulgation of damage from irradiated cells to unirradiated
neighbors. One line of evidence indicates that some bystander effects are dependent on
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cell-cell contact and gap junction intercellular communication (GJIC) (6, 10). Other reports
have demonstrated that irradiated cells can release a soluble factor into the medium that
can cause damage in un-irradiated cells subsequently exposed to the same medium (11-15).
Normal cells or tissues were used in all of these studies. There have been only a few
reports of bystander effects in tumor cells. Human salivary gland tumor cells have been
reported to release nitric oxide following heavy ion irradiation and that the medium from
these irradiated cells can inhibit cell growth and increase micronucleus formation in an
unirradiated tumor cell population (16). Using a microbeam to target helium ions to either
the nucleus or the cytoplasm of individual glioma cells in vitro, Shao et al. showed that
micronucleus formation in the entire population greatly exceeded the number of cells
individually targeted (17, 18). Xue et al., labeled the DNA of human colon
adenocarcinoma cells with 5-[12'I]iodo-2'-deoxyuridine. and showed that the growth
suppression in xenografted tumors in nude mice produced by mixing labeled and unlabeled
tumor cells was much greater than could be accounted for by a direct radiation effect from
the incorporated 12I. The authors attributed this to an in vivo bystander effect (19).
These reports of bystander effects in tumor cells raise the possibility that the effect
can be manipulated or exploited to increase the level of tumor cell kill during tumor
radiotherapy. Two types of therapy for which the bystander effects may be of particular
relevance are boron neutron capture therapy (BNCT) and Radioimmunotherapy. BNCT is
a targeted radiation therapy that significantly increases the therapeutic ratio relative to
conventional radiotherapeutic modalities. BNCT is a binary approach: A boron-10 (°B)-
labeled compound is administered that delivers high concentrations of 10B to the target
tumor relative to surrounding normal tissues. This is followed by irradiation with thermal
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neutrons or epithermal neutrons which become thermalized at depth in tissue. The
thermalized neutrons are used to "activate" the l°B, with the resultant production of highly
localized, high-linear energy transfer (LET) radiation. This is due to the capture of thermal
neutrons by 1013 with the resultant fission reaction [°B + n --*B -7Li + 4He (c) + 2.79
MeV] giving rise to high-energy charged particles with short range in tissue (5-9 KIm). The
micro-location and differential accumulation of 10B have a critical bearing on the
therapeutic effectiveness of BNCT (20). Non-uniform distribution of l°t B and the short
ranges of emitted charged particles (4He and 7Li) result in non-uniform irradiation. In
radioimmunotherapy, the radionuclides are attached to tumor specific monoclonal
antibodies and delivered to the tumor sites. Radioimmunotherapy has been most effective
in blood-borne tumors where access of the antibody to the tumor cells is unimpeded (21).
In solid tumors, however, radioimmunotherapy has had only limited success due largely to
the problems associated with non-uniform binding of the radioimmunoconjugate to the
tumor (22) and/or poor penetration of the antibody into tumor sites (23. 24). By definition,
both cases create bystander cells: cells that are not directly targeted by the radiation within
the solid tumor or the micrometastatic site, but are in the vicinity of the irradiated cells.
Metastatic prostate cancer is refractory to conventional chemotherapy due to systemic
toxicity (25). Radioimmunotherapy for metastatic prostate cancer is an area of active
investigation (26-30). Promising results for alpha-emitting actinium-antibody conjugates
have been reported in a human prostate carcinoma mouse xenograft model (31). A human
prostate carcinoma cell line (DU-] 45) has been chosen for the bystander effect studies.
Two different experimental models were designed to create bystander cells for
studying the bystander effect in DU-145 cells: a model that used grids to partially shield
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the monolayer of cells from alpha-particle irradiation and a model that used a co-culture
approach to create two separated populations of cells (hit and non-hit) in the same medium.
4.2 GRIDS MODEL
4.2.1 Materials and Methods
The grid method was first used by a group in the United Kingdom to study the
unexpected increase in number of clonogenic hemopoietic stem cells transmitting
chromosomal instability after alpha-particle irradiation (32). The grid used in that study
was composed of interwoven brass wires with a rectangular pitch of 1.2 mm and was
placed immediately below, but not touching, the dish base. In the model described here,
the grid was interposed between the alpha source and the Mylar bottom to shield part of
the monolayer of cells from alpha-particle irradiation. By doing so, the monolayer of cells
was divided into two subpopulations: the directly irradiated cells above the opening area
and the non-irradiated cells above the blocked area (see figure 4-1). When the culture was
grown to confluence, the two subpopulations of cells were grown in the same medium,
surrounded and touched by each other in monolayer. The non-irradiated cells worked as
bystander signal recipients and were called the bystander cells in this paper. In theory, this
model system could be used to study both cell-cell contact/GJIC and soluble factor
mechanisms.
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Figure 4-1. Schematic view of the grids model for the bystander effect study. A grid was
used to shield part of the monolayer of cells from alpha-particle irradiation, creating hit
and non-hit cells in a mixed population.
4.2.1.1 Grids design
'There are two questions that need to be answered in this study: was there a
bystander effect in the DU-145 human prostate tumor cells after alpha-particle irradiation?
If yes, was it related to the amount of contact between the hit and non-hit cells'? The
answer to the second question would probably help us understand the mechanism of the
bystander effect. 'The idea was to design and make a series of grids with different opening
patterns but the same opening ratio. The same opening ratio would create the same
percentage of hit cells. Different opening patterns would allow different chances of contact
between the hit and non-hit cells. Since the two subpopulations of cells could only touch
each other at the peripheries of the opening areas, the contact chance was proportional to
the total perimeters of all the opening areas. For simplicity, the opening ratio was set to
50%0. Therefore, half of the cells was subject to direct alpha-particle irradiation and would
be killed if the irradiation dose was high enough. The resulting cell surviving fractions
could tell if there was a bystander effect or not. In addition, the cell survival results from
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grids with different opening patterns could help one understand whether or not the
bystander effect was related to cell-cell contact.
The next step was to construct the grids. Commercially available woven mesh was
first considered, as described in (32). But it was soon rejected because of the uneven
surfaces. The alpha-particle source used in this study was an un-collimated source. Alpha
particles hit the cells from all directions. The uneven surface of the mesh would introduce a
discrepancy between the percentage of mesh openings and the actual percentage of hit
cells. It was decided that a flat surface was essential for exposure pattern control. Due to
the limitation of commercially available products, it was decided to customize the grids.
Two materials were considered: stainless steel and plastics. Since there was no other
requirement for the grid than shielding short range alpha particles and supporting the
Mylar dish, plastic was chosen for its ease of machining.
The pattern of the openings should be homogeneous in order to produce a
homogeneous response in the entire population. Two shapes of openings were considered:
square and round. Since the Mylar dish had a round growing surface, the opening should
also be round and radially symmetric. In addition, round openings were easier to machine
than square ones. Therefore a round shape was chosen for the opening pattern.
To interpose the grid between the alpha source and the Mylar dish, a new adaptor
was needed to hold the grid as close to the blades of the shutter as possible. Another
stainless steel adaptor was designed and made for this purpose. There was a fringe around
the working area on the grids for handling. An aluminum piece of o-ring shape of
collimator was used to center the Mylar dish on the grid surface to ensure 50% opening.
During the experiments, the adaptor was placed on the shutter; the grid was placed on the
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adaptor; the collimator was placed around the adaptor; the Mylar dish was placed on the
grid and in the middle of the collimator. There was a 1.4-ptm-thick Mylar film between the
top surface of the grid and the monolayer of cells.
4.2.1.2 Alpha-particle hit-pattern visualization by CR-39
The CR-39 track-etch detector was used to visualize the alpha-particle hit patterns
at the cells position with the three grids. This was for the purpose of visualizing the hit
pattern instead of alpha-particle flux measurement. The irradiation time was long enough
to produce a clear hit pattern on CR-39. In the experiment, one of the grids was placed on
the specially designed adaptor; the Mylar dish containing a piece of custom-cut CR-39 was
placed on the grid and the CR-39 was irradiated at the cell position. The irradiation time
was 0.5 s with grid A, 5 s with grid B and 30 s with grid C. After the irradiation. the CR-39
was processed by chemical etching in 7 N NaOH at 90 C for 50 minutes to visualize the
alpha-particle tracks.
4.2.1.3 Dosimetry
In order to determine the dose rate delivered to the cells above the opening areas of
the three grids, dosimetry was carried out using the same methods described in Chapter 2.
Briefly, the energy spectra were measured at the exposed cell position. The LET spectra
were generated from the energy spectra by converting the energy in each channel of the
energy spectrum into a corresponding LET value using the ASTAR program. The
weighted-average LET was calculated from the LET spectrum using the alpha-particle
counts per channel as the weighting factor. The alpha-particle flux at the exposed cell
position was measured using the track-etch" technique. The CR-39 was irradiated for 0.5
seconds with grid A, 5 seconds with grid B and 30 seconds with grid C. The irradiation
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time was chosen to generate a countable number of tracks in the exposed areas with
statistical significance. Images of the etched tracks were recorded in a square area of 1.03
mm2 using a CCD camera at 50x magnification. The image area was calibrated by using a
stage micrometer at the same magnification. The track images were printed and the track
numbers were scored in 20 random fields for grid A and grid B, and in 10 random fields
for grid C due to the large number of tracks per field (more than 1300 tracks). The PIPS
detector was also used to measure the alpha-particle flux in the exposed areas with the
pinhole method described in Chapter 2. The results from the two different methods were
compared.
The average absorbed dose rate to the exposed cells on the Mylar surface was
calculated by multiplying the alpha-particle fluence N by the average LET in the cells, and
by the appropriate conversion factors: Dose (Gy) = NxSx0.016. The alpha-particle dose to
the non-hit cells was zero.
4.2.1.4 Cell irradiation with grids
The clonogenic assay, as described in Chapter 3, was used to determine the cell
surviving fraction after alpha-particle irradiation with different grids. Briefly, about 5 x 105
DU-145 cells were plated into pre-coated Mylar dishes and grown to confluence. The
medium was changed half an hour before the irradiation. The cells in the Mylar dishes
were irradiated with alpha particles using one of the three grids for graded periods of time.
The irradiation dose to the exposed cells was calculated by multiplying the irradiation time
by the corresponding dose rate for each case. Following the irradiation, the cells were
trypsinized (0.25% trypsin with 0.1% EDTA at 37 °C for 3 min), re-suspended with full
growth medium and plated into 100 mm Petri dishes for colony formation assay. The
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medium was changed once after 5 days of growth. After 10 days of growth, the colonies
were washed with phosphate buffered saline (PBS), fixed with 95% ethanol, and stained
with 1% methylene blue aqueous solution. The colonies that contained 50 or more cells
were counted. Five replicate dishes were scored per dose point in each experiment. The
surviving fractions were normalized to the corresponding plating efficiencies. The data
from four independent experiments were combined and plotted as mean ± standard
deviation in log scale.
4.2.2 Results
4.2.2.1 Grids design
Three grids were designed. Grid A had only one hole, which provided the
minimum amount of contact between the hit and the non-hit cells. Grid C had as many
holes as practically possible (555) in order to provide the maximum amount of contact.
Grid B was designed with the number of holes between grid A and grid C (21 1), to provide
the amount of contact somewhere in the middle (see figure 4-2). The grids were
manufactured by QC Drilling Inc. (Salem, NH). The material was clear Lexan. The
thickness of the grids was 2.36 mm. The detail information for the three grids is shown in
table 4-1.
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Figure 4-2. The three grids designed for the bystander study. They had different numbers
of homogeneously distributed holes, giving 50% opening ratios in the 11.4 cm2 round area.
There is a milled groove with 4.13 cm diameter around the opening area, to define the
periphery of the Mylar dish bottom.
Grid Number Diameter Total Total Percentage of
opening area
No. of holes of holes (cm) perimeters (cm) (cm2 open area
A 1 2.6924 8.4582 5.7 50%
B 211 0.1854 122.9106 5.7 50%
C 555 0.1143 199.2884 5.7 50%
Table 4- 1. Detailed information of the three grids designed for the bystander study.
4.2.2.2 CR-39 track-etch detection
The picture of the three etched CR-39 detectors exposed to the alpha-particle
irradiation with grids A, B and C and the picture of the etched dots above one hole of grid
C are shown in figure 4-3. The etched patterns on the CR-39s (left) replicated the opening
patterns of the three grids.
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Figure 4-3. Left: the CR-39 track etching results for grid A, B and C after alpha-particle
irradiation. Right: the image of the etched tracks above one hole of grid C. The images of
the etched tracks were recorded in a square area of 1.03 mm2 using a CCD camera at 50x
magnification. The sparse dots in the blocked area were believed to come from
environmental radiation during the processing of the CR-39. A control CR-39 was used to
detect the background and showed sparse dots on it. The image is not shown here.
4.2.2.3 Dosimetry
The energy spectra with and without the grids measured by the PIPS detector are
shown in figure 4-4. The converted LET spectra are shown in figure 4-5. The energy and
LET spectra with the grids in place were narrower and more symmetric due to the
collimation effect of the grids (figure 4-6). Table 4-2 compares the alpha-particle flux
results from the PIPS detector and the CR-39 track-etch detector with and without the
grids. The reasons for the significant discrepancy for the #4 source without grid were
explained in Chapter 2 (2.3.2.2). Consistent results between the PIPS detector and the CR-
39 detector were observed from the #4 source with grids A, B and C due to the collimation
effects and longer exposure time (0.5 s, 5 s, and 30 s). Meanwhile, different extents of
collimation effects reduced the alpha-particle flux significantly from grid A to grid C. The
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alpha-particle fluxes measured with the PIPS detector were used for dose rate calculation
in all cases. All dosimetry results are shown in table 4-3.
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Figure 4-4. The energy spectra at the cell position for the #4 source with and without grids.
The energy spectrum of a standard Am-241 alpha source in a vacuum was used to calibrate
the energy scale on the x-axis, as described in Chapter 2. The different extents of narrowed
shapes for grid A, B and C came from the collimation effects of different sizes of holes
(figure 4-6), which cut off the low energy tails of the spectra. The y-axis represents relative
counts of alpha particles in different energy channels.
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Figure 4-5. The LET spectra at the cell position for the #4 source with and without grids.
The collimations effects from different sizes of holes are also reflected in the narrowed
shapes of the LET spectra, resulting in more symmetric peaks and reduced high-LET tails.
Figure 4-6. Schematic view of the collimation effects from different sizes of holes in the
three grids. Smaller holes would block more alpha particles with large incident angles and
therefore reduce the low energy and high LET tails in the spectra, resulting in a narrower
and more symmetric spectrum, as well as reduced alpha-particle flux.
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#4 source #4 source #4 source#4 source
+ grid A + grid B + grid C
Exposure time for CR-39 0.2 0.5 5 30
Alpha-particle flux (CR-39) 1440.3 + 70.2 1047 ± 102 100.4 ± 4.6 43.8 i 0.6
Alpha-particle flux (PIPS) 998 20 900 ± 18 94 ± 1.9 45 ±i 0.9
Table 4-2. Comparison of the alpha-particle flux results between CR-39 track-etch detector
and PIPS detector. The errors of the CR-39 results are the standard deviation from counts
in 20 fields. The errors of the PIPS results came from the reproducibility of the measuring
system. For the #4 source without grid, the PIPS result is significantly smaller than the CR-
39 result. For the #4 source with grids A, B, and C, the results from the two detectors are
consistent.
#4 source #4 source #4 source #4 source
+ grid A + grid B + grid C
Media that alpha 5 mm air 7.66 mm air 7.66 mm air 7.66 mm air
particles pass through 1.4 pim Mylar 1.4 ptm Mylar 1.4 ptm Mylar 1.4 gm Mylar
Alpha-particle flux 998 ± 20 900 + 18 94 + 1.9 45 ± 0.9
(counts/mm 2 s)
Average energy 3.14 0.06 2.81 0.06 3.71 0.07 3.76 0.07
(MeV)
Average LET 1266.1 ± 63.3 1353.5 67.7 1098.4 54.9 1089.1 54.5
(MeV cm 2/g)
Average dose rate to 1.21 0.07 1.17 ± 0.06 0.094 ± 0.005 0.047 ± 0.003
cells at open areas (Gy/min)
Table 4-3. Dosimetry results for the #4 source and the #4 source with and without the
grids. The media that alpha particles passed through were different for the #4 source alone
and the #4 source with grids due to the thickness of the grids and the different designs of
the adaptors. The alpha-particle flux results came from the PIPS detector. The weighted
average energy was calculated from the energy spectra in figure 4-4. The weighted average
LET was calculated from the LET spectra in figure 4-5. The average dose rate was
calculated from the equation: Dose rate = (average LET) x (alpha-particle flux) x 0.016.
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4.2.2.4 Cell irradiation with grids
The cell survival curves for the #4 source with and without grids are shown in
figure 4-7. The survival curve for the #4 source itself is a straight line from the origin on a
log scale. The surviving fractions for the #4 source with grid A and grid B decline at lower
doses and flatten at 50% SF at higher doses. The surviving fractions with grid C decline at
lower doses and the means of the SF fall below 50% at higher doses (44 ± 1.7 % at 2.8 Gy
and 43 + 6.1 % at 3.3 Gy).
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Figure 4-7. The survival curves of the DU-145 cells after alpha-particle irradiations using
the #4 source with and without grids. The measurements were done on the mixed
populations of hit cells and non-hit cells. The x-axis represents the alpha dose to the hit
cells. The y-axis is on a log scale and represents the surviving fraction of the mixed cells in
the Mylar dish.
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4.2.3 Discussion
For grid A and grid B, the cell survival curves reached plateaus at about 50%
survival fractions when the doses were high enough to kill essentially all the hit cells. It
means that all the non-hit cells survived and no bystander effect was detected. In the case
of grid C, some cell survivals fell below 50% at high doses, suggesting that some of the
non-hit cells were killed. In other words, some of the cells receiving no direct alpha-
particle irradiation died from a bystander effect. However, due to the large error bar at 3.3
Gy (43 ± 6 %). the effect was not statistically significant.
The advantage of this method is that the hit cells and the non-hit cells touched and
mixed with each other in the same medium, which is a two-dimensional model for the real
situation in radioimmunotherapy. Another advantage is that it allowed the detection of the
effects of both GJIC and soluble factors.
But there are also some problems associated with this method. In the original plan,
the comet assay would be used for the grid results analysis. The hypothesis was that if the
histogram of comet assay results could separate the hit cells from the non-hit cells as
demonstrated by Jostes et al. (33), then it might be able to distinguish the bystander cells
as well. But our trial of the comet assay in the direct alpha-particle irradiation failed to
reproduce the histogram showed by Jostes et al. Because the comet assay did not give us
the expected high resolution, as required for the bystander study, the clonogenic assay was
used instead. The resolution of the clonogenic assay was still not good enough to detect the
bystander effect; the large error bar at 3.3 Gy makes it hard to draw any conclusion
regarding the bystander effect although there is a trend that surviving fraction at high doses
falls below 50%. Another issue is that even though there were 50% open areas in the three
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grids, the proportion of cells that was exposed to the alpha-particle irradiation was not
exactly 50%. The reason is that for those cells lying on the circumference of the openings,
half of their nuclear areas were exposed to alpha-particle irradiation and half were blocked
on average. But a cell is considered to be irradiated no matter what percentage of the cell
body or cell nucleus is exposed to irradiation. So, all the cells lying on the circumference
of the openings were actually irradiated. In other words, the 50% opening actually resulted
in more than 50% of cells exposed to the alpha particles. For grid A, the effect was
negligible. The longer the total circumference is, the more extra cells were exposed than
the theoretical 50%. Therefore, the increased cell killing with grid C might result from the
increased cell exposure at the edges of the openings.
4.3 CO-CULTURE MODEL
4.3.1 Materials and Methods
4.3. .1 The co-culture system
While the grids model mixed the hit and non-hit cells together, allowing for both
GJIC and soluble factor detection, a co-culture system was designed to create a separate
population of non-irradiated DU-145 cells that shared the same medium as the directly
irradiated cells on the Mylar membrane, but were well beyond the range of the alpha
particles coming from the 241Am foil (figure 4-8). The non-irradiated cells were grown on a
Snapwell insert (item # 3407, Coming Life Sciences, Corning, NY). The Snapwell insert
contains a 12 mm diameter tissue culture-treated polycarbonate membrane with 0.4 pm
pores to allow passage of small diffusible molecules, supported by a detachable ring
(figure 4-9). The detached insert was placed in the Mylar dish facing down, creating 4
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mm distance between the polycarbonate membrane bottom of the insert and the Mylar
bottom of the dish, well beyond the maximum range of the alpha particles in the medium
(< 80 ptm). At least 6 ml medium was needed to cover the bottom of the insert. We define
the directly-irradiated cells growing on the Mylar membrane as the "targeted cells", and
the non-irradiated cells growing on the Snapwell insert as the "co-cultured cells". The co-
culture system excluded the cell-cell contact or GJIC factors and only allowed for effects
caused by soluble factors. Similar systems were also used by several other groups for
soluble factor focused bystander studies (15, 34-36).
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Figure 4-8. The co-culture system for the bystander effect study. The cells growing on the
Mylar bottom were defined as the "targeted cells"; the cells growing on the Snapwell insert
were defined as the "co-cultured cells". which were 4 mm above the targeted cells and
worked as the receptor of the soluble bystander signal from the targeted cells.
Figure 4-9. The Snapwell insert used in the co-culture system from Coming Life Sciences.
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4.3.1.2 Co-culture experiments
For the co-culture experiments, - 5 x 10s DU-145 cells were seeded in the Mylar
dish (3.81 cm diameter, 11.4 cm2 growth area) and - 5 x 104 cells were seeded in the
Snapwell insert (12 mm diameter; 1.13 cm2 growth area). The cells were allowed to attach
overnight. On the day of the irradiation experiment, 6 ml of fresh medium was replaced in
each Mylar dish. The Snapwell inserts were detached from the support rings with a sterile
tweezers and placed upside down in the medium inside the Mylar dishes. The Mylar dishes
were then placed on the alpha-particle irradiator and the bottom layer of cells was
irradiated with graded alpha-particle doses at room temperature. After the irradiation, the
Mylar dish together with the insert was put back into the incubator and co-incubated at 37
°C for 2 hrs (24 hrs in some case). After the co-incubation, the insert was taken out of the
Mylar dishes and the cells in the insert were collected by trypsinization and processed for
the micronucleus assay as described in Chapter 3 (3.2.4 Micronucleus assay). The control
was handled in the same way except that the Mylar dish with the insert was not placed in
the alpha-particle irradiator for the irradiation.
4.3.1.3 Medium only irradiation
To check the effect of medium only irradiation on the co-cultured cells, the insert
with cells was placed into the Mylar dish without cells growing on the bottom. The Mylar
dish together with insert was placed on the irradiator and the full growth medium
containing 140%, serum was irradiated for I min. The cells on the insert were then processed
in the same way as the co-culture experiments described above.
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4.3.1.4 Medium transfer experiments
For the medium transfer experiments, DU-145 cells growing on the Mylar
membrane in the Mylar dish were irradiated for 1 min. Medium from the irradiated cells
(0.8 ml) was transferred to a centrifuge tube with filter (Costar-8160, Spin-x centrifuge
tube filter, 0.22 lm cellulose acetate in 2.0 ml polypropylene tube). The tube was
centrifuged at 2000 rpm for 1 min to remove any cells and debris from the medium. The
filtered medium was then used to replace the medium in an insert with unirradiated DU-
145 cells. The whole filtration and medium transfer procedure took 2-3 min. The cells in
the insert were incubated in the filtered medium for 2 hrs before they were trypsinized and
processed for the micronucleus assay.
4.3.1.5 Co-culture after irradiation experiments
For the co-culture after irradiation experiments, DU-145 cells growing on the
Mylar membrane were irradiated for 1 min without the presence of the insert. The
Snapwell insert with cells was placed upside down into the growth medium above the
irradiated cells immediately (- I min) after the irradiation. Then the cells in the insert were
incubated in the irradiated medium above the irradiated cells at 37 °C for 2 hrs before they
were trypsinized and processed for the micronucleus assay.
4.3.1.6 Scavenger experiments
Two chemical radical scavengers were tested in the scavenger experiments.
Dimethyl sulfoxide (DMSO, Sigma-Aldrich, St Louis, MO) is a hydroxyl radical (OH-)
scavenger. It was added to the medium in the Mylar dish at a final concentration of 1% 10
minutes before the irradiation. PTIO (2-phenyl-4,4,5,5-tetramethylimidazoline-l-oxyl 3-
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oxide; Sigma-Aldrich, P5084) is a nitric oxide radical (NO-) scavenger. It was added to the
medium in the Mylar dish at a final concentration of 100 [pM 10 minutes before the
irradiation. Other procedures were the same as the co-culture experiments. The scavengers
were present in the medium during the irradiation and the subsequent 2-hr incubation. The
co-cultured cells were then harvested and processed for the micronucleus assay.
4.3.2 Results
4.3.2.1 Dose response results
Alpha-particle irradiation of the cells on the Mylar membrane produced a
significant increase in the MN/BN ratio in the co-cultured cells on the Snapwell insert.
Figure 4-10 shows the MN/BN ratios for these co-cultured cells as the alpha-particle dose
delivered to the cells on the Mylar membrane was increased from 0 to 6.0 Gy. The baseline
MN/BN ratio in control DU-145 cells was 10.0 ± 1.0% (figure 4-10). The increased
incidence of NMN formation in the co-cultured cells was statistically significant relative to
the control cells (p < 0.0001) at all alpha-particle doses delivered to the targeted cells.
Though the differences in the magnitude of the bystander effect as a function of the alpha-
particle dose to the targeted cells are only marginally significant, there is a trend for the
bystander effect to increase rapidly, level off, and then decrease at the highest dose
delivered to the targeted cells (see figure 4-10). The MN/BN ratio in the co-cultured cells
was greater at 0).6 Gy than at 0.1 Gy (p - 0.041). The effects at 0.6 Gy and 1.2 Gy were not
different. The effect at 6.0 Gy was less than the effect at 1.2 Gy (p = 0.028). The
percentage of bi-nulceated cells (%BN) observed in the co-cultured cells, after a 1.2 Gy
alpha-particle exposure to the targeted cells (figure 4-10, "1.2 Gy"), was 81 3.7%, which
is essentially the same as the %BN observed in the control population 82 ± 0.1%. These
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data for the %BN cells present after the cytochalasin-B block procedure were derived from
two independent samples from each population and suggest that there was no significant
change in cell cycle time in the co-cultured cells, or in the ability of the co-cultured cells to
progress through the cell cycle, relative to the control cells.
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Figure 4-10. Micronucleus formation in the co-cultured DU-145 cells as a function of
direct alpha-particle doses. The co-cultured cells were incubated in the medium above the
irradiated cells for 2 hrs after the irradiation. The control produced 10.0 ± 1.0% MN/BN
ratio; 0.1 Gy produced 13.5 ± 0.8% MN/BN ratio; 0.6 Gy produced 14.8 + 0.1% MN/BN
ratio; 1.2 Gy produced 14.5 + 1.0% MN/BN ratio; 6.0 Gy produced 13.4 ± 0.3% MN/BN
ratio. The numbers within the shaded bars indicate the number of replicate experiments;
1000-2000 BN cells were scored for each experiment. (*) p < 0.0001 relative to controls.
4.3.2.2 Medium-irradiation, medium-transfer experiments and other experiments
To further examine the nature of the soluble factor released into the medium and
affecting the co-cultured cells, a series of medium-transfer, medium-irradiation and other
experiments were carried out. Figure 4-11 shows the MN/BN ratio in the co-cultured cells
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as a function of these various treatments. As a reference, the baseline MN/BN ratio in the
control cells and the MN/BN ratio in the co-cultured cells from the experiments where the
targeted cells received 1.2 Gy are both reproduced from figure 4-10 and labeled as
"Control" and "-1.2 Gy to targeted cells, co-cultured cells present, then co-incubate for 2 hr
"in figure 4-1 1.
For the experiments shown in figure 4-10, the co-cultured cells on the insert were
present during the irradiation of the targeted cells, and were then co-incubated in the same
medium above the irradiated cells for an additional 2 hrs before trypsinization and
processing for MN analysis. Co-incubation of the cells on the insert for 24 hrs after the
exposure of the targeted cells to 1.2 Gy of alpha particles produced a similar bystander
effect. The MN/BN ratio in the co-cultured cells was 15.2 ± 2.2% (n=6) with the 24-hr co-
incubation compared to 14.5 + 1.0% (n = 15) in the cells with the 2-hr co-incubation.
For the experiments shown in figure 4-10, the co-cultured cells on the insert were
present in the medium above the targeted cells cdring the irradiation. When the insert with
the co-culturedc cells was placed into the medium above the targeted cells on the Mylar
membrane immediately (within 1 min) after the irradiation, and then co-incubated at 37 °C
for 2 hrs, there was no significant increase in the MN/BN ratio in these co-cultured cells
relative to the controls. Delivery of 1.2 Gy to medium-alone (no cells on the bottom Mylar
membrane) produced no significant increase in the MN/BN ratio in the co-cultured cells. In
a separate medium-transfer experiment, the targeted cells received 1.2 Gy and, within 3
min, the medium above these cells was removed, filtered, and added to a well with
unexposed DIJ-145 cells on a Snapwell insert. These cells on the insert were then
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incubated at 37 C for 2 hrs in this filtered medium. The MN/BN ratio in these cells
exposed to the irradiated medium was 11.0 ± 0.6%.
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co-cultured cells and
incubate for 2hr
1.2 Gy to medium only,
co-cultured cells present
then co-incubate for 2hr
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Figure 4-11. Micronucleus formation in the co-cultured cells following various treatments:
"1.2 Gy to targeted cells, co-cultured cells present, then co-incubate for 2hr" is the core
experiment replicated from figure 4-10 and produced 14.5 ± 1.0% MN/BN ratio; 24 hr co-
incubation after irradiation instead of 2hr co-incubation produced 15.2 ± 2.2% MN/BN
ratio in the co-cultured cells; When the co-cultured cells were absent during the 1.2 Gy
irradiation of the targeted cells but added to the medium after the irradiation and then co-
incubate for 2hr, the MN/BN ratio was 10.4 ± 0.6% in the co-cultured cells; 1.2 Gy to
medium alone irradiation produced 10.8 + 0.7% MN/BN ratio in the co-cultured cells; the
filtered medium from irradiated cells produced 11.1 ± 0.6% MN/BN ratios in the co-
cultured cells. In all experiments the co-cultured cells were incubated for 2 hrs after the
irradiation. (*)p < 0.0001.
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4.3.2.3 Scavenger experiments
The experimental design, with the co-cultured cells beyond the range of the alpha
particles, measures a bystander effect mediated by a soluble factor(s) released into the
medium by the irradiated cells. Experiments were carried out with added radical
scavengers in an effort to provide more information on the nature of this medium-mediated
bystander effect. Figure 4-12 shows the MN/BN ratio for the co-cultured cells in the
radical scavenger experiments. As a reference, the background MN'BN ratio in the co-
cultured cells and the MN/BN ratio in the co-cultured cells when the targeted cells received
1.2 Gv are also reproduced from figure 4-10. When the targeted cells received 1.2 Gy of
alpha-particle irradiation in the presence of DMSO (1% vol/vol), the MN/BN ratio in the
co-cultured cel[ls dropped from 14.5 + 1.0% to 10.5 ± 1.2% (n = 6). a level not different
than the controls. The presence of 100 AM PTIO did not decrease the MN/BN ratio
significantly in the co-cultured cells when the targeted cells received 1.2 Gy of alpha-
particle irradiation. Neither DMSO alone nor PTIO alone had any effect on the MN/BN
ratio compared to the controls (figure 4-12).
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Figure 4-12. The effect of radical scavengers on the bystander effect. MN/BN ratio in the
co-cultured cells following irradiation of the targeted cells in the presence of radical
scavengers added to the medium 10 min before the irradiation and maintained in the
medium during the 2-hr incubation after the irradiation. DMSO was used at a
concentration of 1% (vol/vol). PTIO was present at a concentration of 100 [tM. DMSO
alone produced 9.7 ± 0.02% MN/BN ratio; PTIO alone produced 10.2 ± 0.7% MN/BN
ratio; DMSO plus 1.2 Gy produced 10.5 ± 0.1% MN/BN ratio; PTIO plus 1.2 Gy produced
14.3 ± 0.1% MN/BN ratio. (*) p < 0.0001 relative to controls.
4.3.3 Discussion
Experimental approaches for the study of bystander effects fall into three main
categories: 1) irradiation of cells with very low fluences of broad beams of ions where
Poisson statistics predict the fraction likely to sustain a direct hit; 2) the use of accelerator-
based microbeams for targeting individual cells or a fixed percentage of cells in a
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population; and 3) co-culture or medium transfer experiments where two populations of
cells share the same medium, either simultaneously or at different times, but only one
population is directly irradiated. The results reported here fall into the third category and
the discussion will focus primarily on this class of bystander effect studies. For each of
these experimental approaches, the use of different endpoints, the use of different cell
lines, the use of different types of radiation, and variations in the experimental procedures,
have produced a wide variety of, sometimes conflicting, bystander effect results. The use
of normal cell lines in the majority of the alpha-particle-based bystander effect studies is
relevant to the radiation protection and risk assessment scenario, in light of the fact that
>50% of average annual effective dose to the US population is delivered by alpha particles
from the decay of radon daughter products in the lung (polonium, bismuth and lead). For
average residential radon exposures, the alpha-particle fluence in the lung is extremely
low. With the reports of in vitro bystander effects at low alpha-particle fluence, many
investigations have focused on the question of whether risks associated with radon
exposures are underestimated (37-39). The focus of the study here is somewhat different
than the majority of the bystander effect literature: it studied the bystander effects in tumor
cells and modeled the use of alpha particles for tumor therapy. With targeted alpha-particle
therapies for solid tumors or micrometastatic disease, such as the use of monoclonal
antibodies bearing alpha-emitting radionuclides, or of l°B-containing drugs used for boron
neutron capture therapy (40), a non-uniform delivery of the targeting agent results in a
heterogeneous delivery of alpha particles at the cellular level, with the bystander cells
being the ones that escape direct alpha-particle traversals. A 3-D tumor site will be
exposed to alpha particles of all energies and residual ranges during targeted alpha-particle
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therapy. The spectrum of different energies will generate a corresponding distribution of
LET values as the alpha particles slow down. The uncollimated alpha-particle irradiator
described here has been simplified considerably compared to other isotopic alpha-particle
sources described in the literature, e.g., (41-43). This is in keeping with the experimental
objective of these studies: the focus is on the non-hit, co-cultured cells growing on an
insert, the targeted cells receive distributions of alpha-particle energies and LETs that are
more reflective of the actual situation during targeted alpha-particle therapy of solid tumors
or micrometastases.
It is reported here the use of an experimental system that creates two populations of
cells co-cultured in the same medium, only one of which is directly exposed to alpha-
particle irradiation. The experimental results suggest that DU-145 human prostate
carcinoma cells irradiated with alpha particles release a medium-soluble factor that is
capable of causing micronucleus formation in the non-irradiated co-cultured cells.
Scavenger experiments indicated that the bystander signal was not nitric oxide: the nitric
oxide scavenger PTIO did not decrease the effect. The signaling factor has an effective
life-time of less than 1 minute: the co-cultured cells had to be present during the irradiation
to exhibit the increase in micronucleus formation. The signal is derived from irradiated
cells: irradiation of medium-alone had no effect on the co-cultured cells. The approach of
using a co-culture system described in this chapter is similar to that used by others (14, 15,
34, 44), and is designed to detect a bystander effect mediated by soluble factors transmitted
through the medium, without the possible added complication of gap-junction intercellular
communication (GJIC). Although GJIC, which plays an important role in the regulation of
growth, differentiation and apoptosis in normal cells, has been shown to be required for
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expression of bystander effects in fibroblasts (45) and in V79 cells (10). the role of GJIC in
tumor cells is quite different. Most tumor cells have dysfunctional GJIC; some tumor
promoters and oncogenes inhibit GJIC; and therapeutic approaches are being investigated
to reverse the down regulation of GJIC in tumor cells (46).
Two common features of many bystander effect reports are that the magnitude of
the effect is limited and that the bystander effect in the non-targeted cells either increases
rapidly at low doses but saturates with increasing dose to the targeted cells or is
independent of the dose administered to the targeted cells (2, 15, 35, 47). In this study, the
maximum incidence of MN formation in the co-cultured DU-145 cells reached a level that
was -50% greater than the baseline incidence seen in control cells. This same level of MN
formation could be produced in the targeted cells by a direct alpha-particle dose of 0.06 Gy
(figure 3-18). Similar results have been reported for AGO1522 human fibroblasts co-
cultured above cells irradiated with 250 kVp X rays (15). These authors reported that MN
incidence, p21": l induction, and y-HAX foci formation, were all increased approximately
two-fold in the co-cultured cells, and that the increase was independent of the dose
delivered to the targeted cells. The magnitude of the bystander effect was approximately
equivalent to 0.1 Gy of direct X-irradiation (15). Using sister chromatid exchange (SCE) in
a normal human lung fibroblast cell line, and alpha particles from a planar 238Pu source,
Lehnert et al. reported that the magnitude of a medium-transfer bystander effect was about
the same as that observed in cells directly irradiated with an alpha-particle dose of 0.084
Gy (11). Damage in bystander cells may not always be directly comparable to the damage
in the directly-irradiated cells with the use of a more discriminating endpoint. For example,
Huo et al. analyzed the molecular structure of HPRT mutations observed in CHO cells
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exposed to low fluences of 238Pu alpha particles and reported that the DNA damage in
bystander cells consisted primarily of point mutations, whereas, in the directly-hit cells,
there was a significantly greater fraction of partial or total gene deletions. These authors
suggested that the different effects observed in bystander cells compared to the cells
directly traversed by an alpha particle may be caused by different agents or by different
mechanisms (48).
It is reported here that alpha-particle irradiation of complete, serum-containing
medium alone (no cells irradiated on the Mylar membrane) produced no bystander effect in
the co-cultured cells. The role of irradiated medium has been the subject of a number of
studies: the results are contradictory, but the use of different cell lines and different
endpoints make direct comparisons difficult. Lehnert et al. have demonstrated that alpha-
particle irradiation of complete medium did cause a bystander effect (SCE) in normal
human diploid lung fibroblasts when transferred to unirradiated cells, and that the serum
component of the medium was an absolute requirement for a positive bystander effect (2,
11, 49, 50). Suzuki et al. reported that alpha-particle irradiation of medium-only caused no
increase in chromosome aberrations in co-cultured human-hamster hybrid (AL) cells (14).
Using a co-culture system with bystander cells on an insert, Yang et al., reported that X-
irradiation of complete medium alone caused no bystander effects (MN formation, p21 Waf I
induction) in a normal human fibroblast line (15). Similarly, Mothersill and Seymour
reported that complete medium irradiated in the absence of cells with 5.0 Gy of 60 Co
gamma rays had no effect on survival when transferred to unirradiated cultures (12).
The observation that DMSO could completely prevent the bystander effect in co-
cultured DU-145 prostate carcinoma cells can be explained by two possible mechanisms:
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1, since the DMSO was present at the time of irradiation, it might enter the targeted cells to
protect them fiom producing the bystander signal(s) or it might enter the co-cultured cells
to protect them from responding to the bystander signal(s); 2, since the DMSO is a known
hydroxyl radical scavenger and it can react with other ROS like H202. it might react with
the medium-soluble factor that elicits, or at least initiates, this bystander response. There is
considerable experimental support in the literature for the involvement of reactive oxygen
species (ROS) as the signaling agent in medium-transfer bystander effects. Lehnert et al.
showed that addition of the enzyme superoxide dismutase (SOD) to alpha-particle-
irradiated medium, or to conditioned medium harvested from above irradiated cells,
blocked the ability of the medium to cause bystander effects in unirradiated cells. These
authors suggested that superoxide played a central role in mediation of the bystander effect
(11). Yang et Lil., have provided evidence for the role of ROS in medium mediated
bystander damage after low-LET irradiation (15). These authors showed that addition of
SOD or catalase reduced the incidence of micronucleus formation, reduced the induction
of p21wal and reduced the number of -HAX foci in co-cultured bystander cells.
Interestingly, SOD or catalase did not have any effect on the decrease in clonogenic
survival of the co-cultured cells, suggesting that an additional factor may be involved (15).
The presence of ROS in irradiated cells and in bystander cells in medium-transfer
experiments has been detected by prelabeling the cells with fluorescent dyes (15, 50) . The
antioxidant, N-acetylcysteine was shown to suppress bystander effects (decreased survival,
an increase in mitochondrial mass, and increased Bcl-2 expression) caused by medium
from gamma-irradiated human keratinocytes (51) and provides additional evidence that
directly-irradiated cells undergo oxidative stress and release a signal into the medium that
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is capable of causing oxidative stress in bystander cells. The nature of the signal remains
unclear.
One interesting and unique aspect of the data presented here is the very short
effective lifetime of the medium-borne bystander signal. The co-cultured DU-145 cells had
to be present in the medium above the targeted cells Lduring the irradiation in order to
sustain the damage leading to increased MN formation. When the co-cultured cells were
placed into the medium above the targeted cells immediately (< 1 minute) fter the
irradiation, there was no bystander effect. The only difference between full expression of
the bystander effect (- 50% increase in MN) and no bystander effect was the -1-minute
delay between irradiation of the targeted cells and placing the insert containing the co-
cultured cells into the medium. Otherwise, the dose to the targeted cells was the same and
the 2-hr post-irradiation co-incubation was the same. It is the use of a co-culture
experimental approach that has allowed us to make this observation. The presence of the
co-cultured cells during the irradiation enables the detection of the effects of very short-
lived factors.
This issue of the stability of the bystander signal has been addressed by others but
if directly-irradiated cells are still present in the medium during the incubation period that
produces the conditioned medium, which is then transferred to unirradiated cells, it is
difficult to distinguish between the lifetime of the signal and continuous production of a
short-lived signal by the irradiated cells. For example, Suzuki et al., irradiated AL cells
with broad-beam alpha particles, incubated these irradiated cells for 24 hours, and then
transferred the medium to unirradiated cells (14). The unirradiated cells that received the
conditioned medium were incubated for an additional 24 hrs and showed an increased
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incidence of chromosome damage. These authors stated that the unknown soluble factor
responsible for this medium-transfer bystander effect must have a lifespan of at least 24 hrs
(14). It is possible, however, that the lifespan of the signal is short, but that it is produced
continuously by the irradiated cells during the 24-hr incubation period. Lehnert et al.
addressed the issue of the lifetime of the medium soluble agent directly by removing the
medium from above the directly-irradiated cells and storing it for periods up to 24 hours in
an incubator at 37 °C (11). A parallel study was included for medium that had been
irradiated in the absence of cells. The conditioned medium harvested from above irradiated
cells retained the ability to induce SCE in recipient cells for up to 24 hrs. Interestingly,
when irradiated medium-alone (no cells were irradiated to condition the medium) was
immediately transferred to non-irradiated cells, there was an increase in SCE in the
recipient cells, but at the next time point, 30 minutes, the medium had no effect; i.e., the
lifetime of the signal was < 30 min. Thus, these authors have reported the presence of
soluble factors with different apparent lifetimes when stored at 37 C. SOD was shown to
inactivate both the short-lived factor from irradiated medium and the long-lived factor
fromn irradiated cells ( 11 ). The short lifetime of the factor produced by irradiation of serum-
containing medium is reminiscent of the short-lifetime factor reported here. But, in the
case of the Lehnert study, the factor was produced by alpha-particle irradiation of serum-
containing medium alone and in this study the factor was produced by irradiation of the
DU-145 cells. These are the only two reports of very short-lived soluble clastogenic factors
involved in medium-transfer bystander effect studies. Thus, we propose that some of the
variation in the bystander effect literature could be the result of short-lived signaling
factors that are not detected by some medium-transfer experimental protocols.
155
There are only a few literature reports of bystander effects in tumor cells. The role
of nitric oxide (NO) as a mediator of the bystander effect has been clearly established in
two human tumor cell lines (16, 17). Irradiation of human salivary gland tumor cells with
100 keV/[pm carbon ions, followed by co-incubation for 24 hrs with unirradiated cells on
an insert resulted in an increased incidence of MN in the unirradiated, co-cultured tumor
cells (16). The bystander effect was blocked by the NO scavenger PTIO. Microbeam
irradiations of T98G human glioblastoma cells with helium-3 ions (3He2+) have shown that
irradiating only one cell in a population of -1200 increased the MN yield in the entire
population (17). Conditioned medium, produced by 3He2+- irradiation of T98G glioma
cells and incubation for 1 hr, induced an increase in MN formation when transferred to
unirradiated T98G cells, and the NO inhibitor c-PTIO eliminated this medium-transfer
bystander effect (17). NO serves as a signaling agent in a wide variety of pathways, and the
induction of inducible nitric oxide synthase has been shown to be an early signaling event
in response to ionizing radiation (52). The results in the DU-145 human prostate carcinoma
cells differ in that the NO scavenger PTIO had no effect on the observed increase in MN
formation in the co-cultured DU-145 cells. The difference between these reports could be
the result of the different cell lines used, which could respond differently to irradiation and
bystander signals. A medium-mediated bystander effect has also been reported in human
malignant melanoma cells (53). These authors used a co-culture technique that involved
plating cells such that individual large "megacolonies" of 1 cm diameter were present in
the same flask. Selective irradiation of the flask with 5 Gy 60Co gamma rays allowed some
colonies to serve as the irradiated population and the others as the non-irradiated
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bystanders. These authors observed an increased incidence of micronuclei in cells from the
shielded colonies at 24, 48 and 72 hours after irradiation (53).
The in itro bystander effects in tumor cells reported here and in the literature have
demonstrated that there is an effect, mediated by a soluble factor transferred through the
medium, that can lead to increased MN formation. These lesions are believed to be the
result of non-rejoined double strand breaks, providing support for the proposition that a
bystander effect can be of benefit in a clinical situation. There have been very few studies
of the radiation induced bystander effect in three dimensional cell systems. Irradiations of
human or porcine ureter explants have shown that irradiation of individual cells in the
explant can cause damage (apoptosis or micronuclei) in non-irradiated areas of the explant
(54). The overlying medium from irradiated human urothelium explants was shown to
cause effects in unirradiated urothelium explants or cells in culture (55). Pelleted mixtures
of V79 hamster fibroblasts, some with 12'l incorporated into the DNA, have been used to
show cell killing in a greater fraction of cells than was labeled; interpreted as evidence of a
bystander effect in the cell pellet (10, 56).
Will this effect hold in vivo? There is a recent report of a bystander effect in
tumors, in vivio, which suggests that it may. Kassis et oal., incorporated 5-[ 2'I]iodo-2'-
deoxyuridine into tumor cell DNA. mixed the labeled tumor cells with unlabeled tumor
cells in various proportions, and used these mixtures to inoculate subcutaneous tumors in
mice (19). The Auger electrons released from 125l decay have subcellular ranges (<5 pm).
The suppression of tumor growth was much greater than could be attributed to the
radiation dose orning from 12I decay in the labeled tumor cells and was attributed to a
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bystander effect produced by the irradiated cells within the growing tumor nodule. The
mode of signaling is unknown.
In summary, both in vitro and in vivo reports have demonstrated that the biologic
effects of irradiation in tumor cells are not limited to directly-irradiated cells. Bystander
effects in tumors remain an area with a largely unexplored potential for contributing to the
overall therapeutic goal of elimination of all clonogenic tumor cells (57). The nature of the
signal released by tumor cells needs further study. Nitric oxide is involved in some tumor
cell lines, as well as the short-lived factor described in this report. As with the numerous
bystander effect studies in normal cells, the bystander effect in tumors will most likely be a
class of effects that differs in extent and mechanism depending on the type and dose of
radiation used, the cell type involved and the particular endpoint studied. If the radiation-
induced signaling factors involved in these tumor bystander effects can be identified and
mechanisms of action elucidated, there may be an opportunity to manipulate these effects
to improve the effectiveness of radiation therapy. The model system described here is well
suited for further studies of whether the bystander effect in tumor cells can be exploited to
increase tumor cell kill during alpha-particle based therapies.
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Chapter 5 Anti-Cancer Drug Studies
5.1 Introduction
5.1.1 Paclitaxel
Paclitaxel (trade name Taxol) (figure 5-1) belongs to a group of anti-cancer drugs
called taxanes. Taxanes have a unique way of preventing the growth of cancer cells: they
affect cell structures called microtubules, which play an important role in cell functions. In
normal cell growth. microtubules are formed when a cell starts dividing. Microtubules are
conveyer belts inside the cells. They move vesicles, granules, organelles like mitochondria,
and chromosomes via special attachment proteins. They also serve a cytoskeletal role.
Structurally, they are linear polymers of a globular protein called tubulin. Once the cell
stops dividing. the microtubules are broken down or destroyed. Paclitaxel was found to
stabilize microtubules and arrest the cells in the G2 and M phases of the cell cycle (1).
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Figure 5-1. The molecular structure of paclitaxel
In 1984, National Cancer Institute (NCI) began clinical trials that looked at
paclitaxel's safity and how well it worked to treat certain cancers. In 1989, researchers at
The Johns Hopkins Oncology Center reported that tumors shrank or disappeared in 30
percent of patients who received paclitaxel for the treatment of advanced ovarian cancer.
Although the responses to paclitaxel were not permanent (they lasted an average of 5
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months, some up to 9 months), it was clear that advanced ovarian cancer patients could
benefit from this treatment. In December 1992, the U.S. Food and Drug Administration
(FDA) approved the use of paclitaxel for ovarian cancer that was resistant to treatment.
Paclitaxel was later approved as an initial treatment for ovarian cancer in combination with
a platinum-based anticancer drug like cisplatin. In 1994, the FDA also approved paclitaxel
for the treatment of breast cancer that recurred within 6 months after adjuvant
chemotherapy (chemotherapy that is given after the primary treatment to enhance the
effectiveness of the primary treatment), or that spread (metastasized) to nearby lymph
nodes or other parts of the body. Paclitaxel is also used for other cancers, including AIDS-
related Kaposi's sarcoma and lung cancer. One study showed that paclitaxel can
significantly suppress both primary orthotopic murine prostate tumor (RM-1) growth (up
to 60%) and the formation of pseudometastatic tumor colony formation in the lungs (by up
to 46%) in C57BL/6 mice in vivo (2).
Paclitaxel is a compound that was originally isolated from the bark of the Pacific
yew tree (Taxus brevifolia). The natural source, the Pacific yew tree, is an environmentally
protected species, which is also one of the slowest growing trees in the world. Isolation of
the compound, which is contained in the bark, is a complicated and expensive process and
involves killing the tree. The quantities available by this method are pitifully small. It
would take six 100-year old trees to provide enough paclitaxel to treat just one patient.
As demand for paclitaxel grew, NCI, in collaboration with other Government
agencies and the pharmaceutical company Bristol-Myers Squibb, worked to increase the
availability and find other sources of paclitaxel besides the bark of the Pacific yew tree.
This work led to the production of a semi-synthetic form of paclitaxel derived from the
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needles and twigs of the Himalayan yew tree (Taxus bacatta), which is a renewable
resource. The FDA approved the semi-synthetic form of paclitaxel in the spring of 1995.
This form of paclitaxel has now replaced the drug derived from the bark of the Pacific yew
tree.
The radiosensitizing properties of paclitaxel were discovered more than 10 years
ago; it synchronized tumor cells in G2/M phase, the most radiosensitive portion of the cell
cycle. Other radiosensitizing mechanisms of paclitaxel have been also discussed, such as
reoxygenation. promotion of radio-apoptosis and antiangiogenic cooperation. Many phase
I and II studies have been performed, essentially in bronchus and head and neck
carcinomas. Many studies combined cisplatin or carboplatin with paclitaxel, demonstrating
that this combination is feasible and efticient (3). In vitro, paclitaxel was reported to be a
potent radiosensitizer in several ovarian cancer cell lines (BG-1, SKOV-3, and OVCAR-3)
(4, 5), a human grade 3 astrocytoma cell line, G18 (6), and a human laryngeal squamous
carcinoma cell line Hep-2 (7).
Paclitaxel is a radiosensitizer for some but not all human tumor cell lines. The
effect of paclitaxel at concentrations ranging from 0 to 10000 nM on the radiation
sensitivity of human breast (MCF-7), lung (A549), ovary (OVG-1), and pancreas (PC-Sh)
adenocarcinorna cells was determined using clonogenic assays. The radiosensitizing effect
was observed in MCF-7 and OVG-1 cells but not in A549 cells. PC-Sh cells demonstrated
a complex and inconsistent radiosensitization response to paclitaxel: radiosensitization was
observed at 10%o survival and no radiosensitization at 1% survival (8). Using micronucleus
formation as the endpoint, L5178Y, V79 and HeLa showed an additive effect of the single
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treatments (paclitaxel or radiation only). And the human breast cancer cell line MCF-7
showed lower than additive micronucleus frequencies (9).
The radiosensitizing effect of paclitaxel is both drug-dose and radiation-dose
dependent. Paclitaxel was reported to be able to reduce or enhance radiation cell killing, in
HeLa and SQ20B human tumor cells in vitro, depending on the drug concentration.
Reductions of radiosensitivity or antagonistic effects were observed at low drug
concentrations (0.9 nM for SQ20B and 1.6 nM for HeLa). At higher drug concentrations, a
drug dose-dependent, supra-additive radiation-drug interaction was observed (10). Similar
results were observed in two squamous cell carcinomas of the head and neck, SCC-9 and
HEP-2. In general there was slight synergism at low dose-low effect levels (e.g., at a
paclitaxel concentration of 0.002 lg/ml or lower combined with radiation doses of 0.1-0.3
Gy), moderate antagonism at intermediate dose ranges and strong synergism at high dose
ranges (e.g., at a paclitaxel concentration of 0.012-0.06 ptg/ml and radiation doses of 3-10
Gy) (11).
The combination of taxoid derivatives (paclitaxel and docetaxel) with irradiation
was evaluated in ovarian carcinoma cell lines (A2780 and CAVEOC-2) using a
multicellular tumor spheroid (MTS) three-dimensional model and compared to the
conventional monolayer model. In A2780 monolayer culture, the combination was
synergistic for paclitaxel and additive for docetaxel. In spheroids, both compounds induced
a decrease in RSV2 (the residual/control volume ratios at 2 Gy) and SCD50 (the dose
inducing 50% decrease in MTS number) in the two cell lines, and their combination with
radiation was additive (12).
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The combination of radiation and paclitaxel was investigated in human prostate
carcinoma lines in vitro, and in a Dunning rat prostate adenocarcinoma in vivo. Flow
cytometry showed an enhancement of radiation toxicity associated with paclitaxel-induced
cell cycle phase arrest at G2/M. Adverse side effects were minimal. The results implied
that combination of these agents may have clinical potential in prostate cancer treatment
(13).
5.1.2 Oxaliplatin
%p1 
'/
% 0 C NH3\p tC1
NH- 0-c NH3 \C1
Oxaliplatin Cisplatin
Figure 5-2. Chemical structures of oxaliplatin and cisplatin.
Oxaliplatin (common trade name: Eloxatin) is a third-generation platinum
compound containing a 1.2-diaminocyclohexane (DACH) moiety. which has a wide
spectrum of anticancer activity in in vitro systems and has displayed preclinical and
clinical activity in a wide variety of tumors (14, 15). Over the last 30 years. a large number
of platinum analogues have been synthesized to enlarge the spectrum of activity, overcome
cellular resistance, and/or reduce the toxicity of both first (e.g., cisplatin) and second
generation (e.gi., carboplatin) platinum drugs (16). Of these platinum analogues,
compounds containing a DACH carrier ligand, such as oxaliplatin (figure 5-2). have
consistently demonstrated anti-tumor activity in cell lines with acquired cisplatin resistance
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and appear to be active in tumor types that are intrinsically resistant to cisplatin and
carboplatin (7-19).
Like cisplatin, oxaliplatin reacts with DNA, forming primary lesions that block
DNA replication and transcription. Cisplatin and oxaliplatin induce a cell cycle block in
the G2/M phase (20) and generate DNA lesions such as interstrand DNA crosslinks (ISC)
and DNA-protein crosslinks (DPC) (21). Although the molecular mechanism(s) providing
the difference in resistance remain largely unknown, some in vitro studies underline the
importance of DNA repair. Oxaliplatin forms DACH-Pt DNA adducts with the same sites
at the nucleotide level and with the same regional interactions as cisplatin, and both drugs
show a preference for nuclear DNA over mitochondrial DNA. Compared with cisplatin,
oxaliplatin formed significantly fewer Pt-DNA adducts. The adducts formed by both drugs
are repaired with similar kinetics, but oxaliplatin is more efficient than cisplatin per equal
number of DNA adducts in inhibiting DNA chain elongation (22). The differences in the
structure of the adduct produced by cisplatin and oxaliplatin are consistent with the
observation that they are differentially recognized by the DNA mismatch repair system.
Studies have shown that the loss of DNA mismatch repair results in resistance to cisplatin
but not to oxaliplatin (23).
Oxaliplatin was found to be a good radiosensitizer in two head and neck cancer
cells lines, KB and Hep2, in vitro (24). Combined with low-LET radiation, oxaliplatin
showed additive-antagonistic effects for the p53 mutated human colon cancer cell line
(WiDr) but additive-synergistic effects for the p53 wild type human colon cancer cell line
(SW403) (25). Oxaliplatin has been used as radiosensitizer for rectal cancer (26, 27) and
esophageal cancer (28) in clinical trials.
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The to drugs were chosen in our pilot synergy studies due to their reported
radiosensitizing effects in human cancer cell lines.
5.2 Materials and Methods
5.2.1 Anti-cancer drugs on DU-145 cells
Taxol wvas obtained from Sigma (5 mg, product number: T-7191), freshly dissolved
in 1 ml I)MS() resulting in a stock concentration of 5 mg/ml. Oxaliplatin was obtained
from Sigma (5; mg, product number: 0-9512), freshly dissolved in 1 ml distilled water
resulting in a stock concentration of 5 mg/ml. The stock solutions were stored at -20 °C
and further diluted to required concentrations in the medium for the experiments.
In the drug only experiments, about 5 x 105 DU-145 cells were plated into the
Mylar dishes and allowed to attach overnight. Medium containing various concentrations
of Taxol or oxaliplatin was then used to replace the old medium in the Mylar dishes. The
cells were incubated with drugs for 24 hr before they were trypsinized and processed for
clonogenic assay, as described in the 3.2.3 section of Chapter 3. Data are shown as means
+ SD from two independent experiments.
5.2.2 Anti-cancer drugs plus alpha-particle irradiation
Both Taxol and oxaliplatin have been reported to show synergistic effects with low
LET radiation such as X-rays and gamma-rays (4-7, 13, 24-28). The study described here
represents the first investigation of combined effects of these two drugs with high LET
alpha-particle irradiation.
In the experiments, 5 x 105 DU-145 cells were plated into the Mylar dishes and
allowed to attach overnight. Medium containing various concentrations of Taxol (0.005,
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0.01 or 0.05 ,ug/ml) or oxaliplatin (0.5 or I jtg/ml) was then used to replace the old
medium in the Mylar dishes. The cells were incubated with drugs for 24 hr or for 96 hr.
The drug-containing medium was then replaced with fresh medium before the cells were
irradiated with graded doses of alpha particles at room temperature. Finally, the cells were
processed for clonogenic assay, as described in the 3.2.3 section of Chapter 3.
5.2.3 Anti-cancer drugs plus the bystander effect
A bystander effect was observed in the DU-145 cells in the co-culture system
described in Chapter 4. The objective of the study described here was to study the
combined effects of the two anti-cancer drugs with the bystander effect.
For the experiments, - 5 x 105 DU-145 cells were seeded in the Mylar dish and - 5
x 104 cells were seeded in the Snapwell insert (12 mm diameter; 1.13 cm2 growth area).
The cells were allowed to attach overnight. The cells in the insert were treated with Taxol
or oxaliplatin for 24 hr. On the day of the irradiation experiment, 6 ml of fresh medium
was added to each Mylar dish. The drug-containing medium in the insert was removed and
fresh medium was used to wash the insert once. Then the insert was detached from the
support rings with sterile tweezers and placed upside down in the medium above the cells
in the Mylar dish. The Mylar dish was then placed on the alpha-particle irradiator and the
bottom layer of cells was irradiated at room temperature for I min to deliver an alpha-
particle dose of 1.2 Gy. After the irradiation, the Mylar dish, together with the insert, was
put back into the incubator and co-incubated at 37 °C for 2 hrs (or for 24 hrs in some
cases). After the co-incubation, the insert was taken out of the Mylar dishes and the cells
in the insert were collected by trypsinization and processed for the micronucleus assay as
described in Chapter 3.
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5.2.4 Flow cytometry cell cycle study
Flow cytometry was used to study the effect of Taxol treatment on the cell cycle
distribution of the DU-145 cells. The fluorescence activated cell sorter (FACS) available in
the MIT Flow Cytometry Core Facility of the Center for Cancer Research was used for
these studies. The following is the experimental procedure:
1. About I x 107 DU-145 cells were seeded in each T-75 flask for each treatment and
control. The cells were allowed to attach overnight.
2. Fresh medium containing various concentrations of Taxol or oxaliplatin was used to
replace the old medium, and the cells were incubated in the drug-containing medium
for 24 hr.
3. Harvest the cells by trypsinization and transfer them to a 15 ml conical tube. Check
for single-cell suspension. Centrifuge at 1000 rpm for five minutes and remove the
supernatant.
4. Wash the cells twice in PBS without calcium or magnesium. At the last wash, count
the total number of cells, and record the number on the tube.
5. Resuspend the pellet in approximately 500 Ll of ice-cold PBS. Pipet up and down for
about 20 times. It is important to make a good single-cell suspension at this point, or
the cells will be fixed as clumps.
6. Add 5 ml of cold (-20 ° C) 75% ethanol, drop by drop, while vortexing at speed 7 to
prevent clumping. Fix the cells at 40 C at least overnight.
7. 'Take 5 x 106 cells into a new 15 ml conical tube. Centrifuge at 1000 rpm and remove
the ethanol.
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8. Vortex pellet. Wash twice in 5 ml of PBS + 1% BSA (Albumin Bovine Serum) or
calf serum. (Ethanol-fixed cells are difficult to pellet. Adding BSA or serum to the
wash medium will overcome this.)
9. Resuspend the pelleted cells in 800 tl of PBS containing 1% BSA or 1% calf serum.
10. Add 100 tpl of 10 x propidium iodide (PI) solution (500 tpg/ml PI in 3.8 x 10-2 M
sodium citrate, pH 7.0).
11. Add 100 pil of boiled RNase A (10 mg/ml prepared in 10 mM Tris-HCI, pH 7.5) and
incubate at 370 C for 30 minutes. (If the samples will not be used immediately, they
should be protected from light and stored at 4 °C.)
12. The cell samples wrapped in aluminum foil were carried in a foam box filled with ice
to the MIT Flow Cytometry Core Facility to be analyzed on the flow cytometer.
5.3 Results
5.3.1 Anti-cancer drugs on DU-145 cells
Figure 5-3 shows the cell survival curve after the treatment with various
concentrations of Taxol for 24 hr. Figure 5-4 shows the cell survival curve after the
treatment with various concentrations of oxaliplation for 24 hr.
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Figure 5-3. The survival curve of DU-145 cells after 24 hr treatment with various
concentrations of Taxol. The data points represent the means ± standard deviation of five
replicate dishes in each experiment from two independent experiments.
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Figure 5-4. The survival curve of DU-145 cells after 24 hr treatment with various
concentrations of oxaliplatin. The data points represent the means ± standard deviation of
five replicate dishes in each experiment from two independent experiments.
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5.3.2 Anti-cancer drugs plus alpha-particle irradiation
5.3.2.1 Cell survival results
Figure 5-5, Figure 5-6, Figure 5-7 show the DU-145 survival curves for alpha-
particle irradiation combined with different concentration of Taxol or Oxaliplatin pre-
treatment for 24 hr. The surviving fractions on the y-axis are on log-scale. All survival
curves were normalized for plating efficiency (-46%) in absence of drug.
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Figure 5-5. The DU-145 cell survival curves for alpha-particle irradiation only, alpha-
particle irradiation following 0.005 tg/ml Taxol treatment for 24 hr and alpha-particle
irradiation following 0.5 g/ml oxaliplatin treatment for 24 hr. The data points represent
the means ± standard deviation of five replicate dishes in each experiment from a total of
five independent alpha-only experiments, two -0.005[tg/ml Taxol plus alpha" experiments
and two "0.5 1tg/ml oxaliplatin plus alpha" experiments.
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Figure 5-6. The DU-145 cell survival curves for alpha-particle irradiation only, alpha-
particle irradiation following 0.01 jlg/ml Taxol treatment for 24 hr and 0.05 pg/ml Taxol
treatment for 24 hr. The data points for Taxol plus alpha" represent the means ± standard
deviation of five replicate dishes in one experiment.
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Figure 5-7. The DU-145 cell survival curves for alpha-particle irradiation only and alpha-
particle irradiation following 1 g/ml Oxaliplatin treatment for 24 hr. The data points
represent the means ± standard deviation of five replicate dishes in one experiment.
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5.3.2.2 Quantitative analysis
The combination index (CI) equation of Chou-Talalay (29) is used for the
quantitative analysis of the combined effects.
Simply speaking, the combination index (CI) was calculated by the Chou-Talalay
equation, which takes into account both the potency and the shape of the dose-effect curve.
The general equation for the classic isobologram is given by:
CI = D,(Dr)I (D) 2
where (Dx), is the concentration of the drug only that gives x% inhibition and (Dx)2 is the
alpha-particle irradiation dose only thats give x% inhibition, whereas Dl and D2 in the
numerators are the concentration of drug and dose of radiation in combination that also
inhibit x% (i.e. isoeffective). CI < 1, CI = 1 and CI > I indicate synergism, additive effect
and antagonism, respectively (30).
A simple graphical method called isobologram can be used to tell whether a
combination dose is additive, superadditive (synergistic) or subadditive (antagonistic).
Specifically, a particular effect level is selected, such as 50% of the maximum, and doses of
drug A and drug B (each alone) that give this effect are plotted as axial points in a
Cartesian plot (figure 5-8) (the doses are denoted by italicized letters that correspond to the
respective drugs). The straight line connecting A and B is the locus of points (dose pairs)
that will produce this effect in a simply additive combination. This line of additivity allows
a comparison with the actual dose pair that produces this effect level experimentally. An
actual dose pair such as point Q attains this effect with lesser quantities and is
superadditive (synergistic), while the dose pair denoted by point R means greater quantities
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are required and is therefore subadditive. A point such as P that appears below the line
would probably be simply additive (3 1).
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Figure 5-8. Illustrative isobologram for drug A and drug B. When the dose-response data
for both drugs could be fitted by linear regressions, the diagonal line represents dose pairs
producing additive effects; when non-linear curve fitting is desired or actually required for
the dose-response data for one drug and both drugs, the area defined by the two fine curves
near the diagonal represents additive effects. The shape of the additive area is decided by
the dose response curves of the two drugs (31).
Choosing 50% survival as the particular effect level, table 5-1 gives all the single
dose points and the paired dose points to achieve 50% SF.
50% surviving fraction
alpha alpha
0.2 0 0.095 0.2 0 0.135
(Gy) (Gy)
TaxolOaliplatin
0 0.01 0.005 0 0.86 0.5(lgi ml) ( g/ml)
Table 5-1. the dose information for 50% surviving fraction.
The isobologram at 50% SF for Taxol plus alpha-particle irradiation is shown in
Figure 5-9 and the isobologram at 50% SF for oxaliplatin plus alpha-particle irradiation is
shown in figure 5-10.
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Figure 5-9. 50% SF isobologram for 24 hr Taxol treatment and alpha-particle irradiation.
The 0.2 Gy alpha-particle dose on the y-axis and the 0.01 ug/ml Taxol concentration on the
x-axis define the additivity line; the 0.005 ug/ml Taxol plus 0.095 Gy alpha-particle dose
define the actual dose pair point (empty dot). The dose pair point falls right on the line,
suggesting an additive effect.
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Figure 5-10. 50% SF isobologram for 24 hr Oxaliplatin treatment and alpha-particle
irradiation. The 0.2 Gy alpha-particle dose on the y-axis and the 0.86 ug/ml Oxaliplatin
concentration on the x-axis define the additivity line; the 0.5 ug/ml Oxaliplatin plus 0.135
Gy alpha-particle dose define the actual dose pair point (empty dot). The dose pair point
falls above the line, suggesting a subadditive effect or probably just additive effect, as
explained by Figure 5-8.
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Using the classic isobologram equation described before. the CIs could be
calculated as following:
For alpha + Taxol:
6a >, (D (D), 0.095 0.005CI= + - + - = 0.975(D) I ,(D,), 0.2 0.01
For alpha + oxaliplatin:
X7 (D), + (D), 0.135 0.5C -= +-- -- - =1.26
(D), (D ), 0.2 0.86
5.3.3 Anti-cancer drug plus the bystander effect
5.3.3.1 Micronucleus assay results
Treatment of DU-145 cells with 0.5 VLg/ml oxaliplatin for 24 hr followed by the
bystander treatment produced a very low number of bi-nucleated cells using the
micronucleus assay. The reason for this is due to the interference between the drug
oxaliplatin and cytochalasin-B. Treatment of DIJ-145 cells with 0.5 jtg/ml oxaliplatin for
24 hr only produced a modest toxicity in clonogenic assay (see figure 5-4). This drug
concentration as chosen for the combinational studies. But the mechanism of this
interference needs further study. As a result, the following studies have focused on Taxol
treatment plus the bystander effect.
Figure 5-11 shows the MN/BN results for Taxol plus the bystander effect. Two
different concentrations of Taxol were used: 0.005 jpg/ml and 0.01 ltg/ml. Mathematical
analysis of the results is presented below.
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Figure 5-1 1. The horizontal histogram of MN/BN ratio for the combined effects of Taxol
plus the bystander effect. Data are shown as means + SD. The control produced 10.0 ± 1.0
% MN/BN; the bystander effect at 1.2 Gy direct dose produced 14.5 1.0 % MN/BN;
0.005 ptg/ml Taxol alone treatment for 24 hr produced 20.0 ± 0.6 % MN/BN; 0.005 pg/ml
Taxol treatment plus the bystander effect produced 24.3 ± 1.1 % MN/BN; 0.01 [ig/ml
Taxol alone treatment for 24 hr produced 36.7 + 1.0 % MN/BN; 0.01 pg/ml Taxol
treatment plus the bystander effect produced 44.3 I 1.7 % MN/BN. The right parts of the
bars for the Bystander" and 'Taxol+Bystander" are the schematic increments from
corresponding baselines (control or drug only). The numbers to the right of the bars
represent the numerical values of the incremental means. The "n" within the bars indicates
number of independent samples analyzed.
5.3.3.2 Cell cycle distribution
Figure 5-12 shows the cell cycle distribution results from the flow cytometer, for
control, 0.005 g/ml and 0.01 pg/ml Taxol treatments for 24 hr.
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Figure 5-12. The cell cycle distributions of DIJ-145 cells for control (top left), 0.005 ptg/ml
Taxol treatment for 24 hr (top right) and 0.01 [pg/ml Taxol treatment for 24 hr (bottom).
The left peak is GO/GI phase; the right peak is G2/M phase; the lower area with oblique
lines between the two peaks is S phase; the solid lower area on the left and underneath the
left peak is sub-GI phase and indicates apoptosis. 0.005 plg/ml Taxol treatment for 24 hr
did not change the cell cycle distribution significantly from the control, except that a small
amount of apoptotic cells were present as the sub-GI phase; 0.01 g/ml Taxol treatment
for 24 hr significantly shifted the cells from GO/Gi phase to G2/M phase and increased
apoptosis in sub-GI phase was observed.
5.3.3.3 Quantitative analysis
A simple quantitative analysis using an online statistical calculator provided by
GraphPad Software, Inc., is given below under the assumptions that all variables follow a
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Gaussian distribution and that the measurements of two groups are not paired or matched
to each other. This analysis intends to provide quantitative data for the schematic
increments in Figure 5-11 and compare them. A comprehensive analysis of the combined
effects of the bystander effect and Taxol requires more experimental data and appropriate
statistical tools and methods, which is part of the future work described in Chapter 6.
* The control group produced 10.0 + 1.0 % MN/BN; the bystander group produced
14.5 ± 1.0 % MN/BN. The difference between the two groups is:
Mean(l 2)= Meanl - Mean2 = 14.5% - 10.0% = 4.5%
(SD,=  (SD) 2= (1.0%)2 +(1.0%) 2= 1.414%
So the net increment is: N1 = 4.5 ± 1.41 %
* The 0.005 g/ml Taxol group produced 20.0 ± 0.6 % MN/BN; the 0.005 g/ml
Taxol plus bystander group produced 24.3 ± 1.1 % MN/BN. The difference
between the two groups is:
Mean( 1-2) = Meant - Mean2 = 24.3% - 20.0% = 4.3%
SD(I-2) /(SD )2 + (SD2) =(1.1%)2 +(0.6%)2 = 1.253%
So the net increment is N2 = 4.3 - 1.25 %
* The 0.01 Itg/ml Taxol group produced 36.7 + 1.0 % MN/BN; the 0.01 pg/ml Taxol
plus bystander group produced 44.3 ± 1.7 % MN/BN. The difference between the
two groups is:
Mean(i 2)= Meanl - Mean2 = 44.3% - 36.7% = 7.6%
SD(I-2) = (SDI (SD2 ) = (1.7%) 2 + (1.0%)2 = 1.972%
So the net increment is N3 = 7.6 ± 1.97 %
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By inputting the mean, the SD and the number of independent samples (n) of each
N, the statistical differences between N1 and N2, N1 and N3 were obtained using an
unpaired t-test (GraphPad Software, Inc.). Each N represents the difference between two
groups of experiments with different n values (number of independent samples). So which
"n" should be used as the input of unpaired t-test for comparison? In theory, the smaller
n" should give a stricter comparison, that is to say. n=15 for N1, n=9 for N2 and n=5 for
N3. In the following analysis, an alternative n value is used just to see the difference in the
results:
· N2 (n=9) vs. NI (n=15): The two-tailed P value equals 0.7301
By conventional criteria, this difference is not statistically significant.
* N2 (n=10) vs. N1 (n=16): The two-tailed P value equals 0.7176
By conventional criteria, this difference is not statistically significant.
* N3 (n=5) vs N1 (n=15): The twvo-tailed P value equals 0.0011
By conventional criteria, this difference is very statistically significant.
* N3 (n=6) vs Ni (n=15): The two-tailed P value equals 0.0007
By conventional criteria, this difference is extremely statistically significant.
* N3 (n=7) vs NI (n=15): The two-tailed P value equals 0.0004
By conventional criteria, this difference is extremely statistically significant.
The quantitative analysis indicates that N2 is not statistically different from N1, N3
is significantly different from N 1.
5.4 Discussion
In this Chapter, the effects of Taxol and oxaliplatin on the DU-145 cells were first
studied. Then the combined effects of the two drugs with high-LET alpha-particle
irradiation were studied. Finally the combined effects of Taxol with the bystander effect
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described in chapter 4 were studied. Those experiments were intended as pilot studies to
apply the established model system in new applications. The results were preliminary.
Taxol and oxaliplatin were reported to show radiosensitizing effects in several
human cancer cell lines in vitro as well some cancers in clinical trials. They include human
ovarian cancer cell lines (BG-1, SKOV-3. and OVCAR-3) (4, 5), a human grade 3
astrocytoma cell line, G18 (6), a human laryngeal squamous carcinoma cell line Hep-2 (7)
and a human prostate carcinoma line (13) for Taxol; two head and neck cancer cells lines
KB and Hep2 (24), a p53 wild type human colon cancer cell line (SW403) (25), rectal
cancer (26, 27) and esophageal cancer (28) in clinical trials for oxaliplatin. The effects
were dependent on both drug concentration and radiation dose. Although with different
functional mechanisms, the radiosensitizer properties of both drugs are believed to be
related to their abilities to arrest cells in the G2/M phase, which is believed to be the
radiosensitive phase of cell cycle (3) (20). Our preliminary data (the survival curves) of the
combined effects of the two drugs and the high-LET alpha-particle irradiation on the
human prostate tumor cell line DU-145 qualitatively suggested additive to slightly
antagonistic effects at various Taxol concentrations (0.005gg/ml, 0.01[tg/ml and
0.05[tg/ml) and oxaliplatin concentrations (0.5 gtg/ml and 1.0 1tg/ml) for 24 hr treatment
(figure 5-5, 5-6, 5-7). The qualitative analysis was based on the shapes of the survival
curves. The quantitative analysis using the isobologram at 50% SF and the combination
index (Cl) equation of Chou-Talalay indicated an additive effect between 0.005 [tg/ml
Taxol and the alpha-particle irradiation, and an antagonistic effect between 0.5 [tg/ml
oxaliplatin and the alpha-particle irradiation. Since looking for a synergistic situation was
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the aim, when an additive or sub-additive effect was observed in a certain case, no more
experiments were conducted.
In theory, the radiosensitizing effects of Taxol and oxaliplatin combined with low-
LET radiation may not hold true for the high-LET alpha-particle irradiation. As discussed
before, the synergism comes from the two drugs' abilities to arrest the cells in the G2/M
phase (3) (20). which is believed to be the radiation sensitive phase of the cell cycle (32-
34). This is generally true for low-LET radiations such as X-rays, where the
radiosensitivity comes from inefficiency of DNA damage repair in the G2/M phase
compared to GI and S phases (more DNA content; less checkpoints before mitosis).
Because DNA double strand breaks (DSBs) produced by high-LET radiations are more
difficult to repair than single strand breaks (SSBs) produced by low-LET radiations, the
radiosensitizer effects of the two drugs as a result of G2/M arrest may not work as well for
high-LET alpha-particle irradiation.
The micronucleus induction results of the combined effects of Taxol and the
bystander effect showed that the increment between "control" group and "bystander"
group N1 is not statistically different from the increment between "-0.005 g/ml Taxol"
group and 0.005 Taxol + bystander" group N2; Ni is statistically different from N3, the
increment between 0.0l lg/ml Taxol" group and 0.01 Taxol + bystander" group. Flow
cytometric analysis of the cell cycle indicated that 0.01 g/ml Taxol treatment for 24 hr
induced G2/M arrest and some apoptosis seen as cells with the sub-G 1 DNA content, while
0.005 jtg/ml Taxol treatment for 24 hr did not change the cell cycle distribution from the
control. No conclusion is drawn on the combined effects of Taxol and the bystander effect
at this point.
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Chapter 6 Future Work
A bench-top alpha-particle irradiator was constructed and calibrated as described in
Chapter 1. The small size and easy operation of the alpha-particle irradiator make it very
convenient and flexible to use. The established alpha-particle irradiator can be used as a
high-LET irradiation source in future work such as combinational studies between low-
LET X-ray and high-LET alpha-particle irradiations, in which the irradiator could be
placed inside the X-ray machine so that the cells in the Mylar dish are subject to both types
of irradiations. There are five alpha foils with nominal activities ranging from 0.01 Ci/cm2
to 100 Ci/cm2 . They can be used in applications ranging from low activity to high activity.
A bystander effect was observed in the co-culture system described in Chapter 4.
The DMSO, PTIO and medium transfer studies suggested some properties of the bystander
signal (involvement of a radical species other than nitric oxide; an effective life-time of
less than I minute, etc.). More experiments are planed to investigate the mechanisms of the
bystander effect. The experimental co-culture system can be improved by designing and
making some insert-holders to fix the position of the insert inside the Mylar dish. By
changing the distance between the two layers of cells, the effective migration distance of
the bystander signal can be studied. In the described bystander studies, the bottom layer of
cells was irradiated at room temperature. By placing the alpha-particle irradiator in a
refrigerator or an incubator, the experiment can be carried out at different temperatures (4
°C or 37 C) to study the chemical/biological properties and thermal stability of the
bystander signal. If the effect is based on an enzyme activity, no effect will be observed at
4 OC.
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Other than the micronucleus formation endpoint used in this study, other endpoints
like cell clonogenic survivals, p21Wafl induction, apoptosis and y-H2AX foci formation can
be used to study the co-cultured cells. Furthermore, DNA microarrays can be used to study
the genetic information of the co-cultured cells. The bystander effect studied here is for the
DU- 145 human prostate tumor cell line with alpha-particle irradiation. It will be interesting
to see whether the same cell line will produce and respond to a bystander effect with low-
LET x-rays. In addition to DU-145, other mammalian cell lines, (tumor cell lines or normal
tissue cell lines) can also be studied in the same experimental system for bystander effect
detection.
The drug experiments in this project were intended as pilot studies. A complete
combinational study between the alpha-particle irradiation and the anti-cancer drugs should
include a range of radiation doses and drug concentrations in multiple independent
experiments. Commercially available software CalcuSyn (Biosoft, Ferguson, MO) could be
used to analyze the experimental data. The program provides a measure of whether the
combined agents act in an additive, synergistic, or antagonistic manner.
The study of the combinational effects between the anti-cancer drugs and the
bystander effect is a brand new topic in the field. The experimental data for the
combinational studies between the bystander effect and 24 hr Taxol treatment described in
Chapter 5 suggested an additive effect at a Taxol concentration of 0.005 tg/ml and a
synergistic effect at a Taxol concentration of 0.01 pig/ml. Flow cytometry studies on cell
cycle distribution indicated a G2/M arrest after 24 hr treatment with 0.01 g/ml Taxol but
no cell cycle change after 24 hr treatment with 0.005[tg/ml Taxol. Those results suggested
a correlation between the G2/M phase of the cell cycle and the sensitivity of the bystander
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effect. Different Taxol concentrations and different Taxol treatment times other than 24 hr,
together with cell cycle distribution, could be further studied to develop a clearer picture of
interactions as well as the relationship between cell cycle and the bystander effect. The
combinational study between the bystander effect and 24 hr oxaliplatin treatment did not
produce an analyzable result. A different endpoint such as apoptosis can be used for the
evaluation to avoid the involvement of cytochalasin-B.
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